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Abstract 
Alzheimer´s disease (AD) is a neurodegenerative disorder with aging as most significant risk factor. AD is 
the most common form of dementia, being responsible for 60 to 80% of the cases. The number of 
diagnosed patients per year is growing rapidly and intense research focuses on the development of 
effective therapeutics as well as on ways to prevent the disease. While it is well known that 
accumulation of the neurotoxic amyloid β (Aβ) peptide, a cleavage product of the amyloid precursor 
protein (APP), is the key event of the disease, the physiological role of the APP protein family is still not 
fully understood. To develop potential therapeutic approaches it is essential to elucidate the 
physiological role of the APP protein family and their secreted peptides. It is necessary to understand 
how APP/APLPs modulate synaptic function as also a shift in the balance between APPsα and APPsß 
ectodomains might cause AD.  
Investigation of gene targeted mice allowed me to examine the physiological function of APP family 
proteins and their cleavage fragments in synaptic transmission and activity-dependent synaptic plasticity 
in the hippocampus, the highly plastic brain region severely affected within AD. I could show that the so 
far less attended APP homolog APLP1 has an age-dependent role in supporting basal synaptic 
transmission at the hippocampal CA3-CA1 synapse. Moreover, the generation of a conditional APP triple 
knockout mouse model allowed me to study synaptic plasticity in surviving adult mice and revealed an 
important role for all three family members during brain development. Besides investigating the APP 
proteins in full-length, the role of their functional domains was addressed. My studies indicated that the 
Fe65 protein family is an important downstream actor of APP as the link between the adapter family and 
APP is essential to modulate synaptic function by intracellular signaling. The detailed analysis of the α-
secretase cleavage product of APP, APPsα, supported the reports of its neurotrophic properties. I could 
show that the stable, viral driven expression of APPsα in APP/APLP2 deficient mice as well as in a mouse 
model of AD restored LTP deficits presumably by acting at presynaptic terminals. In contrast, the 16 
amino acid shorter APP fragment APPsβ seems not to be involved in processes of synaptic plasticity. The 
analysis of dendritic spine density revealed a pivotal role for APPsα ameliorating spine density in AD mice 
and APP/APLP2 deficient cultures, while APPsβ was again ineffective. Elucidating the role of the 16 
amino acids differentiating APPsα and APPsß, revealed that it is the domain carrying the functional 
neuroprotective properties of APPsα. Pharmacological experiments performed to provide a potential 
targeted receptor further yielded that the α7-nAChR receptor might be involved in synaptic signaling.  
The key messenger in processes of activity-dependent synaptic plasticity is calcium (Ca2+) and several 
studies indicate that the Ca2+ homeostasis is severely affected in AD patients. Investigation of Ca2+ 
dynamics in primary hippocampal cultures of APP/APLP2 deficient mice underscored a deficit in chemical 
LTP induction and Ca2+ homeostasis, which was rescued by the viral transduction of cultures with APPsα. 
Moreover, I observed a dysregulation of endomplasmatic reticulum Ca2+ handling and store-operated 
Ca2+ channel (SOCC) activity in APP/APLP2 deficient cultures consistent to results found in the literature 
for AD mice, emphasizing that APP family members are important regulators of Ca2+ dynamics in the 
brain. Moreover, these results highlight the neurotrophic role of APPsα and strengthen its potential as 
therapeutic agent for AD. 
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Zusammenfassung 
Die Alzheimerkrankheit (AK) ist eine neurodegenerative Erkrankung bei der das Alter einen der höchsten 
Risikofaktoren bildet. Die AK ist mit 60 bis 80% der Demenzerkrankungen die häufigste Demenzform. Die 
Zahl der diagnostizierten Patienten steigt pro Jahr stark an, sodass intensive Forschung darauf fokussiert 
ist, effektive Behandlungsmöglichkeiten zu entwickeln und ebenso versucht Wege zu finden, die 
Krankheit zu verhindern. Während das Schlüsselereignis, der ansteigende Gehalt des neurotoxischen 
amyloidogenen Aß-Peptides als Spaltproduktes des amyloidogenen Vorläuferproteins (APP) bekannt ist, 
bleibt die physiologische Rolle der APP-Proteinfamilie nur hinreichend geklärt. Um jedoch potenzielle 
Therapiemöglichkeiten zu entwickeln, ist es essentiell die physiologische Rolle der APP-Proteinfamilie 
und ihrer sekretorischen Peptide zu verstehen. Ebenso wichtig ist es die Bedeutung von APP/APLPs 
hinsichtlich der Funktion von Synapsen zu klären, da auch ein Ungleichgewicht in deren Ektodomänen 
APPsα und APPsß die AK verursachen kann.  
Die Untersuchung von transgenen Mäusen ermöglichte es die physiologische Funktion der APP-Protein-
familie sowie ihrer Spaltprodukte im Hinblick auf synaptische Transmission und aktivitätsabhängige 
Plastizität im Hippokampus zu erforschen, der plastischen Hirnregion, die in der AK stark betroffen ist. 
Ich konnte zeigen, dass das solang wenig betrachtete APP Homolog APLP1 eine altersabhängige Rolle 
einnimmt, die darin besteht die basale synaptische Transmission zwischen den hippokampalen CA3-CA1 
Synapsen zu unterstützen. Weiterhin ergab die Analyse eines adulten, lebensfähigen konditionalen 
Dreifach-Knockouts von APP hinsichtlich synaptischer Plastizität, dass alle drei Familienmitglieder eine 
wichtige Rolle in der Gehirnentwicklung einnehmen. Neben der Untersuchung der APP-Proteine in voller 
Länge, wurde die Rolle der funktionellen Domänen erforscht. Die Untersuchung ergab, dass die Fe65 
Proteinfamilie einen wichtigen Downstream-Akteur von APP bildet, da der Link zwischen der Adapter-
familie und APP essentiell für die Modulation der synaptischen Funktion über intrazelluläre Signalwege 
ist. Die detaillierte Analyse des α-Sekretase Spaltproduktes von APP, APPsα, spiegelte die 
Forschungsergebnisse zu seinen neurotrophen Eigenschaften wider. Die stabile, virus-vermittelte 
Expression von APPsα in APP/APLP2-defizienten Mäusen und in einem AK-Mausmodell behob 
vorhandene LTP-Defizite, mutmaßlich über die Aktivität an Präsynapsen. Im Gegensatz dazu zeigte sich, 
dass das 16 Aminosäuren (AS) kürzere APPsß-Peptid die Prozesse von synaptischer Plastizität nicht 
moduliert. Die morphologische Analyse der Spine-Dichte erwies, dass nur APPsα die Anzahl an Spines in 
AK-Mäusen sowie APP/APLP2-defizienten Kulturen verbessert, während APPsß keinen Einfluss hatte. Die 
Untersuchung der 16 AS, die APPsα und APPsβ differenzieren, ergab, dass sie die neuroprotektiven 
Eigenschaften von APPsα enthalten. Pharmakologische Experimente bezüglich eines Zielrezeptors 
zeigten, dass der α7-nAChR in der synaptischen Transmission beteiligt sein könnte.  
Das Schlüsselmolekül für Prozesse der synaptischen Plastizität ist Calcium (Ca2+) und Studien belegen, 
dass die Ca2+ Homöostase in der AK stark gestört ist. Untersuchungen bezüglich der Ca2+ Dynamik an 
primären hippokampalen Kulturen APP/APLP2-defizienter Mäuse ergaben Defizite in der Induktion der 
chemischen LTP sowie in der Ca2+ Homöostase, die jedoch durch die Transduktion der Zellen mit APPsα 
wiederhergestellt werden konnten. Weiterhin wurde eine Fehlregulation von Ca2+ im endoplasmatischen 
Retikulum und der store-operated Ca2+-Kanalaktivität in APP/APLP2-defizienten Kulturen beobachtet, wie 
sie in der Literatur für AK-Mäuse beschrieben ist. Dies hebt die Rolle der APP-Familienmitglieder als 
wichtige Regulatoren der Ca2+ Dynamik im Gehirn hervor. Weiterhin betonen diese Ergebnisse die 
neurotrophe Funktion von APPsα und stärken sein Potential als Medikament für die AK.  




“Today, someone in the country develops Alzheimer's disease every 66 seconds. By 2050, one new case of 
Alzheimer's is expected to develop every 33 seconds, resulting in nearly 1 million new cases per year.” 
(Alzheimer's, 2016) 
 
“Alzheimer's disease: the silver tsunami of the 21st century” (Sarkar et al., 2016) 
 
These are only two examples out of many headlines or facts, one is reading more and more often in the 
news. It is projected that by the year 2050 more than 100 million people across the world will be battling 
with Alzheimer´s disease - a quite exploding development. In the last eleven years, the number of adults 
suffering from the disease increased from almost 26 million to more than 36 million (Figure 1.1A). And 
even more alarming is the expected increase within the next 33 years to more than 100 million 
(Alzheimer's, 2016). The rise in patients is restricted to a so called aging population as the National 
Institute of Health diagnosed patients after the age of 65 with women having a higher estimated risk to 
develop Alzheimer´s than men (Seshadri et al., 2006)(Figure 1.1B).      
 
 
Figure 1.1: (A) Worldwide projections of Alzheimer´s prevalence. The numbers of cases in millions for the years 2005 to 2050 
are shown, differentiated by the stage of disease (early or late stage). (Adapted from Medicalexpress.com, Report by Carla 
Denly, January 6, 2016) (B) Estimated lifetime risk for Alzheimer´s disease by age and sex created from data of the Framingham 
study. (Adapted from Alzheimer´s, 2016) 
 
1.1 Alzheimer´s Disease 
In 1906 Alois Alzheimer documented the first case of Alzheimer´s disease (AD). His patient Auguste Deter 
displayed the typical symptoms of sporadic AD including disorientation, depression and progressive 
memory decline. AD is the most common cause of dementia and accounts for estimated 60 to 80 
percent of the cases. Patients suffering from this disease display difficulties in remembering recent 
conversations, events or names and often also show apathy and depression as early clinical symptoms. 
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Symptoms occurring at later stages include impaired communication, disorientation, confusion, poor 
judgement, behavioral changes and in the end difficulties in speaking, swallowing as well as walking 
(Alzheimer's, 2016). The pathological hallmarks of AD, seen and described already in 1907 by Alois 
Alzheimer, are the progressive extracellular accumulation of the amyloid-β (Aβ) protein fragment in so 
called amyloid plaques (or senile plaques) and the formation of intracellular neurofibrillary tangles 
(NFTs). NFT deposits are fibrillar aggregates of the microtubule associated binding protein tau which 
exhibits hyperphosporylation as well as oxidative modifications (Selkoe, 2002). Plaques and NFTs are 
mainly observed in brain regions that are involved in learning and memory processes as well as in 
emotional behaviors like the entorhinal cortex, the hippocampus, the basal forebrain and the amygdala. 
Within these brain regions, the number of synapses representing the contact sites between neurons is 
reduced and neurites in proximity to plaques are often damaged. This degeneration finally leads to 
shrinkage of affected brain areas with neurons exhibiting increased oxidative damage, impaired energy 
metabolism and altered calcium homeostasis (Mattson, 2004). Aβ plaques and NFTs built the major 
hallmarks of AD, while additionally genetic, molecular, epidemiological and immunological alterations 
are proposed to contribute to the disease (Heneka and O'Banion, 2007, Povova et al., 2012, Heneka et 
al., 2014). The greatest risk factors for sporadic AD are older age (Hebert et al., 2013), having several 
familiar AD cases (Fratiglioni et al., 1993, Lautenschlager et al., 1996) and being carrier of the APOE-e4 
gene (Farrer et al., 1997, El Haj et al., 2016). Currently two hypotheses exist that describe the origin of 
the disease. In the familial form of AD (FAD), mutations in presinilin-1 and 2 (PS1 and PS2) as well as 
mutations in the amyloid precursor protein (APP) cause the disease and lead to an increased production 
of Aβ or changes in the ratio of Aβ42 and Aβ40 (Selkoe and Hardy, 2016). In contrast to the inherited 
forms of AD, a failure in Aβ clearance mechanisms is the primary cause of non-dominant disease forms 
resulting in gradually rising Aβ levels in the brain. In both cases of the amyloid cascade hypothesis, the 
accumulation and oligomerization of Aβ42 is observed in limbic and association cortices and subtle 
effects of Aβ oligomers on synaptic efficacy are noticed. The following gradual deposition of Aβ42 
oligomers in diffuse plaques activates microglia and astrocytes, the supportive cells of the brain (Purves 
et al., 2001) and attendant inflammatory responses. Later stages of the cascade are characterized by 
alterations in neuronal ionic homeostasis and the appearance of oxidative injury. Moreover impairments 
in kinase and phosphatase activities lead to tangle formation within neurons. Overall these alterations 
result in a widespread neuronal and synaptic dysfunction accompanied by selective neuronal loss 
associated to neurotransmitter deficits (Selkoe and Hardy, 2016). Synaptic dysfunction is represented by 
impairments of synaptic plasticity as intact synaptic structure and function are fundamental for synaptic 
encoding forming stable memories (Mayford et al., 2012, Korte and Schmitz, 2016).   
 
1.2 Synaptic Plasticity 
It is by now widely believed and accepted that neurons in mammalian brain regions, relevant for learning 
and memory, are highly plastic. In this regard, plasticity means that activity patterns generated by 
sensory organs modulate neuronal function as well as their structure. Activity-dependent synaptic 
plasticity that alters the efficacy of synaptic transmission (functional plasticity) and modifies the 
structure and number of synaptic connections (structural plasticity) are essential for processes of 
learning and memory (Korte and Schmitz, 2016). Neuronal plasticity builds the foundation for learning 
and memory while additionally neuronal networks need to be adjusted. In 1949 already the psychologist 
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Donald Hebb postulated how neurons adapt to patterns of activity by forming engrams during learning 
and memory (Morris, 1999): 
 
“When an axon of cell A is near enough to excite a cell B and repeatedly or persistently takes part in firing 
it, some growth process or metabolic change takes place in one or both cells such that A’s efficiency, as 
one of the cells firing B, is increased ’’. 
 
“….any two cells or systems of cells that are repeatedly active at the same time will tend to become 
‘associated’, so that activity in one facilitates activity in the other ’’.          (Donald Hebb, 1949) 
 
In 1973 Timothy Bliss and Terje Lømo experimentally verified the Hebb´s postulate. They observed that 
high electrical frequency stimulation of the hippocampal perforant path projecting to granule cell 
synapses resulted in long-lasting strengthening of synaptic connections (Bliss and Lomo, 1973), a 
phenomenon nowadays termed long-term-potentiation (LTP, see chapter 1.2.1 and 1.2.2). LTP was first 
described in the hippocampus which is also today one of the most studied brain regions in mammals in 
regard to activity-dependent synaptic plasticity. 
 
1.2.1. The Hippocampus 
The hippocampus with its bulb-like shape, protruding into the lateral ventricles is an evolutionary old 
bilateral structure of the cerebral cortex (Andersen et al., 2006). It is essential for the formation of 
spatial, contextual and episodic memory and moreover for the recall of consolidated memory (O’Keefe 
and Nadel, 1978, Eichenbaum, 2004). The hippocampus integrates incoming sensory and spatial 
information from the entorhinal cortex into context-specific representations, so that short-term memory 
is transferred into long-term memory. Especially the formation of declarative memory, involving facts 
about ourselves and our surrounding world, is an essential feature of the hippocampus (Korte and 
Schmitz, 2016). This is furthermore supported by hippocampal lesion studies like the one of the well-
known case of the epileptic patient H.M. 60 years ago. The hippocampus of H.M. was bilaterally removed 
during a surgery resulting in a permanent anterograde and partial retrograde amnesia (Scoville and 
Milner, 1957). H.M. displayed an intact short-term and working memory and was able to retrieve very 
old memories, while the acquisition of new declarative memories was impossible. The fact that the 
hippocampus is further essential for spatial memory formation was also shown by Mumby and 
colleagues in 1999 using hippocampal lesioning of rodent hippocampi. Rats with hippocampal lesions 
that were trained in the Morris water-maze task were no longer able to form a spatial map to locate the 
platform as exit of the maze (Mumby et al., 1999). Both studies further indicate that the hippocampus is 
an attractive region to study neurological disorders like epilepsy or Alzheimer´s disease (AD), because 
pathological processes are observed within that brain area and novel therapeutics can be tested.  
The hippocampus has a unique and highly organized structure making it a suitable model for 
investigations in mammals. It is organized in a lamellar way and comprises the dentate gyrus (DG) and 
the ammon’s horn (CA, lat. cornu ammonis). Related cortical subregions are the entorhinal cortex (EC), 
the subicular complex, the pre- and parasubiculum forming together with the CA and the DG the 
hippocampal formation (HF). The ammon´s horn is further divided into three subdivisions: CA1, CA2 and 
CA3 with distinct neuronal populations of excitatory connected cells forming a trisynaptic circuit (see 
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Figure 1.2A, B). Information enters the hippocampus from the EC which itself is connected to various 
cortical areas. The EC projects unidirectional via the perforant path to the principal cells of the DG. The 
axons of DG granule cells give rise to axons called mossy fibers that connect DG granule cells with 
pyramidal neurons of the hippocampal CA3 area. The axons of pyramidal cells of CA3 in turn build the 
major input to CA1 neurons by the Schaffer collateral pathway. The CA1 neurons of the hippocampus 
project to the subiculum and moreover to the EC, while the subiculum itself projects to the pre- and 
parasubiculum, but predominantly to the EC. Thereby, CA1 and the subiculum close the hippocampal 
information processing loop starting in the superficial layers of the EC and ending into its deep layers 
(Andersen et al., 2006). The CA2 area, a very small region of the hippocampus, receives its input from DG 
neurons and innervates CA1 neurons (Kohara et al., 2014). Beside the 95% excitatory hippocampal 
neurons in all subregions also inhibitory cells exist, mediating feedback and feed-forward inhibition and 
thus shape the rhythm of activity. Interneurons are inter-connected and display oscillations with variable 
frequencies to ensure the synchronization of the hippocampal network (Buzsaki, 2002). 
The unique hippocampal architecture with axons projecting in-line with pyramidal neurons (see Figure 
1.2C) makes it a suitable model to investigate synaptic plasticity not only in vivo, but also in vitro as 
transversal slice preparations keep neuronal projections mostly intact (Korte and Schmitz, 2016). In this 
dissertation I recorded basal synaptic transmission as well as activity-dependent alterations between 
synapses of area CA3 and CA1 that were connected by the Schaffer collateral pathway in murine slice 
preparations.     
 
 
Figure 1.2: The hippocampal formation. (A) Section of a rabbit hippocampus stained with the original Golgi method (1886) 
showing the cell population in their different layers (Golgi et al., 2001). (B) Neurons in layer II of the entorhinal cortex (EC) 
project to the dentate gyrus (DG) and the CA3 field of the hippocampus via the perforant pathway. Neurons in layer III of EC 
innervate cells of the CA1 field of the hippocampus and the subiculum (Sub) via the perforant and alvear pathways. The granule 
cells of the DG project to the CA3 field of the hippocampus via mossy fiber projections. Pyramidal neurons in the CA3 field of the 
hippocampus project to CA1 via Schaffer collaterals. Pyramidal cells in CA1 innervate neurons of the subiculum. Both, CA1 and 
the subiculum project back to the deep layers of the EC. (C) Projections along the transverse axis of the hippocampal formation 
where the DG is located proximally and the EC distally (adapted from The Hippocampus Book). 
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1.2.2 Long-Term Potentiation and Long-Term Depression 
The fascinating capacity of the mammalian brain to be plastic allows it to modify synaptic strength 
among connected neurons upon activity patterns generated by experiences (Citri and Malenka, 2007, 
Abrahamsson et al., 2016) initially described by D. Hebb (1949). Activity either enhances or depresses 
synaptic transmission at excitatory synapses on timescales ranging from milliseconds to hours or even 
days. Distinct stimuli alter synaptic efficacy, thus high-frequency stimulation (200 ms to 5 s at 10 to 200 
HZ) results in an persistent increase in synaptic strength lasting for at least one hour called long-term 
potentiation (LTP) (Bliss and Lomo, 1973, Zucker and Regehr, 2002), while low-frequency stimulation 
produces synaptic weakening named long-term depression (LTD) (Ho et al., 2011, Luscher and Malenka, 
2012). The underlying mechanisms of LTP and LTD are not uniform as they depend on the circuit in which 
they occur. For example, LTP at mossy fiber-CA3 synapses is independent from the N-methyl-D-aspartate 
receptor (NMDA-R) while synapses of the perforant path-DG pathway or the Schaffer collateral-CA1 
pathway are NMDA-R dependent (Lynch, 2004, Luscher and Malenka, 2012, Volianskis et al., 2015). The 
most intensively studied and well described form is the NMDA-R-dependent LTP (and LTD) at CA3-CA1 
synapses in the hippocampus and in the focus of this thesis. 
The NMDA-R is a ligand-gated ion channel with glutamate as agonist and glycine as well as D-serine as 
co-agonists (Henneberger et al., 2013) being permeable for sodium (Na+) and calcium (Ca2+). Under 
resting membrane conditions NMDA-R function is prevented due to a magnesium block hindering the 
channel pore to open for Na+ and Ca2+ (see Figure 1.3A). Hence, basal synaptic transmission is mainly 
mediated by α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors (AMPA-R) allowing Na+ 
and potassium (K+) influx in response to glutamate binding (Citri and Malenka, 2007). Following 
postsynaptic depolarization the Mg2+ block is released from the NMDA-R and when simultaneously 
glutamate binds, the receptor gets permeable for Na+ and Ca2+ (Herron et al., 1986). Due to the 
characteristic that the NMDA-R is only conductive when pre- and postsynapse are active at the same 
time he functions as a coincidence detector. This defines moreover one of the three key properties of 
LTP (Bliss and Collingridge, 1993):  
1) Input specificity meaning that only activated synapses release glutamate at the presynaptic site and 
that only postsynapses that receive the neurotransmitter get stimulated and not adjacent inactive ones. 
2) Cooperativity confining LTP to a critical number of synapses that are coincidently active and  
3) Associativity representing the capacity to potentiate a weak input (a small number of synapses) when 
it is activated in association with a strong input (a larger number of synapses).  
The key characteristics of NMDA-R dependent LTP and LTD are to require active connections between 
synapses, the presynaptic terminals and postsynaptic dendritic spines. Spines are small membrane 
protrusions that consist of a bulbous head and a thinner neck connecting the spine to the dendritic shaft 
(Ho et al., 2011). Interestingly, the spine head size and spine volume correlate with synaptic strength 
(Kirov and Harris, 1999, Holtmaat and Svoboda, 2009), implying that spines with large heads contain 
more receptors for neurotransmitter and reflect a greater synaptic strength (see Figure 1.3B). As spines 
serve as single compartmentalized signaling units, they build the active postsynaptic part of the synapse 
changing in number and shape during synaptic plasticity (Engert and Bonhoeffer, 1999). While during 
LTP, AMPA-Rs are inserted into the membrane to support synaptic strengthening, they are internalized 
in processes of LTD (Figure 1.3B). Prolonged low frequency stimulation induces only a moderate increase 
in postsynaptic Ca2+ levels whereas contrary high frequency stimulation strongly increases the amount of 
Ca2+ in the postsynapse. Low Ca2+ levels result in the activation of phosphatases, e.g. calcineurin or 
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protein phosphatase PP1, which in turn increases the endocytosis of AMPA-R at extrasynaptic sites. 
Tetanic stimulation increases cytosolic Ca2+ levels in the postsynapse and leads to the activation of 
protein kinases, e.g. calcium/calmodulin-dependent kinase II (CaMKII), enhancing AMPA-R exocytosis 
and mediate the fusion of recycling endosomes by Rab11a as well as AMPA-R stabilization within the 
post-synaptic density (PSD) (Citri and Malenka, 2007, Korte and Schmitz, 2016) (Figure 1.3B).  
 
 
Figure 1.3: Cellular processes at resting membrane conditions and following synaptic plasticity. (A) Schematic synaptic 
transmission at excitatory synapses. Left: During basal synaptic transmission presynaptically released glutamate binds to AMPA-
Rs and NMDA-Rs, but results only in activation of AMPA-R mediating Na
+
 influx while the NMDA-R is blocked by Mg
2+
. Right: 
Depolarization of the postsynaptic cell released the Mg
2+




 to enter the spine. 
(B) Schematic AMPA-R trafficking during LTP and LTD. Top: Under resting membrane conditions, AMPA-R cycle between the 
postsynaptic membrane and intracellular compartments by lateral movement of receptors into endocytic zones. AMPA-R 
containing early endosomes were transferred to recycling endosomes and returned to the plasma membrane by exocytosis. 
They move again laterally into the synapse and are there retained. Bottom left: LTP induction leads to enhanced AMPA-R 
exocytosis. Inserted AMPA-R are stabilized at the synapse through a Ca
2+
-driven process involving the CamKII, while fusion of 
recycling endosomes is mediated by Rab11a. Bottom right: LTD induction results in enhanced AMPA-R endocytosis at 
extrasynaptic sites in a Ca
2+
-dependent process including the protein phosphatase PP1 or calcineurin. Endocytosed AMPA-Rs are 
retained within the cell or degraded. (C) Action potential driven pre- and postsynaptic signaling. The arrival of an action 
potential at the presynaptic terminal induces a Ca
2+
 influx via voltage-gated Ca
2+
 channels triggering the fusion of synaptic 
vesicles and the exocytosis of glutamate. The neurotransmitter binds and thus activates kainite receptors and AMPA-R at the 
postsynapse mediating the influx of Na
+
 into the cell. The initiated depolarization released the Mg
2+
 block from the NMDA-R 
allowing additional Ca
2+
 to enter the cell. Increase in cytosolic Ca
2+
 levels activates Ca
2+
-dependent enzymes like CamKII, protein-
kinase C (PKA) and adenyl cyclase facilitating AMPA-R trafficking by phosphorylation of specific receptor subunits (adapted from 
Korte and Schmitz, 2016).   
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At resting membrane conditions AMPA-Rs provide most of the inward currents generating an excitatory 
postsynaptic response (EPSP), while NMDA-Rs are strong voltage dependent and are blocked by Mg2+. 
When an action potential reaches the presynaptic terminal of a neuron, voltage-gated Ca2+ channels 
(VGCCs) are activated and allow the influx of Ca2+ (Figure 1.3C). This in turn triggers the fusion of synaptic 
vesicles filled with neurotransmitter with the presynaptic membrane and the exocytosis of glutamate (at 
excitatory synapses). Following diffusion of glutamate through the synaptic cleft it binds and thus 
activates in first instance kainite receptors and AMPA-Rs expressed on the postsynaptic membrane. The 
two channels allow Na+ to enter the cell which in turn depolarizes the postsynapse and results in the 
dissociation of the Mg2+ block from the NMDA-Rs allowing additional Ca2+ to enter the cell. The influx of 
Ca2+ via NMDA-Rs activates Ca2+-dependent enzymes like CamKII, protein-kinase C (PKA) and adenyl 
cyclase facilitating AMPA-R trafficking by phosphorylation of specific receptor subunits. There is strong 
evidence that the activation of CamKII is the key component to trigger the molecular machinery of LTP. 
Supportive for the essential role of CamKII is the prevention of LTP induction in knock-out mice lacking a 
critical CamKII subunit (Silva et al., 1992) or in knock-in mice in which the endogenous CamKII was 
replaced by a from that lacks the autophosphorylation site (Giese et al., 1998). Following LTP induction 
the CamKII gets autophosphorylated and initiates downstream signaling cascades including the synthesis 
of new proteins (Fukunaga et al., 1995, Barria et al., 1997). However, the early phase of LTP (E-LTP), 
lasting from one to three hours is independent of protein synthesis, while maintained LTP lasting longer 
than three hours is dependent on altered gene expression and referred to as late LTP (L-LTP) (Bliss and 
Collingridge, 1993, Kandel, 2001, Korte and Schmitz, 2016). Comparably to L-LTP also the long-lasting 
maintenance of LTD (L-LTD) is dependent on de novo protein synthesis (Manahan-Vaughan et al., 2000, 
Sajikumar et al., 2005). Furthermore, the expression of long-lasting LTP or LTD is dependent on the type 
of stimulation; so that only repetitive or tetanic stimulation of synapses with prolonged (~200 ms to 5 s) 
trains of stimulation applied at high frequencies induce long-lasting changes in synaptic efficacy. In 
contrast, short bursts of activity result in plasticity lasting only for several milliseconds to minutes and 
are called mechanism of short-term synaptic plasticity (Zucker and Regehr, 2002, Citri and Malenka, 
2007).  
1.2.3 Temporal Phases of LTP 
Excitatory synapses of the mammalian brain express different forms of synaptic plasticity that can be 
differentiated by their varying temporal phases. Short-term plasticity (STP) elicits changes in synaptic 
strength lasting from milliseconds to minutes and is believed to be important for short-term adaptations 
to sensory inputs as well as transient changes in behavior and for a short-lasting form of memory (Citri 
and Malenka, 2007). Following short burst of activity, Ca2+ accumulates transiently in the presynaptic 
terminal and causes changes in the probability of neurotransmitter release due to the modification of 
biochemical processes that mediate synaptic vesicle exocytosis (Zucker and Regehr, 2002). Thus, STP is a 
presynaptic phenomenon and can be investigated easily by applying two stimuli within a short interval. 
The response of the second stimulus to the first one can thereby either be enhanced (Paired-Pulse-
Facilitation, PPF) or depressed (Paired-Pulse-Depression, PPD) depending on the length of the inter-
stimulus interval delivered (ISI) (Katz and Miledi, 1968). At ISIs less than 20 ms PPD is observed caused by 
the inactivation of voltage-dependent Na+ or Ca2+ channels as well as by the transient depletion of the 
ready releasable pool (RRP) of synaptic vesicles at the presynaptic membrane. At ISIs longer than 20 ms 
and up to 500 ms PPF is detected due to residual Ca2+ left from the first action potential in the 
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presynaptic terminal increasing the release of synaptic vesicles to the second stimulus (Zucker and 
Regehr, 2002, Kaeser and Regehr, 2017). Similar to PPF, additional mechanisms might be involved in the 
facilitation like the activation of protein kinases modulating the activity of phophoproteins expressed in 
the presynapse (Citri and Malenka, 2007, Regehr, 2012). Importantly, the same synapse can display PPF 
or PPD depending on its recent history of activation and modulation. Synapses with a very high 
probability of neurotransmitter release will show a depression to the second stimulus applied, while 
synapses with a low probability of neurotransmitter release exhibit a facilitation in transmitter release to 
the second pulse (Dobrunz et al., 1997, Dobrunz and Stevens, 1997). PPF thereby defines a form of 
presynaptic Ca2+-dependent STP reflecting the probability of neurotransmitter release with reduced 
ratios representing an increased probability of vesicle release (Briggs et al., 2017). Moreover, the 
presynaptic vesicle release probability is inversely associated with the post-tetanic potentiation (PTP) 
magnitude and the paired pulse ratio (Zucker and Regehr, 2002, Brager et al., 2003). 
High frequent stimulation induces long-lasting forms of STP named augmentation which lasts five to ten 
seconds and PTP with a time course of several seconds to minutes (Citri and Malenka, 2007). 
Augmentation and PTP describe both an enhancement of neurotransmitter release and are caused by an 
increase in the probability of synaptic vesicle release in response to stimuli leading to a buildup of higher 
Ca2+ concentrations as well as biochemical alterations of proteins in the presynaptic terminal (Zengel and 
Magleby, 1982, Zucker and Regehr, 2002). PTP characterizes furthermore the initial induction phase of 
LTP that is followed by STP being the phase of LTP lasting for up to one hour. The time-course of early 
LTP (E-LTP) is detectable for less than a few hours, while the late component of LTP (L-LTP) lasts from 
several hours in vitro to up to weeks or months in vivo (Citri and Malenka, 2007, Reymann and Frey, 
2007). STP is an essential feature of synapses as it enables them to influence the information processing 
and thus STP can be seen to act as filter between synapses. Early and late LTP and LTD are seen as 
cellular correlates for learning and memory and to understand their mechanisms plays an important role 
with regard to neurodegenerative disorders like epilepsy, Parkinson’s and Alzheimer’s disease.    
1.2.4 Synaptic Plasticity in Alzheimer’s Disease  
It is by now commonly accepted that Alzheimer´s disease (AD) is caused by a synaptic failure. Indeed, it 
begins with subtle alterations in the efficacy of synaptic transmission (Selkoe, 2002). These alterations 
are not caused by the pathological hallmarks of the disease, Aβ plaques and neurofibrillary tangles (see 
chapter 1.1), but by the amyloid peptide Aβ that accumulates during the disease progression to form Aβ 
plaques (Selkoe, 2008, Parihar and Brewer, 2010). Aβ is a natural proteolytic product that is 
extracellularly released following sequential amyloidogenic cleavage of the amyloid precursor protein 
(APP, see chapter 1.3.1). Different Aβ peptides are generated upon the initial endopeptidase cleavage of 
APP due to multiple carboxypeptidase cleavages that each remove three to four C-terminal amino acids 
(Okochi et al., 2013, Fernandez et al., 2014). In this regard, Aβ42, Aβ43 and longer Aβ peptides were 
shown to be more hydrophobic and to highly self-aggregate (Kim et al., 2007). Aβ is found in the brain 
and the cerebrospinal fluid (CSF) of humans and animals (Haass et al., 1992). At picomolar 
concentrations and in its monomeric form, Aβ plays an important physiological role. Aβ was shown to 
modulate presynaptic vesicle release and therefore proven to be essential for processes of synaptic 
plasticity (Abramov et al., 2009, Wang et al., 2012) as LTP was enhanced upon exogenous Aβ42 
administration (Puzzo et al., 2008). Nevertheless, when Aβ42 reaches nanomolar concentrations 
neurotoxic effects are observable. Subneurotoxic concentrations of Aβ peptides (Aβ42, Aβ40 or Aβ25-
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35) exogenously applied on hippocampal slices inhibited LTP induction at the medial perforant path to 
DG cells and at the Schaffer collateral CA1 pathway without altering basal synaptic transmission (Chen et 
al., 2000, Chen et al., 2002, Zhao et al., 2004). Supporting results were gained in the in vivo study of 
Walsh and colleagues (2002), where injection of secreted Aβ into the hippocampal CA1 region prevented 
stable LTP induction. In that study it was further shown, that only soluble Aβ oligomers but not 
monomeric Aβ or Aβ fibrils cause the LTP deficit (Walsh et al., 2002). Furthermore Aβ42 alters the 
counterpart of LTP, LTD. An in vivo injection of Aβ42 was shown to facilitate LTD and reversal LTD in the 
CA1 region of the hippocampus (Kim et al., 2001). Aβ mediated alterations of synaptic plasticity occur at 
both sites of the synapse. It was shown that Aβ co-localizes with the postsynaptic density marker PSD95 
(Lacor et al., 2004) and augments NMDA-R currents in the DG of acute hippocampal slices without 
affecting AMPA-R currents (Wu et al., 1995). Moreover, synthetic Aβ42 peptides as well as naturally 
secreted Aβ from APP/PS1 transgenic mice (AD mouse model: mice express the human APP gene 
carrying the Swedish double mutation (K595N/M596L)) promoted the endocytosis of NMDA-R from the 
postsynaptic surface depressing the NMDA-R current in wildtype cortical neurons (Snyder et al., 2005). 
Also reduced expression of AMPA-R on the cell surface was noted in neurons that overexpress wildtype 
APP or the APP Swedish double mutation as well as in neurons where exogenously Aβ42 peptides were 
applied (Almeida et al., 2005, Hsieh et al., 2006). Aβ mediated alterations within the postsynapse suggest 
that it alters Ca2+-dependent signaling pathways that usually support synaptic plasticity like the 
exocytosis of AMPA-R or the phosphorylation of AMPA-R subunits which were affected in the presence 
of nanomalor Aβ (Hsieh et al., 2006, Minano-Molina et al., 2011). The amyloid peptide was moreover 
shown to influence presynaptic function as Aβ42 oligomers directly inhibited presynaptic P/Q type Ca2+ 
channels and decreased the synaptic vesicle release (Nimmrich et al., 2008). In vitro studies in which 
synthetic Aβ was applied on cultured hippocampal neurons revealed downregulation of dynamin, a 
protein that is essential for synaptic vesicle endocytosis and additional interrupted synaptic vesicle 
recycling (Kelly et al., 2005, Kelly and Ferreira, 2007). Kelly and colleagues further reported that 
decreased levels of dynamin depend on NMDA-R mediated Ca2+ influx and the activation of the 
intracellular cysteine protease calpain by Ca2+, supporting the presence of retrograde signaling from the 
post- to the presynapse (Kelly et al., 2005, Kelly and Ferreira, 2006). As Ca2+ is an essential mediator of 
basal synaptic transmission it is therefore not surprising that synaptic dysfunction and altered Ca2+ 
homeostasis are key pathologies of Alzheimer´s disease (Agostini and Fasolato, 2016). Besides Aβ, 
sequential cleavage of APP releases a variety of functional domains that might additionally contribute to 
the disease, possibly by their reduced generation or by modified gene expression (Nhan et al., 2015). The 
investigation of the physiological function of the APP family and its proteolytic products is still poorly 
understood and in the focus of this thesis. 
 
1.3 The Amyloid Precursor Protein Family    
The amyloid precursor protein (APP) is a type I integral membrane protein involved in the pathogenesis 
of Alzheimer´s disease (AD). The APP gene is localized on chromosome 21 in humans and its expression 
gives rise to three major isoforms: APP695, APP751 and APP770 that all have a molecular weight of 
around 170 kDa and are generated via alternative splicing (Robakis et al., 1987, Barthet et al., 2012). The 
APP695 isoform is primarily found in neurons, especially in excitatory neurons as well as in GABAergic 
interneurons, while the two longer APP versions are expressed in other tissues and cell types (Wang et 
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al., 2014, Hick et al., 2015, Nhan et al., 2015, Del Turco et al., 2016). The mammal APP is part of a larger 
gene family including two homologs, the amyloid precursor-like protein 1 and 2 (APLP1 and APLP2). The 
APP/APLPs share a common structure comprised of a large extracellular domain containing the 
conserved regions E1 and E2, while the cytoplasmic region is relatively short. Importantly, the AD 
associated Aβ domain, is expressed only in APP but not in its homologs. The complete X-ray structure of 
APP is not solved by now, but for some independently folded subdomains structural information is 
available. The E1 domain of APP695 is subdivided into the heparin-binding/growth factor-like domain 
(GFLD) and the so-called copper-binding domain (CuBD), while APP751 and APP770 moreover contain 
one or two differentially spliced exons encoding for the Kunitz-like protease inhibitor domain (KPI) and a 
short Ox-2 antigen domain (Rossjohn et al., 1999, Dahms et al., 2010). The second conserved region, the 
E2 domain, contains the RERMS motif which is implicated in trophic functions and moreover another 
heparin binding domain (Ninomiya et al., 1993, Roch et al., 1993). These individual domains enable the 
APP isoforms to interact with a variety of proteins or receptors like Alcadein (Araki et al., 2003), F-
spondin (Ho and Sudhof, 2004), Reelin (Hoe et al., 2009), LRP1 via the adapter Fe65 (Pietrzik et al., 2004), 
sorL1/LR11 (Schmidt et al., 2007), Nogo-66 receptor (Park et al., 2006) and Notch2 (Chen et al., 2006a). 
Additionally, the E1 domain was demonstrated to be crucial for the homo- and heterodimerization of 
APP family members (Soba et al., 2005). The APP structure and function is moreover modulated by 
posttranslational modifications like N- and O-glycosilation and sialyation (Dawkins and Small, 2014) 
which might further influence the proteins function. The expression of APP mRNA arises early in 
embryonic development (E7.5) and is found during adulthood dependent on the isoform throughout the 
body nervous system (brain, spinal cord, retina), immune system (thymus, spleen), muscle (smooth, 
cardiac, and skeletal), kidney, lung, pancreas, prostate gland, and thyroid gland (Wasco et al., 1993, Liu 
et al., 2008, Aydin et al., 2012). Interestingly, the APP and APLP2 proteins are found at particularly high 
levels in the brain where their expression patterns largely overlap in pyramidal neurons of the cortex and 
hippocampus (Lorent et al., 1995). In vitro studies revealed APP expression in astrocytes and microglia 
that is increased following brain injury (LeBlanc et al., 1997, Rohan de Silva et al., 1997). A more recent 
study reported that APP expression is restricted to neurons and cannot be found in major glial cells like 
astrocytes or microglia under basal as well as neuroinflammatory conditions (Guo et al., 2012a) due to 
the fact that utilized antibodies were not specific. The APP homolog APLP1 shows in contrast to APP and 
APLP2 nervous system specific expression (Lorent et al., 1995, Thinakaran and Koo, 2008, Klevanski et al., 
2014). The intracellular domain of APP family members contains the highly conserved YENPTY motif 
which was shown to promote clathrin mediated endocytosis, modulate Aβ generation, interfere with 
Ca2+ homeostasis and interact with multiple kinases and adapter proteins (Leissring et al., 2000, Ring et 
al., 2007, Jacobsen and Iverfeldt, 2009). Although APP/APLP structure is well studied, the precise cellular 
functions of the APP family proteins remain elusive. Several studies tried to assess putative functions of 
the protein family during development and in the adult nervous system (Jacobsen and Iverfeldt, 2009). 
Certainly, one of the most intriguing discoveries in this respect is the involvement of APP and its cleavage 
products in processes of synaptic plasticity (Korte et al., 2012).  
1.3.1 Amyloid Precursor Protein Processing    
APP family members undergo very complex processing, whereupon secretase activities a variety of 
biological active fragments are generated. Depending on their site of release, extra- and/or 
intracellularly, they might have functions as signaling molecules or initiate signaling cascades by binding 
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to different types of receptors. Proteolytic processing of APP is depicted in Figure 1.4 and was shown to 
be similar among APP family members except for the release of Aβ as this coding sequence is absent in 
the APP homologs (Eggert et al., 2004, Walsh et al., 2007). The current view allows differentiation 
between three different processing pathways initiated by the α-, β- or -η-secretase. In the non-
amyloidogenic pathway the α-secretase, in neurons and brain the α-disintegrin and metalloproteinase 
(mainly ADAM-10), cuts within the Aβ domain liberating the large APPsα ectodomain and a membrane-
anchored C-terminal fragment α (CTFα) (Kuhn et al., 2010). The latter is further cut by the γ-secretase 
releasing the p3 fragment extracellularly and the remaining APP intracellular domain (AICD) into the 
cytoplasm. The amyloidogenic processing of APP by the β-secretase BACE-1 (β-site APP cleaving enzyme) 
yields the APPsβ ectodomain and the membrane-tethered CTFβ, afterwards the activity of the γ-
secretase generates the AICD peptide along with Aβ (Vassar et al., 1999). In contrast to the α- and β-
secretase, the γ-secretase is composed of a large protein complex including presinilin 1 and 2 (PSEN1 and 
PSEN2) building the catalytic core unit, while additionally the presinilin enhancer (Pen-2) as well as the 
anterior pharynx-defective 1 (APH-1) and nicastrin are involved (Tomita, 2014). Recently Willem et al. 
(2015) identified a η-secretase cleavage site in the extracellular domain of APP releasing a short 
extracellular APPsη ectodomain. Subsequent processing of the remaining membrane anchored CTFη by 
the α- or β-secretase generates two new peptides, Aη-α and Aη-β (Willem et al., 2015). Importantly, APP 
processing is not restricted to the plasma membrane, but was also shown to occur within synaptic 
vesicles (Del Prete et al., 2014). In the healthy organism APP is cleaved in 90% of cases in the non-
amyloidogenic pathway and thus precludes the secretion of Aβ.   
In vivo studies have shown that secreted APP fragments have a half-life time of four to five hours in the 
adult moue brain while full-length APP reveals a much lower half-life-time with only one hour (Morales-
Corraliza et al., 2009). APP family proteins are present in somatodendritic as well as axonal 
compartments of neurons. In axons they are enriched at active zones (Lassek et al., 2013). In conclusion, 
Aβ can be released both, from dendrites and axons (DeBoer et al., 2014). APP family proteins are 
enriched in intracellular compartments, mainly the golgi apparatus and the trans-golgi-network (TGN), 
and only a small proportion is embedded in the membrane (Thinakaran and Koo, 2008). Is APP not 
cleaved while being embedded in the membrane, it is reinternalized into endosomes so that the amount 
of surface APP is defined by secretory trafficking, internalization and the efficiency of secretase 
processing (Jiang et al., 2014). APP family members reveal different levels of cell surface expression with 
APLP1 being the most abundant (Kaden et al., 2009), indicating that APP family members might have 
individual functions in the brain.  
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Figure 1.4: Proteolytic processing of APP. Full-length APP can be processed by α-, β-, η-, and γ-secretases in three different 
pathways. The left panel illustrates the η-secretase processing of APP. Initially η-secretase cleavage releases the soluble APPsη, 
while CTFη remains embedded in the membrane. It is further processed by α- or β-secretase at the extracellular side generating 
An-α or An-β. Shedding of CTFη within the transmembrane domain by γ-secretase yields the APP intracellular domain (AICD) 
containing the highly conserved interaction motif (YENPTY, yellow box) or the short extracellular peptides Aβ seen in the 
amyloidogenic or p3 within the non-amyloidogenic pathway. The non-amyloidogenic pathway depicted in the middle is driven 
by the α-secretase liberating APPsα in the extracellular space. Subsequently processing of membrane tethered CTFα by γ-
secretase generates the p3 peptide and cytoplasmic AICD. The right panel illustrates APP processing in the amyloidogenic 
pathway by β-secretase resulting initially in the release of the APPsβ ectodomain. Following γ-secretase shedding of the 
membrane tethered CTFβ the Aβ peptide is secreted along with AICD in the cytoplasm. (Ludewig and Korte, 2017) 
1.3.2 Physiological Functions of the APP Family and their Proteolytic Fragments in the Brain 
The physiological role of APP family proteins and their proteolytic products is well-focused in the 
research as APP/APLPs are multifaceted proteins involved in the regulation of biological processes 
including transcription as well as synaptic function. Depending on their structure and expression they act 
as cell surface receptor-like proteins or as ligands initiating downstream signaling starting at the cell 
surface or via their secreted domains.   
When APP/APLPs are present at the plasma membrane they were shown to form homo- and heterotypic 
cis interactions and have been proposed to mediate cell–cell interactions in trans (Soba et al., 2005, 
Kaden et al., 2009, Baumkotter et al., 2012, Mayer et al., 2016). APP family mediated synaptic adhesion 
is thereby not only crucial to build and maintain synaptic contacts, but also to regulate synaptic 
plasticity. Highest expression levels at the membrane were observed for APLP1 suggesting that it might 
be the family member with the upmost potential to mediate cell contacts (Kaden et al., 2009). Recently, 
the study of Mayer et al. (2016) identified APP and APLP2 to exhibit basal adhesive properties while 
APLP1 mediated neuronal adhesion is dynamic and regulated by zinc. Importantly, enhanced trans or cis 
interaction of APPs or APLPs is accompanied by a reduction of ectodomain shedding of the APP/APLP 
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proteins (Stahl et al., 2014, Mayer et al., 2016) and might therefore interfere with the ability to modulate 
synaptic function.  
1.3.2.1  Functions of Full-Length APP Family Members 
Information about APP/APLPs in vivo function is gained by mouse mutants ranging from single (KO) to 
double (DKO) and even triple knockouts (TKO) as well as from conditional and knock-in (KI) mouse lines.  
APP-KO: The constitutive APP-KO is well-studied and revealed reductions in brain and body weight, grip 
strength and increased susceptibility to epileptic seizures (Steinbach et al., 1998). Quite interesting are 
the age-dependent alterations in synaptic plasticity, mainly LTP, which were found only in aged (9 to 12 
months), but not in younger animals. Adult APP-KOs revealed normal basal synaptic transmission 
properties and short-term synaptic plasticity (STP) which was in line with the intact behavioral learning 
and neuronal morphology, while in aged mice behavior and spine number were significantly impaired 
(Seabrook et al., 1999, Ring et al., 2007, Lee et al., 2010, Tyan et al., 2012). These results indicate that 
the loss of APP does not impair synaptic plasticity and other biological functions in the adult organism 
and thereby APLP2 and maybe APLP1 are considered to perform redundant functions, but fail to 
compensate for APP deficiency with age.  
APLP2-KO: The function of APLP2 in synaptic plasticity has also been addressed in detail since this 
protein shares the highest degree of sequence homology with APP within the gene family. Furthermore, 
the spatial and temporal expression pattern of APLP2 is highly reminiscent to that of APP (Wasco et al., 
1993). In contrast to APP-KO mice, young and aged APLP2 single KOs behave like wildtype mice. They 
display no impairments in LTP, STP, PPF or basal synaptic transmission (Weyer et al., 2011, Midthune et 
al., 2012, Weyer et al., 2014). These observations go in line with normal learning and memory 
performances in cognitive tasks like the Morris-Water-Maze (MWM) or the passive avoidance test 
(Heber et al., 2000, Guo et al., 2012b). The functional effects are consistent with investigations of 
dendritic spine numbers of excitatory neurons. Whereas the spine density assessed in vivo was affected 
in aged APP-KO animals, it was unaltered in APLP2-KO mice as well as in organotypic hippocampal 
cultures (OHCs) of APLP2-KOs in vitro (Lee et al., 2010, Midthune et al., 2012, Weyer et al., 2014). It 
seems likely that endogenous APP is able to compensate for the genetic ablation of APLP2 with age, 
while vice versa APLP2 is incapable to compensate the loss of APP in aged animals. This implicates that 
APP has either different or dominant neuronal functions compared to APLP2. 
APLP1-KO: The APLP1 family protein was not studied in similar detail maybe due to the fact that APLP1 
has a different expression pattern than APP and APLP2. APLP1 shows restricted expression to the brain 
(Lorent et al., 1995, Thinakaran and Koo, 2008, Klevanski et al., 2014), but might therefore has a unique 
neuronal role and be of particular importance for synaptic plasticity. However, Heber et al. (2000) 
described only minor (if any) distinct phenotypes of APLP1-KO with unaltered cognitive behavior. In vivo 
analysis at the perforant path-granule cell synapse (PP-DG) in young adult APLP1-KO mice (16 to 20 
weeks old) revealed unaltered STP and LTP, while enhanced excitatory transmission has been observed 
(Vnencak et al., 2015). The authors argued that maybe a larger number of perforant path synapses or an 
increased synaptic strength in APLP1-deficient mice may cause this enhancement, but final clarification is 
missing. Furthermore the paired-pulse-inhibition (PPD) paradigm of the population spike pointed 
towards decreased GABAergic network inhibition in APLP1-KOs, an effect observed also for other APP-KO 
models.  
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APP/APLP2-DKO: The high content of APP and APLP2 especially in pyramidal cells of the cortex and 
hippocampus (Lorent et al., 1995) and their localization at synaptic sites (Lassek et al., 2013) suggest a 
role in synaptic transmission and synaptic plasticity. Addressing the function of these redundantly 
expressed proteins by a combined KO is unfeasible as APP and APLP2 DKO mice die perinatally (von Koch 
et al., 1997, Heber et al., 2000) indicating an indispensable role for both proteins during development. 
The lethal phenotype of these DKO mice is most likely due to important functions of APP and APLP2 at 
the neuromuscular junction (NMJ) (Wang et al., 2005, Weyer et al., 2011). Neuromuscular transmission 
is severely impaired due to a reduced amount of synaptic vesicles and their impaired release. While the 
Knock-In of APPsα in the APP/APLP2-DKO mouse (APPsα-DM) rescued the lethal phenotype it resulted in 
muscular weakness and severe alterations in NMJ morphology (Ring et al., 2007). Elucidating the CNS 
specific role of APP and APLP2 was achieved by a conditional approach used by Hick and colleagues 
(2015) leaving the PNS unaffected. Crossing of APPflox/flox on an APLP2 null background to NexCre-deleter 
mice generated viable double mutants (cDKO). In these mice the depletion of APP is initiated from 
embryonic stage 11.5 onwards in excitatory neurons of the forebrain, while APLP2 is constitutively not 
expressed allowing the investigation of neurodevelopmental effects. Young adult mice revealed a 
pronounced deficit in LTP induction and maintenance as well as impairments in PPF. Alterations during 
the initial phase of LTP, the so-called post-tetanic potentiation (PTP) and also STP provided a hint 
towards an impaired presynaptic function. In contrast, the functionality of the postsynapse remained 
unaffected as basal synaptic transmission was unaltered. Impairments in hippocampal LTP were further 
reflected in impaired hippocampus-dependent learning and memory tasks with deficits in the Morris 
water maze and in radial maze performance. Moreover, the quantitative analysis of adult hippocampal 
CA1 neurons yielded pronounced reductions in total neurite length, dendritic branching, reduced spine 
density and reduced spine head volume (Hick et al., 2015). Another study using young conventional 
APP/APLP2 deficient mice (surviving escape mutants) described increased PPF and synaptic frequency 
facilitation (FF) (Fanutza et al., 2015), supporting the assumption that APP and APLP2 are involved in 
presynaptic function. 
The combined KO of APLP2 with one of the other APP family member is embryonic lethal due to severe 
neuromuscular deficits (Heber et al., 2000, Klevanski et al., 2014). Strikingly, APP/APLP1-DKOs are viable 
and thus indicating that APLP2 serves unique functions when APP or APLP1 are missing. This moreover 
indicates that APP family members conduct redundant functions when they are regionally co-expressed. 
1.3.2.2  Role of APP Proteolytic Fragments 
The before mentioned impairments in physiological function might be caused either by deletion of 
APP/APLPs in full-length or because their proteolytic active fragments are absent. A large body of 
evidence points to APPsα as the neurotrophic domain within the APP family. Several studies implicated 
an important function of APPsα in synaptic plasticity as that extracellular APP domain facilitates LTP 
induction in hippocampal slices (Ishida et al., 1997) and was moreover shown to enhance memory in 
mice, rats and chicken (Roch et al., 1993, Meziane et al., 1998, Mileusnic et al., 2000, Mileusnic et al., 
2004). APPsα acts on a rapid time-scale shown by the rescue of the LTP deficit described by Hick and 
colleagues (2015) in APP/APLP2 cDKO mice through the acute application of the recombinant peptide in 
vitro. These results confirmed previous observations by Taylor et al. (2008) reporting that 
intrahippocampal infusion of recAPPsα in the dentate gyrus (DG) of anesthetized rats enhances LTP 
recorded at the PP-DG pathway in vivo. Moreover, a recent study showed that recAPPsα is able to rescue 
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age-dependent LTP deficits in vitro (Moreno et al., 2015). APPsα is further essential for spine density 
regulation and dynamics highlighted by the exogenous application of the extracellular domain (Tyan et 
al., 2012) or by the Knock-In of APPsα rescuing the spine phenotype in APP deficient mice (Weyer et al., 
2011, Weyer et al., 2014). In-line with the results following exogenous application of APPsα are the 
opposite effects observed after α-secretase inhibition leading to a reduction in APPsα production. The 
conditional KO of the major α-secretase ADAM-10 resulted in strongly impaired LTP and altered STP 
(Prox et al., 2013) and is consistent with the observations gained in studies using conventional α-
secretase inhibitors in OHCs (Weyer et al., 2011) or in vivo (Taylor et al., 2008). It is by now not clear how 
APPsα mediates the rescue in activity-dependent synaptic plasticity and which receptor might be 
activated. Overall there is good evidence for a prominent role of APPsα directly at the synapse, in 
particular by influencing NMDA-R function and synaptodendritic protein synthesis (Taylor et al., 2008, 
Claasen et al., 2009). In contrast, for APPsβ being only 16 amino acids shorter than APPsα, no 
modulatory role with regard to synaptic plasticity (Taylor et al., 2008, Hick et al., 2015), neuroprotection 
(Li et al., 2010, Chasseigneaux et al., 2011), synaptic protein synthesis (Claasen et al., 2009) or spine 
morphology and density (Tyan et al., 2012) has been attributed. Interestingly, the newly identified η-
secretase leads to the production of two small peptides Aη-α and Aη-β which have like APPsα and APPsβ 
differential roles in synaptic plasticity (see Figure 1.4, (Willem et al., 2015)). While both peptides had no 
influence on baseline synaptic transmission, hippocampal LTP was severely impaired by Aη-α but not by 
Aη-β administration in vitro. The structural difference between the two molecules is a C-terminal 
elongation of the Aη-α peptide by 16 additional amino acids, the same 16 amino acids that are also 
present at the C-terminus of the APPsα fragment, but not APPsβ. This short peptide sequence contains a 
predicted neuroprotective domain and a heparin binding site (Furukawa et al., 1996) and might lead to 
differential conformations enabling the peptides to activate different receptors. While APPsα and Aη-α 
share an overlapping sequence, they modulate LTP in an opposite way with Aη-α inhibiting LTP and 
neuronal activity as demonstrated by Ca2+ imaging experiments in vivo (Willem et al., 2015). That present 
results indicate that clearly more work is needed to investigate the underlying mechanism at the synapse 
mediated by the proteolytic domains of APP.   
Several studies indicate that also the APP intracellular domain (AICD) has essential roles at synaptic sites. 
APPΔCT15-DMs, mice that lack the last 15 amino acids of APP including the highly conserved YENPTY 
motif on an APLP2 deficient background, reveal impaired induction and maintenance of LTP paralleled by 
severely altered hippocampus-dependent behavior. These mice have altered postsynaptic properties and 
a trend toward defective protein-synthesis dependent late-LTP which is presumably caused be abolished 
YENPTY interactions (Klevanski et al., 2014). For instance, APP interaction partners like Dab1, Shc, Grb, 
and Mint/X11 proteins mediate not only clathrin-mediated endocytosis of APP, but are also involved in 
the translocation of APP to the cell-surface (Aydin et al., 2012, van der Kant and Goldstein, 2015). Of 
particular importance might be the interaction with the adapter protein family Fe65. Interestingly 
Fe65/Fe65L1 double deficient mice show a similar phenotype of cortical dysplasia as APP triple KO 
animals (Guenette et al., 2006). The Fe65 proteins co-localize with APP in the endoplasmatic reticulum 
(ER) and Golgi apparatus and facilitate the translocation of the precursor protein to the cell surface (Sabo 
et al., 1999). In addition, these proteins also regulate the shuttling of a multimeric complex of 
AICD/Fe65/Tip60 into the nucleus to regulate gene transcription (Cao and Sudhof, 2001). The link 
between APP and Fe65 seems to be essential and the modulatory role regarding synaptic function should 
therefore be further elucidated.     
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1.4 Scope of the Study 
AD is a neurodegenerative disorder with a quite dramatic development in numbers of diagnosed patients 
per year. Beside the cortex, the hippocampus is one of the first brain regions being affected by impaired 
synaptic function progressively resulting in cell death and causing cognitive deficits in humans. Today, it 
is widely accepted that the major cause of the disease is the Aβ-fragment. It accumulates in the brain 
upon increased processing of APP within the amyloidogenic pathway. Early stages of the disease are 
characterized by oligomeric Aβ which later on accumulates to Aβ plaques and are accompanied by 
inflammatory processes. But might it not also be the other way around that decreased levels of 
proteolytic APP products generated in the healthy organism within the non-amyloidogenic pathway lead 
to synaptic dysfunction? To develop potential therapeutic targets it is essential to understand first of all 
the physiological role of the APP protein family and their secreted peptides and how they modulate 
synaptic function. To this extent I investigated different gene-targeted mice to elucidate the role of 
APP/APLPs and their functional domains in processes of activity-dependent synaptic plasticity. I 
examined the age-dependent deletion of APLP1, the APP homolog which has been less attended in the 
research so far, as well as the role of the Fe65 protein family as downstream actors of APP, because 
several previous studies supposed an essential link between the adapter family and APP modulating 
synaptic function by intracellular signaling. Moreover, the generation of a conditional APP triple KO 
allowed me to study synaptic plasticity in surviving adult mice as the constitutive KO of APLP2 with one 
of the other family members is embryonic lethal. Furthermore I proved if the α-secretase cleavage 
product of APP, APPsα, is capable to rescue LTP deficits in APP/APLP2 deficient mice as well as in a 
mouse model of AD (APP/PS1ΔE9 tg) upon stable viral-driven overexpression. Within those readouts I 
included the analysis of APPsβ as well to monitor if the 16 amino acid shorter extracellular APP fragment 
might not be involved in processes of synaptic plasticity as claimed so far by the literature. Beside the 
functional analysis I included morphological investigations of spine density using the Golgi-Cox staining 
upon APPsα and APPsβ overexpression in AD mice and checked for the functional consequences 
resulting from the acute inhibition of the α-secretase ADAM-10 in wild-type mice. All experiments 
regarding synaptic plasticity were performed on acute hippocampal slices as the hippocampus is well 
known to be involved in learning and memory and is the brain region being affected within AD. In vitro 
recordings at the Schaffer collateral-CA1 pathway are well described and provide a suitable in vitro 
model for investigations of synaptic plasticity due to the lamellar structure of the hippocampus keeping 
neuronal circuits in transversal slice preparations intact. Beside the mainly electrophysiological read-outs 
I included Ca2+ imaging experiments where I chemically induced LTP in primary hippocampal cultures of 
APP/APLP2 deficient mice as Ca2+ signaling is essential for functional synaptic plasticity and was shown to 
be impaired in AD. Within those experiments I examined the neurotrophic properties of APPsα by AAV-
driven overexpression following viral transduction of cultures. As APPsα was indeed able to rescue LTP in 
AD transgenics and APP deficient mice and restored moreover Ca2+ homeostasis in APP/APLP2 deficient 
cultures, while APPsβ was ineffective, I extended my experiments to study the role of the 16 amino acids 
differentiating both extracellular APP domains. Administration of the recombinant peptide should show 
if it carries the functional neuroprotective properties of APP and additional pharmacological experiments 
should give insights if the α7-nAChR receptor might be a potential receptor targeted. Overall, the 
investigations of the physiological role of APP family members performed might reveal new targets for 
AD treatment.     
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2 Material and Methods 
2.1  Mouse strains 
To elucidate the physiological role of the APP protein family using electrophysiological techniques, I 
investigated different mutant mouse strains. Beside the well-established and commercial available AD 
transgenic mouse model APPswe/PS1ΔE9, I examined gene-targeted mice carrying deletions of APP, 
APLP1 and APLP2 or APP family transgenes generated in the laboratory of Prof. Dr. Ulrike Müller, 
University Heidelberg. Table 2.1 provides an overview over the different mouse mutants and their 
genotypes as well as the age of mice analyzed in this thesis.  
Table 2.1:  Names, genotypes and age of transgenic mice. 
Name Genotype Age 





4-6 and 11-13 months 
NexCre cDKO  
























2.1.1 Constitutive APLP1-Knockout 
The generation of the constitutive APLP1-knockout (KO) is described in detail in the publication of Heber 
(2000). It comprises the construction of a gene targeting vector that allowed the inactivation of the 
murine APLP1 gene by an ~8 kb genomic deletion involving the promotor, start codon and nearly 50% of 
the APLP1 coding region. The targeting vector was inserted into embryonic stem cells by electroporation. 
Heterozygous embryonic stem (ES) cells for the APLP1 gene, in which homologues recombination was 
successful, were transferred into foster mothers. Chimeric males were mated to C57Bl/6 females to 
generate heterozygous offspring that were further intercrossed to generate homozygous APLP1-/- mice.  
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2.1.2 Conditional Double or Triple Knockout of APP Protein Family Members 
Any co-deletion of APLP2 with one of the other family member is embryonic lethal caused by defects in 
neuromuscular transmission and morphology (Heber et al., 2000; Wang et al., 2005). To circumvent 
postnatal lethality and to open the possibility to study the functions of the APP protein family members 
in synaptic plasticity, conditional null alleles for the APP and APLP2 gene have been generated. Therefore 
the promotor and the exon 1 of the APP or APLP2 gene were flanked by loxP sites in the targeting vector 
which was electroporated in ES cells (APPflox/flox or APLP2flox/flox) (Mallm et al., 2010). By homologous 
recombination obtained heterozygous ES cells were implanted in foster mothers and male chimeric 
offspring were mate with C57/BL6 females. Heterozygous offspring were intercrossed to generate 
homozygous APPflox/flox or APLP2flox/flox mice. APPflox/flox mice were then further bred with APLP2–/– KO mice 
(Heber et al., 2000) to generate the conditional APPflox/flox APLP2–/– KO mouse model. APP triple KOs were 
generated by crossbreeding of APPflox/flox to APLP2flox/flox and APLP1–/– KO mice. These gene floxed mice 
built the possibility to selectively delete APP (and APLP2) at defined time points and in a tissue specific 
manner when crossed to Cre-transgenic deleter strains. I analyzed APPflox/floxAPLP2–/– or 
APPflox/floxAPLP2flox/floxAPLP1–/– mice that were crossed to the NexCre+/T strain (Goebbels et al., 2006) to 
receive either NexCre+/TAPPflox/floxAPLP2–/– or NexCre+/TAPPflox/floxAPLP2flox/floxAPLP1–/– individuals. 
NexCre+/TAPPflox/floxAPLP2–/– were crossbred with APPflox/floxAPLP2–/– to obtain 50% 
NexCre+/TAPPflox/floxAPLP2–/– (NexCre cDKO) and 50 % APPflox/floxAPLP2–/– (littermate control). To study 
conditional triple KOs, crossbreeding of NexCre+/TAPPflox/floxAPLP2flox/floxAPLP1–/– (NexCre cTKO) and 
APPflox/floxAPLP2flox/floxAPLP1–/– (littermate control) was done to generate respective offspring with a 
probability of 50 %. Nex is a gene encoding for a neuronal basic helix-loop-helix (bHLH) protein and was 
shown to be involved in neuronal differentiation. As Nex is expressed from E11.5 onwards in excitatory 
pyramidal forebrain neurons it triggers from then on constitutively the Cre-mediated APP removal.  
Additionally stereotactically injected NexCre cDKO and littermate controls were investigated. Injection of 
AAV-viruses (either AAV-Venus, AAV-APPsα or AAV-APPsβ) was performed by M. Richter (IPMB, 
University Heidelberg) bilaterally into the hippocampus using 2 µl of viral preparation 
(1010 vg/hippocampus) at a rate of 0.2 µl/minute. For optimal virus spreading, two injection sites per 
hippocampus were used. Stereotactic AAV delivery was performed at an age of 12-15 weeks and 
investigation of synaptic plasticity was done 2 months later at an age of 4-5 months. In-between animals 
were housed in a temperature- and humidity-controlled room with a 12 h light-dark cycle and had access 
to food and water ad libitum. 
2.1.3 AD Model Mice - APPswe/PS1ΔE9 Transgenics 
Male APPswe/PS1ΔE9 mice (referred as APP/PS1ΔE9; Jackson Laboratories, Bar Harbor, USA) and age-
matched littermate control mice (C57BL/6JxC3H/HeJ) were used for electrophysiology and spine density 
analysis. APP/PS1ΔE9 mice express the human APP gene carrying the Swedish double mutation (K595 
N/M596L) and moreover the human PS1ΔE9 variant lacking exon 9 (Borchelt et al., 1997, Jankowsky et 
al., 2004). Transgenic and littermate control mice were stereotactically injected with AAV-viruses (either 
AAV-Venus, AAV-APPsα or AAV-APPsβ). The stereotactic surgery was performed by R. Fol and J. 
Braudeau (INSERM U1169 / MIRCen CEA Fontenay aux Roses 92265 France and Université Paris-Sud, 
91400 Orsay, France). Viral constructs were bilaterally injected into the hippocampus using 2 µl of viral 
preparation (1010 vg/hippocampus) at a rate of 0.2 µl/minute. Two injection sites per hippocampus were 
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used to optimize virus spreading. Investigation of synaptic plasticity and spine density were perfromed 4-
5 months after injection at an age of 12-13 months. In-between animals were housed in a temperature- 
and humidity-controlled room with a 12h light-dark cycle and had access to food and water ad libitum.  
 
2.1.4 Fe65 and Fe65L1 Single and Double Knockouts 
The generation of mice with targeted alleles for Fe65 and Fe65L1 is detailed described by Guenette et 
al., 2006. The Fe65 targeting vector was constructed to replace a 6.5 kb genomic sequence including a 
part of the C-terminus of exon 2 and intron 2 as well as a portion of the exon 3 N-terminus. The Fe65L1 
targeting vector was constructed to replace 692 nucleotides of exon 4. Targeting vectors were inserted 
into ES cells by electroporation. Heterozygous ES cells for the Fe65 or Fe65L1 gene, in which homologues 
recombination was successful, were transferred into foster mothers. Chimeric males were mated to 
C57Bl/6J females to generate heterozygous offspring that were further intercrossed to generate 
homozygous Fe65-/- or Fe65L1-/- mice. Fe65–/– mice lack both isoforms, p97 and p60. Intercrossing of both 
single mutants generated Fe65-/-FEe5L1-/- dKO animals. Proofing the absence of Fe65 and Fe65L1 proteins 
in targeted mutant mice by western blot analysis revealed for Fe65–/– and Fe65–/–Fe65L1–/– mouse brains 
an upregulation of a p58 band (approximately 50 % increase) with unknown identity (Guenette et al., 
2006).  
 
2.2  Electrophysiology 
2.2.1 Artificial Cerebral Spinal Fluid (ACSF) 
The components of the Artificial Cerebral Spinal Fluid (ACSF) mimic the ion composition of the cerebral 
spinal fluid in vivo and provide thereby an optimal possibility to keep brain slices ex vivo viable. The 
composition of the ACSF with the respective ion concentrations used is shown in Table 2.2. All the 
chemicals are purchased from AppliChem (Germany). The ACSF and its physiological pH of 7.3, achieved 
by continuously saturation with 95 % O2 and 5 % CO2, provided an optimal environment for proper 
neuronal function. Dependent on the mouse model investigated, I used two different high Mg2+ ACSFs 
for preparing acute hippocampal slices (see Table 2.2), one that contained CaCl2 and one without CaCl2. 
As the Ca2+ influx and Ca2+-induced Ca2+-release is already elevated in aged rodents and mouse models of 
AD, Ca2+ free media was used to slow down metabolism and to minimize Ca2+-dependent hypoxic and 
excitotoxic damage during dissection (Sajikumar et al., 2005, Gant et al., 2006, Mathis et al., 2011). The 
further high Mg2+ concentration in both ACSFs blocked the NMDA-R and prevented its pre-activation 
during slice preparation. The recovery of prepared slices took place in high Mg2+ ACSF for all 
experiments. The bathing media used for electrophysiological recordings differed between transgenic 
mice analyzed. The mutant APP/APLP mouse lines revealed a low threshold to induce long-term 
potentiation (LTP) so that for recording the high Mg2+ ACSF was used to uncover differences in synaptic 
plasticity without causing hyperpolarization. The opposite, meaning lowered potential to enhance 
synaptic strength, is reported for aged AD mouse models so that recordings were performed in low Mg2+ 
ACSF (Mathis et al., 2011). 
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Table 2.2: Composition of the ACSFs. 
 
2.2.2 Preparation of Acute Hippocampal Slices 
The transversal slice preparation used in this thesis is a powerful tool to investigate synaptic properties 
ex vivo as the preparation retains the cytoarchitecture and synaptic circuitry of the hippocampus intact. 
After a brief anesthesia with 200 µl Isofluran (Baxter Healthcare Corporation, Deerfield, USA), the mice 
were rapidly decapitated and the brain was removed from the scull. This procedure was done in less 
than 90 sec as duration of this step is crucial for neuronal cell survival. The subsequent transfer of the 
brain into cold (4 °C), carbogenated high Mg2+ ACSF for 3 minutes slowed metabolism and reduced 
oxidative stress. To keep the tissue in the best conditions, the following preparation procedure was 
performed using ice-cold ACSF as well. The removal of the cerebellum and prefrontal cortex with a razor 
blade was followed by the separation of both hemispheres along the intrahemispheric fissure. In each 
hemisphere the hippocampus was first of all removed from the striatum with two rounded spatula from 
the medial side. Placing the spatula underneath the fimbria allowed folding out the hippocampus and 
further its separation from the cortex after cutting the subiculum. In all steps of preparation care was 
taken to avoid any damage of the hippocampus by direct touching or stretching. After dissecting the 
hippocampi, their ventral end was glued onto a specimen plate leaning upright against an agar block 
with the dentate gyrus facing the agar. The hippocampus was sectioned into 400 µm thick transversal 
slices along its longitudinal axis by a vibrating microtome (VT 1200S; Leica, Nussloch, Germany) being 
bathed in ice-cold ACSF. The slowly, but very gentle cutting with the vibrating blade caused less neuronal 
damage near the slice surface. After cutting, the slices were transferred into a custom-made submerged 
chamber constantly perfused with carbogenated high Mg2+-ACSF and were allowed to recover for at 
least 90 min at room temperature.  
2.2.3 Extracellular Field Recordings 
In vitro extracellular recordings on acute hippocampal slices were performed on two submerged setups 
with similar technical equipment. Glass microelectrodes were used to record electrically evoked field 
excitatory postsynaptic potentials (fEPSPs, Figure 2.2A). The recording electrodes were pulled from 
borosilicate glass capillaries (0.58 x 1.00 x 100 mm, Biomedical Instruments, Germany) with a 
Flaming/Brown Micropipette Puller (P-97, Sutter Instruments, USA) generating tips of approximately 1 to 
3 MΩ resistance. Submerged slice recordings in which continuously carbogenated ACSF flows over the 
substance high Mg2+ ACSF [mM] low Mg2+ ACSF [mM] Ca2+ free-ACSF [mM] 
NaCl 125 125 125 
KCl 2,5 2,5 2,5 
NaH2PO4*H2O 1,25 1,25 1,25 
MgCl2*6 H2O 1 2 2 
NaHCO3 26 26 26 
D+-Glucose  25 25 25 
CaCl2*H2O 2 2 - 
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entire slice at a rate of 1.5 ml/min started after a period of 1.5 to 2 h enabling the recovery of slices from 
the preparation procedure. Dependent on the application of recombinant peptides or inhibitors either 
silicon tubings (PharMed® Ismaprene, Ismatec) avoiding absorbance of substances by the tubing walls or 
PVC tubings (TYGONE, Ismatec) for standard recording procedures were used. The submerged recording 
chamber (RC-22, Warner instruments, USA) was fixed onto a vibration damped table (Spindler & Hoyer, 
Germany and TMC, Massachusetts, USA) and further onto an aluminum heating base (PH-1, Warner 
Instruments) which was connected to a thermistor measuring to achieve constant temperature being 
crucial for stable recordings. Additionally, both setups contained a pre-heating and by connection to an 
adjustable Dual Channel Heater Controller (TC-334B, Warner Instruments) a constant temperature of 22 
– 24 °C (RT) for fiber volley experiments and 32 ± 0.2 °C for all other type of recordings were achieved. 
The lamellar organization of the 
hippocampus is well preserved after 
transversal slice preparation keeping the 
majority of intra-hippocampal connections 
intact. In order to prevent recording of cells 
that might likely be injured by the slicing, 
glass microelectrodes filled with 3M NaCl 
were precisely placed in the stratum 
radiatum of hippocampal area CA1 (Figure 
2.1) to a depth of ~130 to 170 µm beyond 
the surface of the slice. The recording 
electrode was therefore fixed to an 
electrical micromanipulator (SM-5, Luigs 
and Neumann or Nano-Stepper, WSE 
Electronics) and moved by a motor driven 
remote control. The stimulation electrode, 
a lacquer coated, monopolar tungsten 
electrode (WPI, USA) with a resistance of 
0.1 MΩ, was positioned into the stratum 
radiatum of CA3, stimulating the Schaffer 
collateral axons (Figure 2.1). Movement of 
the stimulation electrode was achieved 
with a mechanical micromanipulator (Leitz, 
Germany), while precise positioning of the 
electrodes was possible by visual control 
with a stereo microscope (SMZ 654, Nikon, Japan or Heerbrugg at Leica Microsystems). As the negative 
pole of the stimulation electrode was connected to a stimulus isolator (A360 or A365, WPI, USA) defined 
stimuli patterns programmed in the master pulse generator Master 8 (A.M.P.I., Israel) could be applied. 
Stimuli consisted of constant current rectangular pulses lasting 200 μs applied at 0.1 Hz and ranged from 
20 to 40 μA for baseline stimulation. The stimulus current thereby depended on the age and mice strain 
analyzed as well as on the preparation quality and treatment. The negative pole of the stimulation 
electrode was connected to an Ag/AgCl pellet (E201, WPI, USA) serving as indifferent electrode, which 
Figure 2.1: Localization of the hippocampus in the rodent brain and 
position of electrodes in a transversal acute slice. Upper panel: Position 
of the hippocampus inside the rodent brain and in red the transversal 
intersecting plane. Lower panel: The stimulation electrode was placed in 
the hippocampal CA3 region to stimulate the Schaffer collateral pathway 
(Sc). The recording electrode was positioned in the stratum radiatum of 
the CA1 region. Adapted from (Korte and Schmitz, 2016) 
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was bathed in ACSF and further connected to the amplifiers headstage (Axoclamp-2B, Axon Instruments 
at Molecular Devices, USA). On the headstage the recording electrode was additionally mounted either 
directly or indirectly by a cable. Therefore, the recording electrode was inserted before into an electrode 
holder (WPI, USA). Evoked fEPSPs were recorded in bridge mode and amplified (200 times) by the 
Axoclamp2B differential amplifier (Axon Instruments Molecular Devices, USA) and band-pass filtered 
(LHBF-48X, NPI Electronic, Germany). Another 50-60 Hz filter (Hum Bug, Quest Scientific, UK) eliminated 
noise that would have otherwise contaminated the recorded responses. The signal was digitized with a 
multi-IO card (National Instruments, USA) and stored on a personal computer for subsequent analysis 
with National Instruments LabView based software (DAP Version 4.751, written by M. Korte and 
V.Staiger) or online monitoring during recording. The signal was checked in parallel with an oscilloscope 
(HM507, Hameg, Germany). In all recordings the initial negative slope provided a measurement of the 
monosynaptic excitatory CA3-CA1 current. It corresponds directly to the activation of depolarizing 
synaptic currents in CA1 pyramidal neurons in response to glutamate release from Schaffer Collateral 
terminals. Following the acclimatization of the slice to the altered conditions in the submerged recording 
chamber like temperature and ion conditions of the bathing medium reflected by a stable signal size, 
electrophysiological recordings started. First of all, a stimulus–response curve was obtained at the 
beginning of each experiment to define the minimal stimulus strength generating a population spike in 
the fEPSP (Figure 2.2B). For LTP experiments stimulus intensity was adjusted to elicit a slope size 
resulting in 40 % of the maximal fEPSP slope. 
2.2.4 Stimulation Protocols 
All stimulus paradigms used, were programmed in the Master 8 pulse generator which triggered the 
application of currents with defined frequencies. Baseline synaptic transmission was investigated by 
input-output (IO) measurements. The IO measurements were performed either by application of defined 
current values (25–250 μA with 25 µA steps) at 32°C or by adjusting the stimulus intensity to certain fiber 
volley (FV) amplitudes (0.1–0.8 mV with 0.1 mV steps). The FV represents the presynaptic part of the 
fEPSP or in more detail the summated action potentials of the population of axons stimulated and 
thereby provide a direct correlation of stimulus strength and fEPSP response (Figure 2.2). FV recordings 
were performed at RT (22- 24 °C) to avoid an overlay of FV and fEPSP signal like it occurs at 32 °C (Figure 
2.2A, C).   
Short-term synaptic plasticity and presynaptic function were investigated with the Paired-Pulse-
Facilitation (PPF) paradigm. PPF is the simplest form of plasticity exhibited by the most excitatory 
synapses in the hippocampus. It is defined as an increase in the synaptic response size to a second pulse 
delivered within a short interval of time following the first pulse. PPF is maximal at short interstimulus 
intervals (ISIs) and declines exponentially over a period of ∼500 msec. It is well established that PPF is a 
presynaptic phenomenon depending on the probability of neurotransmitter release (see chapter 1.2.3 
(Citri and Malenka, 2007)). PPF was investigated by applying a pair of two closely spaced stimuli in 
different ISIs ranging from 160, 80, 40, 20 to 10 ms at 32 °C (Figure 2.2D).   
To investigate long-term synaptic changes in synaptic plasticity, long-term potentiation (LTP) was 
induced in acute hippocampal slices. Following 20 minutes of stable baseline synaptic recordings with 40 
% of maximal fEPSP slope at 0.1 Hz LTP was induced in the slice by applying theta-burst stimulation (TBS: 
10 trains of 4 pulses at 100 Hz in an 200 ms interval, repeated 3 times). Responses are monitored 
continually for 60 min to access fEPSP strengthening and stability of the LTP. TBS is based on naturally 
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occurring theta firing patterns in the hippocampus and can therefore be seen to be physiological (Vertes, 
2005). Following the brief period of high-frequency stimulation there is a rapidly decaying potentiation, 
often referred to as phase of post-tetanic potentiation (PTP). PTP generally lasts for ∼1 min following a 
tetanus and is also thought to be due to presynaptic changes, similar to those that underlie PPF (see 
chapter 1.2.3 (Regehr, 2012)).  
 
Figure 2.2:  Example traces of the fEPSP, populations spike, fiber volley and PPF recordings from CA1 stratum radiatum. (A) 
Representative tracing of an excitatory postsynaptic field potential (fEPSP) with stimulation artifact. In red the negative slope is 
shown which was measured before and after LTP induction. (B) Example fEPSP with population spike. (C) Example fEPSP with 
clearly identifiable fiber volley signal at room temperature. (D) Representative tracing of the Paired Pulse Facilitation (PPF) 
paradigm. Two stimuli were applied in defined inter-stimulus intervals (ISIs) ranging from 160 to 10 ms. Second fEPSP signal 
becomes larger than the first depending on size of ISIs. 
2.2.5 Pharmaca and Peptides 
Despite viral overexpression of APP peptides (AAV-APPsα or AAV-APPsβ) over a long time range in vivo, 
also acute treatment with recombinant peptides applied ex vivo on acute slices allowed the investigation 
of effects on synaptic plasticity occurring on a rapid time scale. Therefore recombinant Aβ1-16 (recAβ1-
16) or its scrambled version for control experiments, kindly provided by Prof. Dr. Ulrike Müller 
(University Heidelberg), was diluted in 30 mL high Mg2+ ACSF. That volume was sufficient to circulate 
during the entire recordings per day in a closed loop system. By using silicon tubings (PharMed® 
Ismaprene, Ismatec) the absorbance of peptides by the tubing walls was avoided. To further circumvent 
osmolarity changes in the small volume of the high Mg2+ ACSF caused by evaporation, moisturized 
carbogen was introduced in the 30 mL recording solution which was additionally covered with Parafilm® 
(Bemis, USA). Synthetized murine Aβ1-16, the sequence difference between APPsα and APPsβ, diluted in 
PBS or its scrambled version (Aβ1-16 scr) were used in a final concentration of 10 nM. The concentration 
was based on previous acute peptide recordings with recAPPsα (Hick et al., 2015). Before recordings, 
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acute hippocampal slices of APLP2-KO (littermate control) and NexCre cDKO were pre-incubated in 30 
mL gently carbogenated high Mg2+ ACSF containing either Aβ1-16 or Aβ1-16 scr in a custom made 
incubation chamber covered with Parafilm® for 1 h at RT. After that, slices were transferred into the 
submerged recording chamber where 30 mL of high Mg2+ ACSF with the respective peptide circulated in 
a closed loop. Recordings were performed as described before. In another set of experiments, the α7-
nicotininc acetylcholine receptor antagonist (α7-nAChR) α-Bungarotoxin (BTX, Merck Millipore, 
Germany) solved in Aqua dest. was used at a final concentration of 10 nM and either co-applied already 
at the step of pre-incubation together with 10 nM Aβ1-16  on acute slices or washed in 10 minutes 
before baseline recording started. 
2.2.6 Electrophysiology - Data Analysis 
Acquired raw data of recordings were analyzed with custom made programs based on National Lab View 
Software (ANA-DAP version 4.755 or ANA-PPF version 4.2, written by M. Korte and V. Staiger). Using 
those programs precise measurements of the negative fEPSP slopes for fiber volley, EPSP and LTP 
recordings were feasible by a manually defined window. For the analysis of the PPF data, the ratio of the 
slope of the second fEPSP divided by the slope of the first one was calculated, written as equation: (slope 
fEPSP2/slope fEPSP1)*100.   
Both LabView programs generated Microsoft Excel files (Microsoft, USA) containing all single values of 
each fEPSP slope measurement. Baseline synaptic transmission properties assessed with FV, EPSP or PPF 
paradigms were shown as the average of three values per condition analyzed. For LTP recordings six 
values of fEPSP slopes were averaged resulting in the mean value for one minute that was plotted within 
the graphs. The LTP data were shown as an increase compared to baseline synaptic activity. Therefore all 
fEPSP slopes were averaged and set to 100%. The slope sizes obtained after TBS induction were 
normalized to baseline and calculated as following: (slope fEPSPminute/mean slope fEPSPsbaseline)*100.  
Within the analysis only experiments were included that revealed a stable baseline with not more than 
10% variability or where fEPSP after stimulation looked physiological without displaying a large 
population spike or seizure-like activity.  
2.3  Dendrite and Spine Analysis Following Golgi Cox Staining 
For different approaches addressed within that thesis only one hemisphere served for electro-
physiological recordings, while the other was used for morphological analysis using the Golgi-Cox 
method. Golgi staining was done using the FD Rapid GolgiStainTM Kit (FD NeuroTechnologies, Inc., USA) 
according to the manufacturer's instructions. After division of the two hemispheres during slice 
preparation for electrophysiology, one hemisphere was immersed in 2 mL mixtures of equal parts of kit 
solutions A and B and stored at RT for 2 weeks. Solution AB was prepared at least 24 h before first brain 
tissue impregnation and renewed 12 to 24 h later. After 2 weeks, brain tissues were transferred in 
solution C for at least 48 h and up to 7 days at 4 °C before sectioning. Solution C was renewed within the 
first 24 h. Coronal brain sections of 200 μm were cut with a vibrating microtome while embedded in 2% 
Agar in 0.1 M PB (Leica, VT1200S, Germany). Each section was mounted with Solution C on an adhesive 
microscope slide pre-coated with 1 % gelatin/0.1 % chromalaun and stained according to the 
manufacturer´s protocol with exception that AppliClear (AppliChem, Germany) was used instead of 
xylene. Finally, slices were cover-slipped with Permount (Fisher Scientific, Germany).   
Images of hippocampal CA1 and CA3 pyramidal neurons were taken with an Axioplan 2 imaging 
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microscope (Zeiss, Germany) using a 63x oil objective and a z-stack thickness of 0.5 μm under reflected 
light. The number of spines was determined per micrometer of dendritic length (in total 100 µm) at 
apical compartments in midapical regions of the stratum radiatum (second or third order dendritic 
branches) and basal compartments within stratum oriens (>20 µm away from the soma) using ImageJ 
(1.48v, National Instruments of Health, USA). At minimum 4 animals per genotype and 5 neurons per 
animal were analyzed blinded to genotype and particular treatment. Data of Golgi-Cox staining were 
analyzed using GraphPad Prism (Version, 5.01) software. Spine density is expressed as mean±SEM. 
 
2.4  Primary Hippocampal Dissociated Neuronal Cultures 
2.4.1 Media and Solutions 
 
Borate buffer, pH 8.5  Dissolve 0.31 g boric acid and 0.475 g borax in 100 mL sterile MilliQ 
water, adjust pH to 8.5. 
 
Poly-L-Lysine stock solution 10 mg/mL in MilliQ water 
Gey’s balanced salt solution (GBSS), pH 7.4  KCl    0.37 g 
KH2PO4   0.03 g 
MgCl2 * 6H2O  0.21 g 
MgSO4 * H2O   0.07 g 
NaCl    8 g 
NaHCO3   0.227 g 
NaH2PO4   0.12 g  
D-Glucose   1g  
CaCl2 * 2H2O   0.22 g  
MilliQ water   fill up to 1000 mL 
 
Serum medium      FCS    200 μL 
DMEM (2 %)   10 mL 
 
Medium for dissociated hippocampal cultures  Neurobasal (NB) 50 mL 
B27    1 mL 
L-Glutamin (200 mM)  125 μL 
N2 (10x)   5 mL 
 
2.4.2 Preparation of Poly-L-Lysine -Coated Coverslips 
Glass coverslips (Ø 13 mm, 1 mm thick, VWR) were incubated in 10 M NaOH for 3-5 h at 100 °C and 
afterwards washed 5x with MilliQ water. After sterilization at 225 °C, coverslips were coated with 0.5 
mg/mL poly-L-Lysine (P2636, Sigma) in boric acid buffer at 36.5 °C for 2-3 h. Next, they were washed 5x 
with sterile MilliQ water, dried and stored at 4 °C. 
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2.4.3 Preparation of Primary Embryonic Hippocampal Cultures 
Primary embryonic hippocampal cultures were prepared at embryonic day (E) 18.5. Initially, the 
pregnant mouse was sacrificed by cervical dislocation and all embryos were extracted from the uterus 
and decapitated under sterile conditions. The skull was carefully opened and the upper part of the brain, 
containing cortex and hippocampus, was separated from the rest of the brain tissue and quickly 
transferred into ice-cold GBSS/glucose solution. The dorsal parts of the brain (cerebellum and pons) 
were removed and the two hippocampi separated along the midline under visual control using a 
dissecting microscope (Stemi 2000, Zeiss, Germany). Hippocampi were dissected from the cortex and 
digested in 1 mL Trypsin / EDTA (Sigma) for 30 min at 36.5 °C. In order to stop digestion, the 
Trypsin/EDTA solution was sucked away and replaced by 1 mL serum medium. After washing with serum 
medium for 3 times, cells were carefully dissociated using pipets with different tip sizes. The dissociated 
tissue was centrifuged 5 min at 1500 rpm, the supernatant removed and the cell pellet re-suspended in 1 
mL medium. Following cell counting, cells were plated at a density of 7 x 104 cells/well on poly-L-Lysine 
coated coverslips and incubated in medium at 36.5 °C, 5 % CO2 and 99 % humidity. Medium was 
exchanged after 9 days in vitro (DIV9). Cells have been used for experiments between DIV12-16.  
 
2.5  Ratiometric Calcium Imaging 
2.5.1 Media, Solutions, Pharmaca and Viruses 
 
1x Hank’s Balanced Salt Solution (HBSS) 10 x HBSS stock solution 50 mL 
for Imaging (3.8 mM Ca2+)   CaCl2* H2O   145 mg  
NaHCO3   175 mg   
 H2O (MilliQ)    fill up to 500 mL 
 
1x Hank’s Balanced Salt Solution (HBSS) 10 x HBSS stock solution 50 mL 
for Imaging (1.3 mM Ca2+)   NaHCO3   175 mg   
      H2O (MilliQ)    fill up to 500 mL 
 
Fura-2 AM calcium dye stock solution Solve 50 μg Fura-2 AM (Invitrogen, Germany) in 50 µL 
DMSO (Roth, Germany) for a 1 mM stock solution 
 
Glycine stimulation medium (1 mM)  Glycine (1 M in D-PBS)   40 μL 
Strychnine (1 mM in H2Odest.) 40 μL 
1x HBSS    40 mL 
 
CPA medium (10 μM)    CPA (10 mM in DMSO)   40 μL 
Glycine (1 M in D-PBS)   40 μL 
Strychnine (1 mM in H2Odest.) 40 μL 
1x HBSS    40 mL 
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Table 2.3: Pharmaca and AAV viruses used for quantitative calcium imaging. 
 
2.5.2 Fura-2-AM Ca2+ Imaging Experiments 
Fura-2-AM Ca2+ imaging experiments were performed with cultured DIV12 to DIV16 old hippocampal 
neurons. Neuronal cultures were loaded with 4 mM Fura-2-AM (Life Technologies, solved in DMSO) 
solved in Hank’s Buffered Salt Solution (HBSS) with 2.5 % Pluronic F127 (Sigma) for 45 min at 37 °C. 
Following two washing steps with pre-warmed 1x HBSS, the coverslips were mounted on a perfusion 
chamber continuously perfused with HBSS at RT. The perfusion chamber was fixed on a moveable stage 
of an upright Olympus BX61WI fluorescence microscope system (Cell^M software) equipped with a 40× 
0.8-N.A. objective (Olympus) and a CCD camera (VisiCam QE, Visitron Systems) with 4 x 4 binning. 
Visualization of Fura-2-AM calcium signals was achieved using 340 nm and 380 nm UV light while light 
intensity was set to 70.9 % and exposure time constantly held at 130 ms for time lapse imaging taking 
500 images in a cycle time of 326 ms and 200 cycles repetition.   
cLTP induction: After 20 min of adaptation to the chamber conditions, 2 images of spontaneous activity 
(baseline activity) were taken at an interval of 10 min (t-20, t-10). For stimulation and chemical LTP 
induction (cLTP) 1x HBBS containing Glycine (Gly, 1 mM) and Strychnine hydrochloride (Str, 1 µM, 
Sigma), blocking specifically endogenously expressed glycine receptors, were bath applied for 10 min and 
followed by continuously perfusion with 1x HBBS to acquire 3 additional time points upon cLTP induction 
(t0, t10, t40). In another set of experiments the stimulation solution (1 mM Glycine/1 µM Strychnine) 
contained additionally Cyclopiazoic acid (CPA, 10 µM, Tocris) to block the re-uptake of Ca2+ into 
intracellular Ca2+ stores.  
SOCC experiments: Prior to Ca2+ withdrawal by a switch of HBSS perfusion solution to low Ca2+-HBSS (1.3 
mM), one image of spontaneous activity was taken after 20 min of adaptation to the chamber conditions 
(t1). Following acquisition of one Ca2+ signal recording after 10 min of Ca2+ withdrawal (t2), cells were 
perfused with HBSS (3.8 mM) for 5 min to re-build extracellular Ca2+ concentration and to investigate 
intracellular Ca2+ changes in neurons (t3). To examine endoplasmatic reticulum (ER) Ca2+ stores, ER stores 
were unloaded with 10 µM CPA perfused in low Ca2+-HBSS and calcium signals monitored (t4). The 
calcium signals evoked by restoration of external Ca2+ are used to detect store-operated Ca2+ entry 
(SOCE) activity (Linde et al., 2011) being crucial for ER store Ca2+ re-filling (Parekh and Putney, 2005).   
substance concentration or titer reference 
glycine 1 mM AppliChem 
Cyclopiazonic acid (CPA) 10 µM Tocris 
Nifedipine 10 µM Tocris 
Strychnine hydrochloride  1 µM Sigma 
AAV9-ss-Syn-Venus-f 1.4*1010 gc/µL Tobias Abel (PEI, 





Pluronic acid 2.5 % Sigma 
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Images were captured at 340 and 380 nm excitation wavelengths and the mean pixel intensity for each 
cell was determined in the region-of-interest (ROI) using ImageJ. ROIs were set around the cell bodies of 
five neurons per time-point, averaged and corrected for background fluorescence. In case of AAV 
transduced neurons, only cells were included in the analysis that expressed the Venus fluorescent 
protein. Changes in intracellular Ca2+ concentration are represented as Ratio of (fluorescence emission 
intensity at 340 nm – background fluorescence emission at 340 nm)/ (fluorescence emission intensity at 
380 nm – background fluorescence emission at 380 nm). The amplitude of Ca2+ peaks were analyzed and 
plotted to assess differences in Ca2+ dynamics upon neuronal activity between genotypes and 
treatments.  
2.5.3 AAV-constructs and Transduction of Primary Cultures 
The codon optimized (Geneart, Regensburg) mouse APPsα coding sequence (derived from Uniprot: 
P12023-2) was cloned under control of the synapsin promoter into the single-stranded rAAV2-based 
shuttle vector pAAVSynMCS-2A-Venus (Tang et al., 2009) by T. Abel (PEI, Langen, Germany). An N-
terminal double HA-tag was inserted downstream of the APP signal peptide at the N-terminus of APPsα 
as well as the yellow fluorescent protein Venus containing at its C-Terminus a farnesylation signal (FA) 
for membrane anchoring (referred as AAV-syn-APPsα-Venus) allowing easy detection. The control vector 
(AAV-syn-Venus) encodes only for FA-Venus. All constructs were packaged into AAV9 by the MIRCen viral 
production platform as described previously (Berger et al., 2015, Fol et al., 2016). The concentration of 
the vector stocks was estimated by quantitative PCR according to the method described by 
(Aurnhammer et al., 2012) and expressed as viral genomes per mL of concentrated stocks (vg/mL).   
AAV-syn-Venus and AAV-syn-APPsα-Venus were added to primary hippocampal cultures of NexCre cDKO 
or littermate control mice 6 days before imaging with a MOI of 2*104.  
2.5.4 Transfection of Primary Hippocampal Neurons 
Primary hippocampal cultures were transfected after completion of Ca2+ Imaging experiments between 
DIV12 and DIV17 using Lipofectamine® 2000 (ThermoFisher Scientific) transfection reagent with the 
plasmid pmApple-N1 encoding for the red fluorescent monomeric derivative of DsRed to investigate 
spine density. All used amounts were calculated per well. 300 µL Neurobasal (NB) medium without 
supplements were pre-incubated at 37 °C, 5 % CO2 and 99 % humidity. Afterwards, 0.8 µg plasmid DNA 
and 2 µL Lipofectamin were each diluted in 50 µL NB medium without supplements. Following 5 min of 
incubation, the two solutions were combined and incubated for another 20 min at RT. The old cell 
culture medium was replaced by 300 µL of pre-warmed NB medium without supplements, while the old 
cell medium was kept in empty wells and incubated at 37 °C and 5 % CO2. Subsequently, 100 μL 
transfection medium was added drop wise to each well followed by 60 minutes incubation at 37 °C and 5 
% CO2. Afterwards, the transfection medium was replaced by the old culture medium and cells were 
incubated for 24 h at 37 °C and 5 % CO2 before fixation with 4 % PFA in 0.1 M PB.  
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2.6  Immunhistochemistry 
2.6.1 Solutions and Antibodies 
 
0.1M PB       solve 0.78 g NaH2PO4 
3.45 g Na2HPO4 
in 500 mL MilliQ water 
 
4% Paraformaldehyde (in 0.1 M phosphate buffer, pH 7.4)  solve 40 g PFA in 500 mL warm dH2O,  
cool down and filtrate 
add 500 mL of 0.2 M phosphate buffer  
 
10x Phosphatebuffered saline (1 M PBS, pH 7.4)  solve 11.5 g Na2HPO x H2O 
2.0 g KH2PO4 
80.0 g NaCl 
2.0 g KCl 
in ca. 900 mL MilliQ water 
adjust pH to 7.4 
fill up to 1 L final volume with MilliQ 
water 
 
Table 2.4: Primary and secondary antibodies for immunohistochemistry. 
 
2.6.2 Immunhistochemical Staining of Acute Slices 
HA-tag staining: Hippocampal acute slices were fixed overnight in 4 % PFA in 0.1 M PB, de-hydrated in 20 
% sucrose in PBS and either embedded in Tissue-Tek® O.C.T. Compound, frozen at -80 °C and stored at -
20 °C till sectioning or cutted directly following de-hydration into 30 µm free-floating slices using a cyro-
microtome. Slices were collected and washed in 1x PBS, permeabilized with PBS-Triton-X-100 0.25 % and 





anti-HA-16B12 mouse Covance 1:500 
anti-active Caspase-3 rabbit Promega 1:250 
anti-IBA1 rabbit Synaptic Systems 1:1000 
anti-rabbit-Cy3 goat Dianova 1:500 
anti-rabbit-Cy5 goat Dianova 1:500 
biotinylated anti-mouse goat novex life technologies 1:500 
streptavidine Cy5  Life technologies 1:500 
DAPI  Applichem 1:1000 
ABC kit  Vectastain 1:250 for A and B 
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then saturated in PBS-Triton-X-100 0.25 % containing 5 % normal goat serum for 1 hour at RT. Following, 
slices were incubated with the specific primary antibody (HA.11 Clone 16B12, Covance, 1/500 in 5 % 
NGS-PBS-Triton-X-100 0.25 %) overnight at 4 °C. 3 successive washes in PBS-Triton-X-100 0.25 % were 
followed by a secondary antibody incubation (Biotinylated anti-mouse, 1/500 in PBS-Triton-x-100 0.25 %) 
for 1 hour at RT. After 3 successive washes and an incubation with the standard ABC kit (Vectastain, 
1/250 for A and B in PBS, 1 hour at RT) sections were rinsed with PBS-Triton-X-100 0.25 % and incubated 
with Streptavidine Cy5 (1/500 in 0.1 M PBS) for 1 hour at RT. Sections were stained for DAPI, transferred 
on Superfrost glass slides, mounted with Fluorogel with Tris buffer (Electron Microscopy Science) and 
cover-slipped. 
IBA-1 and Caspase-3 staining: Following fixation of acute hippocampal slices in 4 % PFA in 0.1M PB 
overnight, they were de-hydrated in 20 % sucrose in PBS and embedded in Tissue-Tek® O.C.T. Compound 
for cryo-sectioning. 30 µm free-floating slices were collected and washed in 1x PBS, permeabilized with 
PBS-Triton-X-100 0.25 % (2x 5 min) and then saturated in PBS-Triton-X-100 0.25 % containing 10 % 
normal goat serum for 1 hour at RT. Slices were then incubated with the specific primary antibody (IBA-
1, Synaptic systems, 1/1000 in 10 % NGS-PBS-Triton-X-100 0.25 % and active caspase-3, Promega, 1/250 
in 10 % NGS-PBS-Triton-X-100 0.25 %) overnight at 4 °C. 3 successive washes in 1x PBS were followed by 
the secondary antibody incubation (goat anti-rabbit-Cy3 and goat anti-rabbit-Cy5, each 1/500 in PBS) for 
2 hours at RT in the dark. Sections were washed 3 times with PBS (10 min each) stained for DAPI, 
transferred on Superfrost glass slides, mounted with Fluorogel with Tris buffer (Electron Microscopy 
Science) and cover-slipped. 
2.7  Statistical analysis 
The statistical analysis was performed using Microsoft Excel or GraphPad Prism. The data obtained 
between two genotypes or two different experimental conditions were compared using an unpaired 
two-tailed Student's t-test. Data including more than 2 different groups were analyzed using a One-Way 
ANOVA followed by a post-hoc Bonferroni´s or Turkey´s Multiple Comparison Test. Values of p = 0.05 
were considered significant and plotted as follows *p < 0.05; **p < 0.01; ***p < 0.001. All data are 
indicated as mean ± SEM. 
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3 Results 
3.1  The APP Homolog APLP1 Supports Basal Synaptic Transmission 
APLP1 is the protein family member showing exclusive expression in the CNS (Lorent et al., 1995, 
Thinakaran and Koo, 2008, Klevanski et al., 2014), while APP and APLP2 share a common ubiquitous 
expression pattern throughout the body. Due to its local expression, APLP1 might have individual roles 
within the synaptic network. Despite the generation and first characterization of the conventional 
APLP1-KO mouse by Heber and coworkers in 2000, the function of the homolog has been less attended 
in synaptic plasticity. Therefore, a detailed characterization of the conventional APLP1-KO mice at two 
different ages, adult (14 to 16 weeks old) and aged (11 to 12 months old), regarding their 
electrophysiological properties at the Schaffer collateral CA1 pathway was conducted. This analysis 
included measurements of basal synaptic transmission by correlating input-output strength via fiber 
volley size or size of the EPSP and to proof for presynaptic functionality using the PPF paradigm. 
Moreover, investigations to elucidate if the deletion of APLP1 itself or with age altered activity-
dependent synaptic plasticity was examined by induction of LTP by TBS.  
3.1.1 Young APLP1 Knockout Mice  
I investigated activity-dependent synaptic plasticity on acute hippocampal slices of 14 to 16 weeks old 
APLP1-KO mice and their age-matched littermate controls (LM). Acute slices of APLP1-KO mice (open 
circles) displayed an LTP curve that is statistically indistinguishable in induction and maintenance to that 
of littermate controls (black circles, Figure 3.1). Unaltered activity-dependent synaptic plasticity is 
moreover reflected in the average potentiation levels of the last five minutes of LTP recording (Figure 
3.1B). Potentiation levels of APLP1-KO mice with 141.59 ± 2.66% were not significantly different to that 
of littermate controls with 147.31 ± 3.79% (Student´s t-test, p= 0.23). To further test if basal synaptic 
transmission is intact after APLP1 deletion in young mice, I analyzed the input-output characteristics at 
CA3-CA1 neurons. Neuronal excitability at postsynapses was comparable at all stimulus intensities tested 
(25 – 250 µA, Figure 3.1C) and when I measured the fEPSP slopes at defined fiber volley amplitudes (0.1 
– 0.8, Figure 3.1D). Knowing about intact postsynaptic function led to testing in a next step the 
functionality of the presynaptic part of the synapse. Therefore, I used the PPF paradigm which allows 
checking for intact short-term synaptic plasticity (Figure 3.1E). The resulting curve revealed no 
differences between the two genotypes within that paradigm. Overall, these results indicate intact 
activity-dependent synaptic plasticity and no alterations at the pre- or postsynapses following APLP1 
deletion in young mice.       
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Figure 3.1: Unaltered activity-dependent synaptic plasticity in young (14 to 16 weeks old) littermate control and APLP-1 KO 
mice. Field excitatory postsynaptic potentials (fEPSPs) were recorded in CA1 region by stimulating Schaffer collateral axons of 
area CA3 at a frequency of 0.1 Hz of littermate control (LM, black circles) and APLP-1 KO mice (open circles). The LTP induction 
rate is shown as percentage % of mean baseline slope. Data points were averaged over 6 time points and error bars indicate 
SEM, n= number of recorded slices/N= number of animals. Data were analyzed by Student´s t-test. (A) After 20 min baseline 
recording, LTP was induced by application of Theta burst stimulation (TBS, arrowhead). Acute slices of APLP1-KO mice displayed 
an LTP curve that is statistical indistinguishable in induction and maintenance to that of littermate controls. Representative 
insets of original traces at baseline (light grey) or following stimulation (black) (B) Averaged potentiation levels of the last 5 
minutes of LTP (55 -60 minutes after TBS) were 147.31 ± 3.79% in littermate control slices compared to 141.59 ± 2.66% in 
APLP1-KOs (Student´s t-test, p= 0.23). (C) Neuronal excitability was comparable at all stimulus intensities (25 – 250 µA) between 
genotypes. (D) Analyzing the Input-Output (IO) strength revealed no alterations between groups at any FV amplitude. (E) PPF 
was unaltered between littermates and APLP-1 KO mice. 
3.1.2 Aged APLP1 Knockout Mice 
As we know from the well-studied constitutive APP-KO, that alterations in synaptic plasticity or 
behavioral performance can be age-related, I investigated also aged APLP1-KO mice (Seabrook et al., 
1999, Ring et al., 2007). Therefore, I have chosen the same age frame of 11 to 12 months when 
impairments in APP-KO mice became visible.  
LTP induction following TBS resulted in an overall and comparable increase in synaptic strength in aged 
APLP1-KO (open circles) and littermate controls at the initial phase of LTP as well as in its maintenance 
(black circles, Figure 3.2A). Similar potentiation levels of 160.81 ± 4.29% for littermate controls versus 
162.03 ± 4.42% in APLP1-KOs (Student´s t-test, p= 0.85) within the final five minutes of LTP recording 
indicated unaltered synaptic plasticity (Figure 3.2B). When assessing basal synaptic transmission by 
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correlating fEPSP slopes to defined stimulus intensities, APLP1-KO mice showed significantly lowered 
responses at stimulus intensities ranging from 100 to 250 µA (p100= 0.02, p125= 0.02, p150= 0.01, p175=0.01, 
p200= 0.008, p225= 0.006, p250= 0.004, Student´s t-test, Figure 3.2C). I obtained similar results when 
adjusting the fiber volley amplitude to values ranging from 0.1 to 0.8 mV and measured the 
corresponding fEPSP slope (Figure 3.2.D). Again, APLP1-KOs revealed impaired excitability at amplitudes 
from 0.3 to 0.8 mV (p0.3= 0.03, p0.4= 0.01, p0.5= 0.04, p0.6= 0.03, p0.7= 0.03, p0.8= 0.04, Student´s t-test, 
Figure 3.2D). Both measurements performed to investigate basal synaptic transmission revealed 
impaired post-synaptic function in aged APLP1-KO mice in comparison to their age-matched littermate 
controls. With the PPF paradigm I further tested for presynaptic functionality, but found no differences 
in short-term synaptic plasticity or fEPSP responses at varying ISIs (Figure 3.2E). Based on the results 
reported before, I show that aged APLP1-KO mice revealed no deficits in activity-dependent short- and 
long-term synaptic plasticity as well as presynaptic function, while basal synaptic transmission is heavily 




Figure 3.2: Impaired basal synaptic transmission in aged (11 to 12 months old) APLP-1 KO mice, but intact LTP. Field excitatory 
postsynaptic potentials (fEPSPs) were recorded in CA1 region by stimulating Schaffer collateral axons of area CA3 at a frequency 
of 0.1 Hz. The LTP induction rate is shown as percentage % of mean baseline slope. Data points were averaged over 6 time 
points and error bars indicate SEM, n= number of recorded slices/N= number of animals. Data were analyzed by Student´s t-test. 
(A) After 20 min baseline recording, LTP was induced by application of Theta burst stimulation (TBS, arrowhead). Acute slices of 
APLP1-KO (open circles) mice displayed an LTP curve that is statistical indistinguishable in induction and maintenance to that of 
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littermate controls (black circles). Representative insets of original traces at baseline (light grey) or following stimulation (black). 
(B) Averaged potentiation levels of the last 5 minutes of LTP (55 -60 minutes after TBS) were 160.81 ± 4.29% in littermate 
control slices compared to 162.03 ± 4.42% in APLP1-KOs (Student´s t-test, p= 0.85). (C) Neuronal excitability was significantly 
altered at stimulus intensities ranging from 100 µA to 250 µA in APLP1-KO acute slices (25 – 250 µA). (D) Analyzing Input-Output 
(IO) strength revealed significantly lowered output characteristics for APLP1-KO mice at FV amplitudes from 0.3 to 0.8 mV. (E) 
PPF was unaltered between genotypes. 
3.1.3 APLP1 KO: Age-Dependent Comparison of Basal Synaptic Transmission 
The results of young and aged APLP1-KO mice indicate that the APP homolog might have an important 
role in supporting basal synaptic transmission. To further prove if aging itself might have an influence on 
the read-out, I plotted the input-output curves for littermate controls and APLP1-KO separated by age 
(Figure 3.3).  
Correlating stimulus intensities and fEPSP slopes of young and aged littermate controls (LM) (Figure 
3.3A) or fEPSP slopes at adjusted fiber volley amplitudes (Figure 3.3C) revealed unaltered input-output 
characteristics with aging. In contrast, acute slices of aged APLP1-KO mice showed impaired excitability 
when compared to young KOs when the stimulus intensity was increased from 100 to 250 µA (p100= 
0.047, p125= 0.02, p150= 0.009, p175=0.005, p200= 0.004, p225= 0.003, p250= 0.003, Student´s t-test, Figure 
3.3B). The same trend can be seen when the fiber volley amplitude was adjusted and significantly for an 












Figure 3.3: Aged APLP1-KO mice 
are impaired in basal synaptic 
transmission. (A) Neuronal 
excitability is unaltered in LM with 
aging. (B) Aged APLP1-KO reveal 
significantly impaired output 
response at stimulus intensities 
from 100 to 200 µA. (C) No 
alteration in input-output behavior 
at defined fiber volley amplitudes 
between young and aged LM. (D) 
By trend reduced excitability in 
aged APLP1-KOs at adjusted fiber 
volley amplitudes. 
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3.2  Conditional APP Triple Knockout Mice 
The investigation of the APP protein family is hindered by the fact that the constitutive triple and nearly 
all double knockouts of APP proteins are embryonically lethal (von Koch et al., 1997, Heber et al., 2000). 
APP triple KO animals suffer of cortical dysplasia resembling human type 2 lissencephaly and show a 
partial loss of Cajal Retzius cells in the cortex at embryonic stage 18.5 (Herms et al., 2004). The 
generation of a conditional APP/APLP1/APLP2 knockout model (described in 2.1.2 and named APP cTKO) 
opened the possibility to investigate synaptic plasticity in viable mice at an age of 3.5 months. The 
breading of APPflox/floxAPLP2flox/floxAPLP1–/– mice with a NexCre-deleter line led to an APP and APLP2 
ablation in excitatory neurons of the forebrain on an APLP1 deficient background starting at embryonic 
stage 11.5. As littermate controls (LM) I used APPflox/floxAPLP2flox/floxAPLP1–/– negative for the Cre-
transgene which means that these are like the young APLP1-KO mice characterized in section 3.1,  
showing no differences in all electrophysiological read-outs used when compared to C57BL/6 mice.  
To study the APP cTKO mice in activity-dependent synaptic plasticity, I recorded the enlargement of 
fEPSP slope for 60 minutes following TBS and observed a pronounced defect in induction and 
maintenance of LTP in acute slices of triple transgenics (Figure 3.4A). The quantification of the 
potentiation of the last five minutes of LTP recording (75 -80 minutes after TBS) revealed a highly 
significant reduction in APP cTKOs with potentiation levels of 109.42 ± 3.37% when compared to that of 
littermate controls: 144.98 ± 4.88% (Student´s t-test, p= 5.72*10-7). Moreover, I investigated if the LTP 
deficit in APP cTKO mice might be accompanied by alterations in basal synaptic properties and tested the 
functionality of pre- and postsynapses. As shown in Figure 3.4C and D, illustrating the input-output 
characteristic of the fEPSP size as a function of stimulus intensity or fiber volley amplitude, APP cTKO 
mice are significantly impaired in their neuronal excitability. In order to further explore if short-term 
plasticity or presynaptic function are affected, I applied the PPF paradigm. APP cTKO yielded also here an 
impairment as the response at high (p(ISI160ms)= 0.016) as well as very short (p(ISI10ms)= 0.047, Student´s t-
test) Inter-Stimulus-Intervals was altered in APP cTKO mice. Altogether these findings indicate that APP, 





Figure 3.4 (next page): APP cTKO reveal a severe LTP deficit, impaired basal synaptic transmission and altered PPF. fEPSPs 
were recorded in CA1 region by stimulating Schaffer collateral axons of area CA3 at a frequency of 0.1 Hz in acute hippocampal 
slices of littermate control (APLP1-KO, black circles) or APP cTKO mice (open circles) at an age of 3.5 months. The LTP induction 
rate is shown as percentage % of mean baseline slope. Data points were averaged over 6 time points and error bars indicate 
SEM, n= number of recorded slices/N= number of animals. Data were analyzed by Student´s t-test. (A) Acute slices of APP cTKO 
mice revealed significantly lower levels of potentiation directly after LTP induction (TBS, arrowhead) compared to littermate 
controls. This impairment is maintained over the complete recording time. Representative insets of original traces at baseline 
(light grey) or following stimulation (black). (B) Averaged potentiation levels of the last 5 minutes of LTP (75 -80 minutes after 
TBS) were highly significant reduced in APP cTKOs compared to that of littermate controls. (C) Neuronal excitability was 
significantly impaired in APP cTKO mice at all stimulus intensities (25 – 250 µA). (D) Analyzing the Input-Output (IO) strength 
revealed strong alterations between genotypes at every FV amplitude tested. (E) PPF was significantly altered at the longest and 
shortest ISI in APP cTKO mice. 




3.3  The Role of the Fe65 Protein Family as Downstream Actors of APP 
The Fe65 family proteins, including Fe65 and the two like proteins Fe65L1 and Fe65L2, are scaffolding 
proteins interacting with the APP protein family members, lipoprotein receptors and regulators of 
cellular processes (Strecker et al., 2016).  The biological importance of the Fe65 protein family has only 
been started to be understood. There are by now only two knockout models. One is the isoform specific 
p97Fe65-KO mouse which has only a loss of the p97 isoform of Fe65, but an upregulated expression of 
the truncated soluble isoform p60 (Wang et al., 2004, Guenette et al., 2006). These mice reveal deficits 
only in non-spatial learning tasks like the temporal dissociative passive avoidance (Wang et al., 2004) or 
the classical fear conditioning, while only aged mice (> 14 months) show deficits in the MWM task (Wang 
et al., 2009). Beside the behavioral phenotype these mice display impaired early-phase LTP elicited by a 
100 Hz train recorded in vivo (Wang et al., 2009). The other mouse model lacks the p97 as well as the 
p60 isoform of Fe65 and displays muscular weakness (Suh et al., 2015). While severe neuronal 
positioning abnormalities were found that are quite similar to that of APP triple KO mice, Fe65-KO and 
Fe65L1-KO mice showed no morphological phenotype (Guenette et al., 2006). Therefore, I studied the 
role of each individual Fe65 family regarding its function in regulating the electrophysiological 
characteristics of hippocampal neurons.    
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Field excitatory postsynaptic potentials were recorded in the CA1 region upon stimulating Schaffer 
collateral axons in the CA3 at a frequency of 0.1 Hz of WT, Fe65-KO, F65L1-KO, and Fe65/Fe65L1-dKO 
mice (9 to 10 months of age). LTP was induced via theta burst stimulation (TBS) after 20 min of baseline 
stimulation and was recorded for 60 min. During these sixty minutes of LTP recording, acute slices of 
Fe65/Fe65L1-dKO mice exhibited lower potentiation compared to WT (p= 0.023) or Fe65L1-KO mice (p= 
0.023, one-way ANOVA, Fig. 3.4A). The overall shape of potentiation after TBS application (LTP curve) of 
Fe65L1-KO was similar to that of WT mice (Figure 3.5A). The potentiation values of the post-tetanic (PTP, 
5 min after TBS) and the stable phase of LTP were averaged for each genotype. Significantly reduced PTP 
was observed in Fe65/Fe65L1-dKO mice when compared to WT mice (184.34 ± 13.97% vs. 277.74 ± 
29.15%, p = 0.013, one-way ANOVA, Fig. 3.5B). Fe65-KO mice also showed reduced PTP compared to WT 
mice, but this was not statistically significant (205.69 ± 10.52% vs. 277.74 ± 29.15%). A significant 
reduction in the maintenance of LTP, obtained from the mean slope of field potentials during the last 30 
min of LTP recording, was observed for Fe65/Fe65L1-dKO mice in comparison to WT (137.67 ± 4.53% vs. 
173.42 ± 12.98%, one-way ANOVA, p= 0.023, Fig. 3.5B). Importantly, for Fe65-KO mice, only a reduction 
in PTP was observed, whereas the overall LTP level 60 minutes after TBS application was only 
significantly affected in Fe65/Fe65L1-dKO mice, suggesting partial overlapping functions of Fe65 and 
Fe65L1 in synaptic plasticity. In order to further elucidate whether the LTP defect and the lower PTP 
observed in Fe65/Fe65L1-dKO and Fe65-KO mice, respectively, were due to altered synaptic 
transmission, I probed the excitability of hippocampal neurons by increasing the fiber volley (FV) 
amplitude (Figure 3.5C) or the stimulus intensity (Figure 3.5D). Analyzing the input-output strength of 
Fe65 protein family deficient mice yielded no alterations between genotypes at any FV amplitude (p> 
0.1, one-way ANOVA). Although not significant, a trend towards hindered excitability was observed in 
Fe65/Fe65L1-dKOs. FV measurements showed for this genotype the lowest input-output curve of all, 
while a trend towards increased fEPSP responses in Fe65L1-KOs showing the highest input-output curve 
(Figure 3.5C) was observed. Significantly effects in neuronal excitability were seen after correlating the 
stimulus intensity to fEPSP response in Fe65/Fe65L1-dKO and Fe65L1-KO mice (Figure 3.5D). 
Fe65/Fe65L1-dKOs revealed significantly reduced excitability of their hippocampal neurons at stimulus 
intensities ranging from 50 up to 200 µA compared to Fe65L1-KO mice (p50µA= 0.0004, p75µA= 0.0009, 
p100µA= 0.0011, p125µA= 0.0031, p150µA= 0.0088, p175µA= 0.016, p200µA= 0.032, one-way ANOVA). These 
results were a hint towards altered postsynaptic functionality in the Fe65/Fe65L1-dKO mice, an 
impairment that could well be responsible for the observed LTP defect. Nevertheless, acute hippocampal 
slices of Fe65-KO mice displayed a similar input-output curve which was comparable to that of WT 
controls. It should be noted, that there was just one significantly increased response of Fe65L1-KO mice 
at 50 µA compared to Fe65-KOs (p= 0.028, one-way ANOVA). Taken together, none of the other 
genotypes showed any alteration in basal synaptic transmission so that I furthermore assessed 
presynaptic functionality and short-term plasticity using the PPF paradigm (Figure 3.5E). The PPF analysis 
yielded significant alterations in the presynapse of Fe65L1-KO mice as they showed altered fEPSP 
responses in comparison to Fe65-KOs (p40ISI= 0.0014, p80ISI= 0.0023, p160ISI= 0.00068, one-way ANOVA) and 
to WT mice (p40ISI= 0.007, p80ISI= 0.028, one-way ANOVA) at ISIs of 40, 80 and 160 ms. None of the other 
genotypes exhibited any significant difference in PPF values. Collectively these data point towards 
altered presynaptic functionality in Fe65L1-KO mice, impaired PTP in Fe65-KOs after LTP induction and a 
deficit in LTP induction as well as maintenance in Fe65/Fe65L1-dKOs leading to the assumption that the 
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Figure 3.5: Electrophysiological recordings on hippocampal slices of Fe65 deficient and WT mice. Recording of fEPSPs on acute 
hippocampal slices of Fe65 single KO mice (dark grey triangles), Fe65L1 single KO mice (light grey triangles), Fe65/Fe65L1 double 
KO (dKO) mice (open circles) or wild type (WT) mice (black circles) in CA1 region by stimulating Schaffer collateral axons of CA3 
at a frequency of 0.1 Hz. (A) LTP was induced by application of TBS after 20 min baseline stimulation (arrowhead). During sixty 
minutes of LTP recording, acute slices of Fe65/Fe65L1-dKO mice exhibited significant lower potentiation compared to WTs (p= 
0.023) and Fe65L1-KO mice (p= 0.023). The phase of post-tetanic potentiation (5 minutes after TBS) revealed for Fe65-KO and 
Fe65/Fe65L1 dKO-mice significant lower levels of potentiation in comparison to Fe65L1-KO or WT mice. The LTP curve of 
Fe65L1-KO mice was similar to that of WT controls. The LTP induction rate is shown as percentage (%) of the mean baseline 
slope. Data points were averaged over 6 time points and error bars indicate SEM, n= number of recorded slices/ number of 
animals. Representative insets of original traces at baseline (light color) or following stimulation (black). (B) Averaged 
potentiation 5 minutes after TBS indicate significantly reduced PTP in Fe65-KO (205.69 ± 10.52%) and Fe65/Fe65L1-dKO (184.34 
± 13.97%) mice and further a significant reduction in the maintenance of LTP in Fe65/Fe65L1-dKO mice (137.67 ± 4.53%) in 
comparison to WT controls (173.42 ± 12.98%, p= 0.023) and Fe65L1-KOs (168.40 ± 5.67%, p= 0.023) by the mean slope of the 
last 30 minutes of LTP recording. (C) Analyzing the input-output strength of Fe65 deficient mice yielded no alterations between 
genotypes at any FV amplitude. (D) Neuronal excitability of Fe65/Fe65L1-dKOs was significantly lower at increased stimulus 
intensities (50 – 200 µA) compared to Fe65L1-KO mice while Fe65-KO and WTs displayed similar IO curves. (E) PPF yielded 
significant alterations in the presynapse of Fe65L1-KO mice as they showed altered PPF in comparison to Fe65-KO and WT mice 
at an inter-stimulus-interval (ISI) of 40, 80 and 160 ms. Data were analyzed by one-way ANOVA followed by Bonferroni´s post-
hoc test. Significant (p< 0.05, *) or highly significant (p< 0.01; **) differences between Fe65-KO and Fe65L1-KO are displayed by 
#, between Fe65L1-KO and Fe65/Fe65L1-dKO using + and between WT and Fe65/Fe65L1-dKO by *. 
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3.4  Acute Inhibition of the APP α-Secretase ADAM-10 
As several studies pointed to a neurotrophic action of APPsα, especially with regard to synaptic plasticity 
(Ring et al., 2007, Taylor et al., 2008), which might occur on a rapid time-scale (Hick et al., 2015), I 
performed electrophysiological recordings upon acute inhibition of the α-secretase ADAM-10. To 
investigate the role of the α-secretase cleavage products in activity-dependent synaptic plasticity, the 
production of APPsα/APLP1sα/APLP2sα was blocked using the ADAM-10 inhibitor GI254023X (Weyer et 
al., 2011) in C57Bl/6 mice. I recorded LTP at the Schaffer collateral-CA1 pathway and applied the 
inhibitor or vehicle control (DMSO) 10 minutes before TBS, while the inhibitor or vehicle control 
circulated continuously throughout 60 minutes of LTP recording.    
First of all, the ADAM-10 inhibitor itself or DMSO had no effect on the baseline fEPSP slopes that were as 
stable as before the application of the respective compound (Figure 3.6A). Following LTP induction fEPSP 
sizes increased in both groups, but to a lesser extent in the ADAM-10 treated acute slices. The lower 
post-tetanic potentiation (PTP) following inhibition of the α-secretase lasted till the end of recording and 
resulted in potentiation levels (t85-90) of 155.37 ± 6.92% in the ADAM-10 treated slices or 169.44 ± 
7.80% in DMSO controls, failing to reach statistical significance (t85-90: p= 0.20, t30-90 p= 0.13, 
Student´s t-test). Despite the fact that I observed no significant reduction on LTP levels, I further 
investigated if basal synaptic transmission or short-term synaptic plasticity were altered due to α-
secretase inhibition. Therefore, I performed FV or PPF measurements 10 min after application of the 
ADAM-10 inhibitor or DMSO control on acute slices. As shown in Figure 3.6C input-output-behavior was 
unaltered following α-secretase inhibition. Analyzing presynaptic functionality revealed a significantly 
increased response at an inter-stimulus-interval (IS) of 80 ms, while no significant differences between 
treatments were observed at any other ISI. Altogether the findings showed that short-term inhibition of 
the α-secretase ADAM-10 had no significant effect on any synaptic transmission characteristic analyzed. 
 




Figure 3.6: Acute inhibition of the α-secretase ADAM-10 during LTP recording at the CA3-CA1 pathway. Recording of fEPSPs on 
acute hippocampal slices 2 to 3 months old C57Bl/6 mice in CA1 region by stimulating Schaffer collateral axons of CA3 at a 
frequency of 0.1 Hz. (A, B) Either DMSO as vehicle control (black circles) or the ADAM-10 inhibitor (10 µM, green circles) were 
washed in 20 minutes before LTP induction by TBS (arrowhead). During sixty minutes of LTP recording DMSO or the inhibitor 
circulated continuously. After LTP induction fEPSP sizes were slightly smaller in ADAM-10 treated slices and lasted till the end of 
recording, resulting in not significant different potentiation levels (t85-90) of 155.37 ± 6.92% in the ADAM-10 treated slices or 
169.44 ± 7.80% in DMSO controls. The LTP induction rate is shown as percentage (%) of the mean baseline slope. Data points 
were averaged over 6 time points and error bars indicating SEM, n= number of recorded slices/ number of animals. 
Representative insets of original traces at baseline (light color) or following stimulation (dark color). (C) Analyzing the input-
output strength of inhibitor treated slices yielded no alterations at any FV amplitude compared to vehicle treated group. (D) PPF 
was significantly increased in ADAM-10 treated slices at the 80 ms ISI, while no significant differences at any other ISI could be 
observed. 
3.5  Viral Gene Transfer of Extracellular Liberated APP Domains and Their Dose-
Dependent Effects on Synaptic Plasticity in APP/APLP2 Deficient Mice 
As the short-term inhibition of the α-secretase ADAM-10 had not provided convincing results, I started 
next another way to investigate the role of the APP cleavage products in synaptic plasticity. I used 
therefore, the well-characterized conditional APP/APLP2 double knockout model (cDKO) in which APLP2 
is constitutively not expressed and APP via the Nex promoter selectively deleted in excitatory neurons in 
the hippocampus and cortex from embryonic stage 18.5 onwards. These mice reveal a strong 
electrophysiological phenotype with a pronounced deficit in induction and maintenance of LTP as well as 
altered presynaptic function (Hick et al., 2015). I could therefore prove if the viral overexpression of the 
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α-secretase cleavage product APPsα might be able to rescue the before mentioned alterations. First 
hints are thereby provided within the study of Hick et al., 2015 where the acute exogenously application 
of recombinant APPsα rescued the LTP deficit, while no rescue in presynaptic function was achieved.  
3.5.1 High Amounts of APPsα Modulate LTP Negatively 
Four weeks following viral injection with the respective virus (AAV-Venus or AAV-APPsα-Venus) with a 
titer of 8*1010 gc/hemisphere, NexCre cDKO or littermate controls (LM) were analyzed regarding 
synaptic plasticity at an age of three to four months. Recording of fEPSPs was performed in CA1 region 
by stimulating the Schaffer collateral axons of area CA3 at a frequency of 0.1 Hz only in slices showing 
expression of the fluorescent protein Venus in the recording areas. Induction of LTP occurred via TBS 
after 20 min baseline recording and was monitored for another 60 minutes (Figure 3.7A). During these 
sixty minutes of LTP recording acute slices of injected NexCre cDKOs revealed a significantly lower 
induction of LTP. In the ongoing LTP progress only APPsα injected NexCre cDKOs yielded an impairment 
in LTP maintenance reaching potentiation levels (t75-80) of 126.52 ± 2.73% which were significantly 
reduced when compared to LM controls with 148.38 ± 4.84% (p= 0.002, one-way ANOVA). Nevertheless, 
I was not able to detect the before described highly significant LTP defect in NexCre cDKO mice (139.39 ± 
4.90%) that received the AAV-Venus control virus, which might be due to the unstable LTP curve during 
the maintenance of LTP in LM controls. I further assessed basal synaptic transmission properties in the 
injected mice and found impairments only in NexCre cDKO mice injected with AAV-Venus when 
compared to the APPsα injected group. This altered neuronal excitability was only detectable when the 
stimulus intensity was correlated to the fEPSP slope (Figure 3.7C, p50= 0.01, p75= 0.02, p100= 0.02, p125= 
0.01, p150= 0.02, p175= 0.02, p200= 0.02, p225= 0.03, p250= 0.04, one-way ANOVA), while I observed no 
differences using the fiber volley amplitude between the groups (Figure 3.7D). Moreover, I studied short-
term plasticity and presynaptic function using the PPF paradigm (Figure 3.7E). None of the viral injected 
animals yielded altered presynaptic functionality. Overall these findings were not like expected as the 
described electrophysiological phenotype of NexCre cDKOs could not be re-produced under control 
conditions (AAV-Venus injections). Furthermore disappointing was the observation that APPsα 
overexpression did not result in a rescue of the LTP deficit like expected from its neurotrophic 
characteristics and based on the positive findings using an acute treatment with recombinant APPsα 
(Hick et al., 2015). 
Based on the study of Taylor and colleagues (2008) which showed a dose-dependent facilitation of 
APPsα on LTP with low (0.3 nM) or high concentrations (1000 nM) having no effect on fEPSP change, I 
asked the question if the viral titer for injection was rightly chosen. In that publication it was indicated 
that 11 nM APPsα significantly increased fEPSP responses, while 3300 nM significantly decreased the 
fEPSP size at PP-DG synapses in vivo. Moreover, surprising was the visual effect of the fluorescent Venus 
signal under normal light seen on the brain surface, hippocampus and cortex during preparation of acute 
hippocampal slices of AAV injected mice pointing towards a high amount of viral expression in the tissue 
(Figure 3.8A). I used only one hemisphere of each injected mouse for LTP recording and fixed the other 
one in Golgi solution to perform later on spine density analysis. By looking at the overview pictures taken 
with an Axioplan 2 imaging microscope (Zeiss) following staining of the sections, a dramatic loss of 
neurons especially in the CA1 region of the hippocampus for all injected viruses can be noticed (Figure 
3.8B). These results led me to further investigate toxic effects which might be initiated by virus 
expression and to prove if moreover immune responses were induced. To this end, I performed 
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immunohistochemical stainings on slices that I fixed in 4% PFA in 0.1M PB when LTP recording was 
completed. Slicing of 400 µm thick acute slices into 30 µm thick sections allowed the staining for 
astrocytes using GFAP or to prove for the inflammatory factor Caspase 3 (Casp-3). As control I used a 
section without intense yellow coloring caused by high expression of the Venus protein (Figure 3.8C 
upper panel) and compared it to slices having a quite high virus load (Figure 3.8C middle and lower 
panel). Comparing the GFAP staining in slices with a strong Venus expression revealed a more intense 
GFAP signal when exposed for the same time like slices with a weaker Venus expression. Especially in 
hippocampal regions with a strong Venus signal GFAP staining is more pronounced and indicates 
astrogliosis. The results for activated Caspase 3 document the initiation of a protease cascade that 
amplifies the apoptotic signaling pathway and lead to rapid cell death in regions with high Venus 




Figure 3.7: High amounts of APPsα or Venus negatively regulate synaptic plasticity in NexCre cDKO and littermate mice. 
fEPSPs were recorded in CA1 region by stimulating Schaffer collateral axons of area CA3 at a frequency of 0.1 Hz in acute 
hippocampal slices of littermate controls injected with AAV-Venus (APLP2-KO, black circles), NexCre cDKO mice with AAV-Venus 
(open circles) or NexCre cDKO that received AAV-APPsα (red circles) at an age of 3 to 4 months, 4 weeks following virus 
injection. The LTP induction rate is shown as percentage % of mean baseline slope. Data points were averaged over 6 time 
points and error bars indicate SEM, n= number of recorded slices/N= number of animals. Data were analyzed by one-way 
ANOVA. (A) Acute slices of both injected NexCre cDKO mice revealed significantly lower induction of LTP following TBS 
(arrowhead), while only the maintenance of NexCre cDKO APPsα injected mice resulted in impaired LTP maintenance. 
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Representative insets of original traces at baseline (light color) or following stimulation (dark color). (B) Averaged potentiation 
levels of the last 5 minutes of LTP (75 -80 minutes after TBS) were highly significant reduced in NexCre cDKO APPsα injected 
mice compared to that of LMs. (C) Neuronal excitability was significantly impaired in NexCre cDKOs overexpressing Venus at 
stimulus intensities ranging from 50 to 250 µA. (D) Analyzing the Input-Output (IO) strength indicated no difference between 
genotypes at any FV amplitude tested. (E) PPF revealed no alterations between groups. 
 
Figure 3.8: Neurotoxic effects following un-tolerated virus titer injections. (A) Left: mouse brain with injection wholes and 
yellow discoloring on the surface. Middle and right panel: unfolded hemisphere with yellow colored hippocampi and cortex. (B) 
Overview images of Golgi-Cox stained coronal sections of LM and NexCre cDKO mice injected with Venus and NexCre cDKO mice 
overexpressing APPsα. Red arrowheads indicate neuronal loss in the CA1 region of the hippocampus. (C) Coronal microtome 
sections of LM with well-tolerated Venus-titer (upper panel) and strong Venus signal (middle) and NexCre cDKO with extensive 
Venus signal. GFAP staining revealed slight upregulation of astrocytes, while staining for active Caspase-3 (Casp-3) showed high 
amounts in animals with high viral titer injections compared to tolerated virus amounts in the upper panel. 
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3.5.2 Viral Driven APPsα Expression Rescues LTP and Impaired PPF in NexCre cDKO Mice 
I performed another round of experiments at which the viral titer was before proven to be non-toxic 
with regard to neuronal death and without prompting immunological responses in injected brain areas.  
Hence, I analyzed NexCre cDKO or littermate controls (LM) stereotactic injected with the respective virus 
(AAV-Venus or AAV-APPsα-Venus) with a titer of 1*109 gc/hemisphere at least 4 weeks before recording 
activity-dependent synaptic plasticity at an age of three to four months. 
To this end I recorded the enlargement of fEPSP slope for 60 minutes following TBS and observed a 
pronounced defect in induction and maintenance of LTP in NexCre cDKO mice overexpressing the control 
AAV_Venus virus when compared to LM controls similarly injected with AAV_Venus (Figure 3.9A). In 
contrast, NexCre cDKO mice overexpressing the APPsα fragment of APP showed a LTP curve progression 
that was not significantly different to that of LMs + AAV_Venus. The quantification of the potentiation 
levels of the last five minutes of LTP recording (75 -80 minutes after TBS) revealed a highly significant 
reduction in NexCre cDKO mice injected with AAV_Venus (128.12± 3.41%) in comparison to LM controls 
(156.69 ± 4.75%; p< 0.001, one-way ANOVA) similarly injected with the control virus. Viral 
overexpression of APPsα in cDKO animals resulted in a rescue of LTP as the averaged potentiation was 
not significantly different when compared to LM controls (150.34 ± 3.55% vs. 156.69 ± 4.75%, p> 0.5) 
injected with AAV_Venus (p= 0.80) and significantly higher than in cDKO mice that received AAV-Venus 
(p< 0.001, one-way ANOVA). Moreover, I investigated if the LTP deficit in NexCre cDKO mice injected 
with the AAV_Venus control virus might be accompanied by impaired presynaptic functionality as it was 
shown for un-injected mice (Hick et al., 2015) or if other basal synaptic properties might be altered and if 
they might be rescued following APPsα overexpression. Analyzing the input-output strength at different 
fiber volley amplitudes (Figure 3.9C) or stimulus intensities (Figure 3.9D) revealed unchanged neuronal 
excitability for all groups. In contrast, the investigation of short-term plasticity and presynaptic function 
using the PPF paradigm yielded significant alterations in NexCre cDKO AAV_Venus injected mice (Figure 
3.9E). Acute slices showed altered PPF in comparison to LM controls expressing Venus at inter-stimulus-
intervals (ISIs) of 10 ms (p= 0.038) and 20 ms (p= 0.025). Surprisingly, viral overexpression of APPsα 
rescued the PPF deficit and increased the PPF responses at every ISI when compared to AAV injected 
NexCre cDKO mice. Altogether the electrophysiological results indicated that with a well-tolerated viral 
titer, APPsα is able to rescue the pronounced LTP deficit in induction and maintenance in NexCre cDKO 
mice. Furthermore, these results pointed out that APPsα might exert its positive effect by improving the 
function of the presynapse.  
 




Figure 3.9: Viral overexpression of APPsα rescues the LTP deficit and impaired short-term synaptic plasticity in NexCre cDKO 
mice. fEPSPs of acute hippocampal slices of littermate control (LM) mice injected with AAV_Venus (black circles), NexCre cDKO 
animals similar injected with AAV_Venus (open circles) and NexCre cDKO mice that received AAV_APPsα (red circles) were 
recorded in CA1 region by stimulating Schaffer collateral axons of area CA3 at a frequency of 0.1 Hz. (A) LTP was induced by 
application of TBS after 20 min baseline stimulation (arrowhead). During sixty minutes of LTP recording acute slices of NexCre 
cDKO mice expressing Venus exhibited significant lower induction and maintenance of LTP compared to LM controls showing 
similar expression of Venus. The LTP curve of NexCre cDKO mice overexpressing APPsα is not significantly different to that of LM 
controls. The LTP induction rate is shown as percentage % of mean baseline slope. Data points were averaged over 6 time points 
and error bars indicate SEM, n= number of recorded slices/N= number of animals. Data were analyzed by one-way ANOVA 
followed by Bonferroni´s post-hoc test. Representative insets of original traces at baseline (light color) or following stimulation 
(dark color). (B) Averaged potentiation of the last 5 minutes of LTP recording (t75-80) indicated significantly reduced LTP in 
NexCre cDKO mice injected with AAV_Venus in comparison to LM controls. Viral overexpression of APPsα in cDKO animals 
resulted in a rescue of LTP. No alterations were detected analyzing the input-output strength of all viral injected mice at any FV 
amplitude (C) as well as stimulus intensity (25 – 250 µA) tested (D). (E) PPF yielded significant alterations in the presynapse of 
NexCre cDKO mice injected with AAV_Venus at ISIs of 10 ms and 20 ms. Viral overexpression of APPsα rescues the PPF deficit 
and increased the PPF responses at every ISI when compared to AAV injected NexCre cDKO. Significant (p< 0.05, *) differences 
between littermates expressing Venus and NexCre cDKO animals injected with AAV_Venus are displayed by * and between 
NexCre injected with AAV-Venus and APPsα by #. 
3.5.3 APPsβ Has No Modulatory Role on Synaptic Plasticity in NexCre cDKO Mice 
Next I studied the relevance of the APPsβ APP fragment in activity-dependent synaptic plasticity. The 
physiological role of that APP cleavage product has been less attended so far. It was used only in a few 
studies as control to APPsα despite the fact that both extracellular peptides differ only in 16 amino acids. 
APPsβ is released upon cleavage of APP by the β-secretase BACE-1 and is thereby slightly shorter than 
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APPsα (see Figure 1.4). Only two studies addressed so far the role of APPsβ in synaptic plasticity using 
electrophysiological recordings in vitro (Hick et al., 2015) or in vivo (Taylor et al., 2008). Thereby APPsβ 
was administered both times acutely. Within the study of Hick and colleagues (2015) the bath 
application of 50 nM recAPPsβ on acute hippocampal slices of APP/APLP2 cDKO mice had no influence 
on LTP or basal synaptic transmission. I used the same conditional mouse model (NexCre cDKO) which is 
also the same model used in the experiments for the AAV-driven APPsα overexpression (see 3.5.1/3.5.2). 
In contrast to the study of Hick et al. (2015) and Taylor et al. (2008) I investigated mice not after an acute 
treatment with APPsβ, but following seven to eight weeks of stable viral driven overexpression upon 
stereotactical injection in the hippocampus with a titer of 1*109 gc/hemisphere.  
To this end I recorded fEPSPs at the Schaffer collateral CA1 pathway at a frequency of 0.1 Hz. 
Potentiation levels of acute slices of NexCre cDKO mice overexpressing APPsβ were indistinguishable in 
induction and maintenance from that of NexCre cDKO injected with the control AAV_Venus virus (Figure 
3.10A). Finally, TBS induced strengthening of fEPSPs resulted in similar potentiation levels for the last 5 
minutes of recording (t75-80: NexCre_AAV-Venus: 125.58± 2.69% vs. NexCre_AAV-APPsβ: 124.42± 
1.96%, p= 0.68, Students t-test, Figure 3.10B). Analysis of basal synaptic transmission properties revealed 
no differences in the input-output characteristics upon variation of stimulus intensity (Figure 3.10C) or 
fiber volley amplitude (3.10D). Moreover, I assessed presynaptic function and in contrast to APPsα, 
APPsβ had no influence on short-term plasticity and was not able to improve presynaptic function 
(Figure 3.10E). Overall these findings suggested that APPsβ, maybe as a consequence of the missing last 
16 amino acids compared to APPsα, lost the potential to promote activity-dependent synaptic plasticity 
and to positively modulate the function of the presynapse when injected with the same titer.   




Figure 3.10: AAV-mediated overexpression of APPsβ failed to rescue the LTP defect of NexCre cDKO mice. (A, B) Activity 
dependent synaptic plasticity was investigated in 6,5 to 7 months old NexCre cDKO mice 7 to 8 weeks after stereotactical virus 
injection. LTP induction and maintenance of mice overexpressing APPsβ (green circles) was unaltered compared to NexCre cDKO 
injected with AAV-Venus control virus (open circles). TBS induced strengthening of fEPSPs resulted in similar potentiation levels 
for the last 5 minutes of recording. The LTP induction rate is shown as percentage % of mean baseline slope. Data points were 
averaged over 6 time points and error bars indicate SEM, n= number of recorded slices/N= number of animals. Data were 
analyzed by one-way ANOVA followed by Bonferroni´s post-hoc test. Representative insets of original traces at baseline (light 
color) or following stimulation (dark color). (C, D) Neither increasing stimulus intensity nor adjusting fiber volley amplitude 
revealed changes in basal synaptic transmission between both groups. (E) The PPF paradigm yielded no differences between 
viral injected NexCre cDKO mice.  
3.6  AVV-driven Expression of APPsα and APPsβ in APP/PS1ΔE9 tg Mice and Their 
Effects on Synaptic Plasticity and Spine Density  
Having confirmed the neurotrophic properties of APPsα, but not APPsβ upon stable overexpression in 
the hippocampus of APP deficient mice with a severe LTP deficit, I proved the potential of APPsα to 
rescue the LTP impairment in AD mice and included moreover a morphological analysis involving spine 
density assessment of hippocampal neurons. 
3.6.1 AVV-driven Expression of APPsα Rescues Synaptic Plasticity and Spine density in 
APP/PS1ΔE9 tg mice 
Based on the observed neurotrophic activity of APPsα during processes of activity-dependent synaptic 
plasticity in APP deficient mice (see 3.5.2), I next proved its relevance using the AD model mice: 
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APP/PS1ΔE9. I wanted to elucidate if APPsα might have the same effect like in APP/APLP2 cDKO mice to 
enhance or even to restore LTP, which is heavily impaired in AD models. APPsα might therefore be of 
therapeutic relevance for the disease. Consequently, APP/PS1ΔE9 tg mice were injected with either a 
control (AAV-Venus) or AAV-APPsα virus in the hippocampus (1010 vg/hippocampus) at an age of twelve 
to thirteen months, a time-point when spatial memory impairments and altered synaptic plasticity are 
well described (Savonenko et al., 2005b, Heneka et al., 2013).  
Four to five months following injection, I recorded  fEPSPs in the CA1 region by stimulating Schaffer 
collateral axons of CA3 at a frequency of 0.1 Hz on acute hippocampal slices of APP/PS1ΔE9 tg mice and 
wild-type littermates (LM) stereotactically injected with AAV_Venus control virus or AAV_APPsα. 
Induction of LTP occurred via TBS after 20 min baseline recording and was monitored for another 60 min 
(Figure 3.11A). During these sixty minutes of LTP recording acute slices of APP/PS1ΔE9 tg mice expressing 
Venus exhibited already at induction of LTP significant lower potentiation levels which lasted throughout 
the whole recording time compared to LMs. The averaged potentiation for the stable phase of LTP, 
ranging from minute 50 to 80 after TBS, was 178.01 ± 8.98% for LMs and thereby significant higher than 
that of APP/PS1ΔE9 tg mice expressing the same fluorescent protein with 148.47 ± 6.04% (p= 0.023, 1-
way ANOVA). Acute slices of APP/PS1ΔE9 transgenics injected with AAV-APPsα showed nearly the same 
potentiation upon TBS in the phase of PTP and LTP like LM slices expressing Venus (Figure 3.11A) 
confirming the beneficial role of the α-secretase released APP fragment. This was moreover visible when 
comparing the averaged potentiation levels in the bar graph (Fig. 3.11B), where no significant alteration 
in the mean potentiation values for the last 30 minutes between LMs 178.01 ± 8.98% and APPsα 
overexpressing transgenics were detectable (167.31 ± 8.98%, p= 0.86, 1-way ANOVA). Next, I 
investigated if the LTP defect identified in acute slices of APP/PS1ΔE9 tg mice expressing the control virus 
was due to altered synaptic transmission. Therefore, the excitability of hippocampal neurons was tested 
by increasing the FV amplitude (Figure 3.11C) or stimulus intensity (Figure 3.11D) to defined values. 
Analyzing the input-output strength of APP/PS1ΔE9 tg animals injected with AAV_Venus using this two 
paradigms revealed no alterations in basal synaptic transmission in comparison to LM slices also 
expressing the fluorescence protein (EPSP: p≥ 0.74 at all stimulus intensities analyzed by 1-way ANOVA; 
FV: p≥ 0.20 at all fiber volley amplitudes analyzed by 1-way ANOVA). Furthermore, addressing the 
functional consequences of APPsα overexpression in transgenic mice indicated unchanged excitability of 
hippocampal CA3/CA1 neurons compared to the two other groups. Consistently these results yielded 
that none of the genotypes was impaired in its postsynaptic functionality, so that I furthermore assessed 
the function of the presynapse and short-term plasticity using the paired-pulse facilitation (PPF) 
paradigm (Figure 3.11E). The PPF yielded significant alterations in the presynapse of hippocampal slices 
of APP/PS1ΔE9 tg mice that received the control AAV_Venus virus compared to LMs similarly expressing 
Venus. There was nearly no facilitation within shorter inter-stimulus-intervals (ISI) in slices of 
APP/PS1ΔE9 tgs injected with AAV_Venus compared to LM+ AAV_Venus slices, reaching a significant 
impairment in presynaptic functionality at an ISI of 10 ms (p= 0.027 1-way ANOVA). Comparing the PPF 
development of APP/PS1dE9 tg mice overexpressing APPsα to LMs that received the AAV_Venus virus 
revealed similar behavior towards the second stimulus applied within that paradigm, only the shortest 
interval tested showed a smaller ratio for the rescue group without reaching significance (p= 0.48). These 
results additionally underline the beneficial role of APPsα as far as I was not able to detect a defect in 
presynaptic function in APP/PS1ΔE9 tg mice following APPsα overexpression. Taken together, 
investigating synaptic plasticity in the hippocampus in vitro revealed a LTP defect for APP/PS1ΔE9 tg 
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animals expressing Venus probably as a result of impaired presynaptic functionality while excitability of 
the postsynapse was unaltered. Moreover, I showed that APPsα restored LTP and the function of the 
presynapse without altering basal synaptic transmission in these AD model mice. 
As far as defects in hippocampal function might be related to altered morphology of CA1 and/or CA3 
pyramidal neurons I next examined spine density in this two areas where LTP recording took place. I 
determined if the mutation in APP and PSN1 alters the spine number of basal and mid-apical dendritic 
segments of hippocampal CA1 and CA3 neurons that might contribute to the observed LTP defect in 
APP/PS1ΔE9 tg animals by using Golgi-Cox staining (Figure 3.11F). Previous studies already indicated 
reduced spine density in various AD mouse models (Spires-Jones and Knafo, 2012) and consistent with 
the literature, I found an overall reduction in spine density in APP/PS1ΔE9 tg mice at both dendritic 
compartments of CA1 and CA3 neurons in comparison to LMs similarly injected with AAV-Venus (Figure 
3.11G,H). At CA1 neurons, the effect was even more pronounced in the basal (p= 0.002, 1-way ANOVA) 
than in the apical (p= 0.04) dendritic segment. The analysis of CA3 neurons revealed significantly fewer 
spines in both basal (p= 0.01) as well as apical (p= 0.014) dendritic branches when comparing AAV-Venus 
expressing APP/PS1ΔE9 tg mice and non-transgenic LMs. Importantly, AAV-APPsα overexpression 
partially restored spine density in apical compartments of CA1 and CA3 segments. A complete rescue of 
the spine density deficit was achieved in basal dendrites of CA1 (p= 0.019) and CA3 dendrites (p= 0.039) 
of APP/PS1ΔE9 tg mice. Collectively, these data indicated that viral driven APPsα expression substantially 









Figure 3.11 (next page): APP/PS1ΔE9 mice reveal structural and functional synaptic impairments that are ameliorated by 
APPsα expression. (A, B) LTP was induced by TBS at hippocampal CA3-CA1 synapses after 20 min baseline recordings 
(arrowhead). Acute slices of AAV-Venus injected APP/PS1ΔE9 animals (open circles) exhibited significant lower induction and 
maintenance of LTP compared to littermate controls (LM, black circles) showing similar expression of Venus (averaged 
potentiation minutes t50-80: 148.47 ± 6.04% vs. 178.01 ± 8.98%, p= 0.021). Viral expression of APPsα (red circles) restored 
potentiation after TBS (171.48 ± 6.29%) in transgenic animals and resulted in an LTP curve progression comparable to that of LM 
controls. The LTP induction rate is shown as percentage % of mean baseline slope, n = number of slices, N = number of mice. 
Representative insets of original traces at baseline (light color) or following stimulation (dark color). (C, D) Input-Output strength 
of all AAV-injected mice showed no alterations between genotypes at any fiber volley (FV) amplitude or stimulus intensity 
tested. (E) Altered PPF at the 10 ms ISI revealed a significant impairment in the presynapse of APP/PS1ΔE9 mice injected with 





 order dendritic branches of apical and basal dendrites of CA1 and CA3 neurons after Golgi-Cox staining, 
scale bar 8 µm. (G) APP/PS1ΔE9 Venus injected mice had significantly less spines at apical (p= 0.043) and basal (p= 0.002) 
dendrites in comparison to their littermate controls. APPsα overexpression partially restored the spine density deficit at apical 
and completely at basal compartments (p= 0.019). (H) Reduced spine density at CA3 apical (p=0.014) and basal (p=0.011) 
dendritic segments of APP/PS1ΔE9 AAV-Venus injected mice that is partially rescued at apical and completely at basal dendrites 
(p= 0.039) by APPsα. N = number of animals, n = number of neurons. Data represent mean ± SEM and were analyzed by one-
way ANOVA followed by Bonferroni´s post-hoc test. 
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3.6.2 APPsβ Has No Modulatory Role on Synaptic Plasticity and Spine Density in APP/PS1ΔE9 
tg Mice 
Next, I investigated if the β-secretase released APP fragment APPsβ had any influence on activity-
dependent synaptic plasticity. Compared to APPsα, APPsβ lacks the last 16 amino acids present at the N-
terminus of the Aβ peptide (Chasseigneaux et al., 2011). Using APP/APLP2 deficient mice (see 3.5.2) no 
modulatory role on synaptic plasticity was found when APPsβ was virally overexpressed for 2 months or 
acutely applied as recombinant peptide on acute hippocampal slices (Hick et al., 2015). Nevertheless, 
little is known about a possible involvement of APPsβ in the pathogenic process of AD and whether 
APPsβ might have a similar neuroprotective potential as APPsα, but to a lower extent (Furukawa et al., 
1996).    
To examine the effects of APPsβ in activity-dependent synaptic plasticity, I recorded the 
electrophysiological response of neurons four to five months after AAV injection (1010 vg/hippocampus) 
at an age of twelve to thirteen months in APP/PS1ΔE9 tg mice. I evaluated if the discrepancies of the 
soluble APP ectodomains seen in APP deficient mice are further mirrored at the functional network level 
of AD mice. Therefore, I induced after 20 minutes baseline recording LTP by TBS (Figure 3.12A). Acute 
slices of littermate control mice (LM) that solely overexpress Venus exhibited a robust LTP induction and 
maintenance, while consistently to the previous study (see 3.6.1) and results of non-injected 
APP/PS1ΔE9 animals (Corrigan et al., 2012, Jonsson  et al., 2013), transgenic mice overexpressing Venus 
revealed a strong LTP deficit (Figure 3.11A). 60 minutes after TBS acute slices of APP/PS1ΔE9-AAV-Venus 
mice reached significantly reduced potentiation levels of 154.09 ± 7.55% when compared to AAV-Venus 
injected LMs 193.33 ± 5.97% (p< 0.001, one-way ANOVA, Figure 3.12B). Analog to my set of experiments 
reported in section 3.6.2, AAV-driven APPsα expression rescued LTP as shown by potentiation levels of 
198.25±8.62% similar to that of littermate controls (p= 0.99, one-Way ANOVA, Figure 3.12B) and this 
time significantly higher than that of APP/PS1ΔE9-Venus transgenics (p= 0.003). AAV-APPsβ treatment in 
contrast failed to restore the impairment of fEPSP strengthening in response to tetanic stimulation 
reflected by only 156.08 ± 5.03% of potentiation, representing the LTP deficit of APP/PS1ΔE9-Venus mice 
(p= 0.99). As previously, I observed impaired presynaptic functionality in the AD mouse model (3.6.1), I 
addressed again basal synaptic transmission properties. I confirmed that there are no alterations in 
postsynaptic function by comparing fEPSP sizes at defined stimulus intensities (Figure 3.12C) or fiber 
volley amplitudes (Figure 3.12D) between genotypes after AAV-injection. The PPF paradigm revealed and 
confirmed altered presynaptic function of APP/PS1ΔE9-Venus mice, getting significant at an inter-
stimulus interval of 20 ms (p= 0.017) compared to LM AAV-Venus injected controls (Figure 3.12E). While 
AAV-APPsα expression rescued the function of the presynapse at stimuli applied at 20 ms (p= 0.009) and 
with a strong tendency at 10 ms (p= 0.06), AAV-APPsβ treatment was again ineffective.  
Next, I determined spine density at CA1 pyramidal neurons by Golgi-Cox staining in the mice used to 
analyze synaptic plasticity since functional changes in synaptic strength often correlate with 
morphological alterations (Figure 3.12H). Indeed, I observed a significant reduction in spine density at 
mid-apical dendrites of hippocampal CA1 neurons for APP/PS1ΔE9 tg mice (p= 0.008, one-way ANOVA) 
and a tendency at basal dendritic compartments (p= 0.09) compared to LMs similarly injected with AAV-
Venus (Figure 3.12F, G). Strikingly and consistent to what I observed previously (see section 3.6.1), 
unaltered spine numbers were obtained after APPsα treatment for both compartments (p> 0.8), while 
AAV driven APPsβ expression didn´t elevate spine density in transgenic mice. Spine number was 
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significantly reduced in AAV-APPsβ injected APP/PS1ΔE9 tg mice at mid-apical dendrites compared to 
LMs (p< 0.001) or APPsα injected mice (p< 0.001). The reduction in spine density was further evident in 
the basal dendritic compartment (p< 0.003). Overall these data indicated that only APPsα expression 
improves functional and structural synaptic impairments in aged APP/PS1ΔE9 tg mice, while APPsβ is not 
capable. 
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Figure 3.12 (previous page): Only APPsα, but not APPsβ overexpression rescues impaired synaptic plasticity and spine density 
in APP/PS1ΔE9 tg mice. (A, B) Activity-dependent synaptic plasticity induced by TBS (arrowhaed) at the hippocampal Schaffer 
collateral CA1 pathway after 20 min baseline recording is shown as percentage % of mean baseline slope (n= number of slices, 
N= number of animals, representative traces shown for each group before and after TBS). Only acute slices of APP/PS1ΔE9 
transgenics overexpressing APPsα (red circles) showed significantly elevated LTP induction and maintenance like littermate 
controls (LM, grey circles), quantified for the last five minutes of LTP in (B) (LM-Venus: 193.33±5.97% vs. APP/PS1ΔE9-APPsα: 
198.25±8.62% ; Tukey´s post-hoc test: p= 0.997). AAV driven APPsβ overexpression in transgenic mice (black circles) failed to 
increase LTP (156.08 ±5.03%) representing the LTP deficit of Venus expressing APP/PS1ΔE9 transgenics (open circles, 154.0908 
±7.55%) when compared to LM-Venus (p< 0.001) or APP/PS1ΔE9-APPsα (p= 0.003). (C, D) Input-Output characteristics assessed 
by increasing stimulus intensity or adjusting the fiber volley amplitude revealed no alterations between groups. (E) The PPF 
paradigm indicated significantly lowered facilitation towards the second stimulus applied for Venus overexpressing APP/PS1ΔE9 
tg (*p= 0.02) when compared to LM controls. Instead of APPsβ, only APPsα overexpression was able to restore that presynaptic 
impairment (
##
p=0.009). (F, G) APP/PS1ΔE9 tg mice injected with Venus or APPsβ revealed a pronounced spine density deficit at 
CA1 apical (p= 0.008) and basal dendrites (p= 0.001) in comparison to LM controls that is restored by APPsα overexpression 




 order dendritic branches of apical and basal dendrites of CA1 neurons after 
Golgi–Cox staining scale bar 8 μm. 
3.6.3 Effect of AAV-driven APPsβ Expression in Wild-type Littermates 
I furthermore proved, if APPsβ overexpression itself may cause alterations in activity-dependent synaptic 
plasticity or basal synaptic properties in wild-type littermate mice (C57Bl/6JxC3H/HeJ, LM) as so far only 
the study of Taylor and colleagues 2008 addressed this question recording LTP in vivo in the dentate 
gyrus (DG) of anesthetized rats. However, that study found no evidence that APPsβ when infused into 
the DG facilitates LTP. Nevertheless, I investigated activity-dependent synaptic plasticity in twelve to 
thirteen months old littermate mice (LM) four to five months upon AAV injection (1010 vg/hippocampus).  
To this end, I recorded fEPSPs at the Schaffer collateral CA1 pathway at a frequency of 0.1 Hz. 
Potentiation levels of acute slices of LMs overexpressing APPsβ were indistinguishable in induction and 
maintenance from that of LMs injected with the control AAV_Venus virus (Figure 3.13A). Finally, TBS 
induced strengthening of fEPSPs resulted in similar potentiation levels for the last 5 minutes of recording 
(t75-80: LM_AAV-Venus: 193.33 ± 5.96% vs. LM_AAV-APPsβ: 180.84 ± 5.18%, p= 0.13, Students t-test, 
Figure 3.13B). Analysis of basal synaptic transmission properties revealed no differences in the input-
output characteristics upon variation of stimulus intensity (Figure 3.13C) or fiber volley amplitude 
(3.13D). Moreover, I assessed presynaptic function using the PPF paradigm which revealed that 
overexpression of APPsβ had no influence on short-term plasticity and didn´t alter presynaptic function 
(Figure 3.13E).  
Additionally, I addressed the consequences of APPsβ overexpression on spine number and investigated 
mid-apical dendrites of CA1 pyramidal neurons following Golgi-Cox staining (Figure 3.13G). I found a mild 
reduction in spine density at CA1 apical (1.58 ± 0.04 vs. 1.48 ± 0.02 spines/µm, p= 0.014, Student´s t-
test), but not at CA1 basal dendrites upon APPsβ overexpression (Figure 3.13F).  
Overall these findings suggest that enhanced APPsβ expression didn´t alter activity-dependent synaptic 
plasticity at the CA1-CA3 pathway in vitro, but that higher amounts of APPsβ in the hippocampus 
reduced the spine number of CA1 midapical dendrites while basal compartments of pyramidal neurons 
were unaffected in wild-type mice. 
 




Figure 3.13: Unaltered synaptic plasticity and transmission by APPsβ overexpression in littermates, but slightly reduced spine 
density. (A, B) Extracellular field recordings at hippocampal CA1-CA3 synapses after TBS stimulation (arrowhead) indicated 
unaltered induction and maintenance of LTP between LMs overexpressing Venus (grey circles) or APPsβ (open circles). The LTP 
induction rate is shown as percentage % of mean baseline slope. Data points were averaged over 6 time points and error bars 
indicate SEM, n= number of recorded slices/N= number of animals. Data were analyzed by one-way ANOVA followed by 
Turkey´s post-hoc test. Representative insets of original traces at baseline (light color) or following stimulation (dark color).  (C, 
D) Neither increased stimulus intensity nor adjusted fiber volley amplitude revealed differences in basal synaptic transmission. 
(E) PPF yielded normal presynaptic function for both groups. (F) APPsβ overexpressing LMs revealed significantly less spines at 





 order dendritic branches of apical and basal dendrites of CA1 neurons after Golgi–Cox staining scale bar 8 μm. 
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3.7  Disturbed Ca2+ Homeostasis in Primary Dissociated Hippocampal Cultures of 
NexCre cDKO Mice 
Neuronal calcium (Ca2+) signaling is important for normal cell function and impairments in Ca2+ handling 
have been implicated in a variety of neurodegenerative disorders including Alzheimer’s disease (AD). 
Alterations in Ca2+ homeostasis have been reported within several in vitro and in vivo studies of mice 
expressing AD associated transgenes, presenilins (PS) and amyloid precursor protein (APP) 
(Etcheberrigaray et al., 1998, Stutzmann et al., 2004, Stutzmann et al., 2006, Kuchibhotla et al., 2008). 
Ca2+ signaling activates a series of different intracellular cascades and genes like the calmodulin kinase II 
(CamKII) and MAP kinase. Moreover, it induces protein modifications that support synaptic function and 
transmission that are further essential for synaptic plasticity (see chapter 1.2.2). Learning and memory 
are based on functional synapses and intact synaptic transmission, something that is altered in AD. LTP 
and LTD are the electrophysiological correlates of learning and memory and have been shown to be 
impaired in several AD mouse models (Mattson and Chan, 2003, Kuchibhotla et al., 2008, Demuro et al., 
2010, Sun et al., 2014, Zhang et al., 2015a) and APP deficient mice (Ring et al., 2007, Weyer et al., 2011, 
Hick et al., 2015). The APP/APLP2 deficient mouse model generated and characterized by Hick and 
colleagues (2015) has despite a pronounced LTP deficit strong alterations in short-term plasticity, 
indicating a possible presynaptic defect and thereby a conceivable Ca2+ handling deficit. To investigate if 
alterations in Ca2+ homeostasis might underlie the observed synaptic plasticity defect, I performed 
quantitative Ca2+ Imaging experiments and induced chemical LTP (cLTP) in primary dissociated 
hippocampal cultures of NexCre cDKO mice. As shown in this thesis that APPsα positively modulated LTP 
and STP, I performed my experiments following viral transduction of the cultures with either a control 
virus (AAV-Syn-Venus) or an APPsα overexpressing virus (AAV-syn-APPsα-Venus). To perform 
quantitative measurements of Ca2+ changes, I used the dual-wavelength indicator Fura-2AM and an 
experimental schedule that allowed me to perform cLTP experiments on a timescale that is comparable 
to the electrophysiologically induced LTP (eLTP).  
To this end I recorded Ca2+ signals six days following virus transduction in vitro using dissociated 
hippocampal cultures of NexCre cDKO embryos prepared at embryonic stage 18.5. I examined Ca2+ 
dynamics at baseline activity (t-20 and t-10), representing the baseline of eLTP recordings, and following 
cLTP induction (t0, t10, t40), being comparable to the initial phase as well as the maintenance of eLTP. As 
the AAV-vectors contained the synapsin promotor, expression of the encoded fluorescent protein Venus 
or APPsα-Venus was restricted to neurons (Fol et al., 2016) and only cells that revealed expression of the 
fluorescent protein were included in the analysis. I depicted the Ca2+ imaging results obtained in the 
analysis in two different ways to facilitate reviewing of the data. The graph in Figure 3.14A illustrates the 
results of littermate controls (APLP2-KO+AAV-syn-Venus= black bars; APLP2-KO+AAV-syn-APPsα-Venus= 
black and white dotted) and NexCre cDKO cultures (APP/APLP2 cDKO+AAV-syn-Venus= red bars; 
APP/APLP2 cDKO+AAV-syn-APPsα-Venus) separately for the treatment, whereas the graph in Figure 
3.14A’ illustrates every time-point recorded during imaging while all genotypes were compared.  
Littermate cultures that received the AAV-syn-Venus control virus (black bars) showed a significant and 
robust increase in cytosolic Ca2+ when cLTP was induced by glycine (gly) application, while endogenous 
glycine receptors were blocked with strychnine (str) (p(t0)< 0.001 , p(t10)< 0.01 , p(t40)< 0.01, one-way 
ANOVA). Nearly the same result was detected in littermates transduced with the AAV virus 
overexpressing APPsα beside that Ca2+ levels upon gly+str stimulation were not significantly elevated at 
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t40 when comparing Ca2+ concentrations at rest and upon cLTP induction (Figure 3.14A).  However, 
NexCre cDKO cultures treated with the control virus showed a significant increase in cytosolic Ca2+, 
indicating that they were able to induce and maintain cLTP but to a lower extent with regard to the 
amount of Ca2+ and which was only significantly elevated for time-points t0 and t10 following chemical 
stimulation (Figure 3.14A). AAV driven APPsα overexpression in NexCre cDKOs increased Ca2+ levels at 
rest, but resulted only in a significant increase upon cLTP induction at t0. The differences in cytosolic Ca2+ 
amount became more obvious when comparing the genotypes at the different imaging time-points 
(Figure 3.14A´). NexCre cDKO cultures with AAV-syn-Venus revealed significantly lower Ca2+ levels at 
baseline actvity (t-10, p< 0.01) when compared to LMs+AAV-syn-APPsα-Venus and upon induction of 
cLTP (p(t0)< 0.01 in comparison to LMs+AAV-syn-APPsα-Venus, p(t0)< 0.05 compared to NexCre cDKO+ 
AAV-syn-APPsα-Venus; p(t10)< 0.05 compared to LMs+AAV-syn-Venus; p(t40)< 0.01 compared to 
LMs+AAV-syn-Venus and LMs+AAV-syn-APPsα-Venus; one-way ANOVA). Depicting only the control 
situation (Figure 3.14B), meaning littermate and NexCre cDKO cultures that were transduced with the 
AAV-syn-Venus virus, identified a significant reduction in basal Ca2+ levels in NexCre cDKOs (p(t-20)= 
0.01, p(t-10)= 0.01, Student´s t-test). The lowered Ca2+ levels at time-points of spontaneous activity were 
sustained upon glycine administration at t0 (p= 0.086) and significantly at t10 (p= 0.0047) and t40 (p= 
0.002). Separately comparing Ca2+ levels of NexCre cDKO cultures that received either the AAV-syn-
Venus or APPsα overexpressing virus (Figure 3.14B´), I could demonstrate that APPsα first of all restored 
Ca2+ levels at baseline activity (p(t-20)= 0.0097, p(t-10)= 0.02) and moreover that the induction of cLTP by 
gly+stry administration resulted in significantly increased Ca2+ responses at t0 (p= 0.007), t40 (p= 0.007) 
and by trend at t10 (p= 0.069). Based on these results two different alterations in Ca2+ handling were 
observed: impaired Ca2+ homeostasis in NexCre cDKO mice and impaired cLTP which was rescued after 
viral APPsα overexpression. As already impaired cytosolic Ca2+ levels without any stimulation might 
contribute to the observed cLTP defect, Ca2+ ratios obtained after cLTP induction were normalized to Ca2+ 
levels at baseline activity (Figure 3.14C, C´). Only LM+AAV-syn-Venus cultures revealed a stable and 
significant increase upon gly+stry stimulation while all other groups showed only significant increases in 
cytosolic Ca2+ at individual time-points following cLTP induction. However, interesting are the results in 
Figure 3.14C´when normalized Ca2+ ratios were compared at the different imaging time-points. These 
data indicated that the relative change in intracellular Ca2+ was almost the same independent of the 
genotype.  
Altogether the results obtained with quantitative Ca2+ imaging revealed that NexCre cDKO mice had 
strongly altered Ca2+ homeostasis, while these cultures were able to respond to the same extent to 
gly+str stimulation with increases in cytosolic Ca2+ that were observed in littermates when cLTP 
responses were normalized to resting Ca2+ amounts. I could further underlie the neurotrophic action of 
APPsα that rescued the Ca2+ homeostasis deficit of NexCre cDKO mice and led to cLTP responses 
observed in control littermates. 
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Figure 3.14 (previous page): Quantitative Ca
2+
 Imaging uncovered a severe Ca
2+
 homeostasis deficit in NexCre cDKO mice 
resulting in impaired cLTP, but can be rescued following APPsα overexpression. Imaging time-points t-20 and t-10 mirror Ca
2+
 
concentration at basal activity, while t0, t10 and t40 reflect the quantified cytosolic Ca
2+
 amount upon glycine (gly) and 
strychnine (str) application. (A) Upon glycine stimulation littermate controls transduced with AAV-syn-Venus showed a strong 
increase in cytosolic Ca
2+
 levels, while littermates overexpressing APPsα failed to reach a significant elevation in cytosolic Ca
2+
 at 
t40. NexCre cDKO cultures treated with the control virus yielded however a significant increase, but to a lower extent. Following 
APPsα overexpression Ca
2+
 levels were significantly higher. (A´) Differences in cytosolic Ca
2+
 became more obvious when 
comparing genotypes at different imaging time-points. NexCre cDKO cultures revealed significantly lower Ca
2+
 levels at basal 
activity (t-10) and upon induction of cLTP. (B) Depicting only the control situation, meaning both genotypes that were 
transduced with the AAV-syn-Venus virus, identified a significant reduction of basal Ca
2+
 levels in NexCre cDKOs. The lowered 
Ca
2+
 levels were sustained upon glycine administration by trend at t0 and significantly at t10 and t40. (B´) Illustration of the 
“rescue” situation (APPsα overexpression in NexCre cDKO cultures) compared to NexCre cDKOs treated with AAV-syn-Venus 
showed that cytosolic Ca
2+
 at basal conditions and upon cLTP induction were restored, beside a strong tendency at t10. (C) 
Normalized cytosolic Ca
2+
 levels to Ca
2+
 load at rest revealed only for LM+AAV-syn-Venus cultures a stable and significant 
increase upon gly+stry stimulation while all other groups showed only significant increases in cytosolic Ca
2+
 at individual time-
points following cLTP induction. (C´) Comparing normalized Ca
2+
 levels between genotypes at single imaging time-points 
revealed no differences in Ca
2+
 increase following gly+stry stimulation. Significances were plotted as *p < 0.05, **p < 0.01 and 
***p < 0.001. Error bars indicate ± SEM, n= number of experiments, N= number of culture preparations. 
3.7.1 Disturbed ER Activity in NexCre cDKO Mice Contributes to Impaired cLTP 
Neurons have several sources of Ca2+ and regulate Ca2+ entry by a variety of channels from the 
extracellular space or by the release of Ca2+ from internal stores. Ligand-gated (e.g. NMDA-R), voltage-
gated Ca2+ (VGCCs or CaV) and store-operated Ca
2+ channels (SOCCs) allow Ca2+ entry following 
depolarization of the membrane, while the main internal Ca2+ stores in neurons are located in the 
endoplasmatic reticulm (ER) (LaFerla, 2002). Cytosolic Ca2+ is pumped by the sarco-/endoplasmic 
reticulum calcium ATPase (SERCA) in the ER Ca2+ store. In contrast, the release of Ca2+ from the ER can 
take place by three different ways. First of all, active G-protein coupled receptors on the plasma 
membrane induce an inositol-1,4,5-trisphosphate (IP3) dependent activation of IP3-receptors or second 
the influx of extracellular Ca2+ into the cytosol triggers ryanodine receptors that in turn induce a Ca2+ 
induced Ca2+ release (CiCR) from the ER. Lastly, the ER contains leak channels composed of Sec61 core 
complexes enabling Ca2+ the efflux from the ER into the cytosol (Samtleben et al., 2013). Ca2+ levels are 
maintained and relatively low at basal conditions (50 to 300 nM), while upon electrical, synaptic or 
receptor-activation the amount of Ca2+ increases rapidly. Thereby the depletion of ER Ca2+ stores initiates 
the influx of extracellular Ca2+ into the cytosol via SOCCs located in the plasma membrane. Hence, 
accumulated cytosolic Ca2+ is replenished and taken up in the ER by the SERCA ATPase. This mechanism is 
called capacitive Ca2+ entry and known to be implicated in the pathogenesis of AD (Leissring et al., 2000, 
LaFerla, 2002). Knowing that ER Ca2+ is mainly implicated in cytosolic Ca2+ levels and was imaged within 
the quantitative approach to investigate if deficits in synaptic plasticity observed in NexCre cDKO mice 
might be the reason led me to the following experiments: to investigate which role plays the ER Ca2+ as 
source for cytosolic Ca2+ entry. Therefore, I blocked the re-uptake of Ca2+ via the SERCA ATPase back into 
the ER by a co-application of cyclopiazonic acid (CPA, 10 µM) during the stimulation of cultures with 
glycine and strychnine.   
Blocking the SERCA-ATPase activity during cLTP induction heavily impaired the maintenance of cLTP in 
littermates with AAV-syn-Venus and AAV-syn-APPsα-Venus as well as NexCre cDKO transduced with 
AAV-syn-APPsα-Venus (Figure 3.15A). Following glycine, strychnine and CPA stimulation all three groups 
revealed only initially a significant increase in cytosolic Ca2+ levels at time-point t0 and a decline of the 
Ca2+ amount in the ongoing imaging procedure. In contrast, NexCre cDKO cultures overexpressing Venus 
showed a highly significant increase in cytosolic Ca2+ levels at t0 and t10 and only a decrease at t40, due 
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to the fact that the reversible CPA blocker was washed out. Even clearer was the picture when 
comparing the genotypes at the different time-points with each other (Figure 3.15A´). NexCre cDKO 
cultures transduced with AAV-syn-Venus revealed significant lower cytosolic Ca2+ levels at basal activity, 
but unaltered Ca2+ increase following gly+stry stimulation when the SERCA ATPase was blocked pointing 
towards altered function of the ER loading ATPase. I moreover normalized the Ca2+ amounts gained upon 
stimulation to the Ca2+ levels at baseline activity (Figure 3.15B, B´). Like in Figure 3.15A, only an initial 
increase at t0 was observable in cytosolic Ca2+ upon gly+str stimulation when CPA was co-applied in both 
littermate cultures as well as NexCre cDKOs transduced with APPsα. In contrast, an intense increase was 
observable in NexCre cDKO cultures overexpressing Venus at initial time-points after cLTP induction (t0 
and t10), which was not maintained till t40. The comparison of normalized Ca2+ levels between 
genotypes at single imaging time-points demonstrated the powerful increase in cytosolic Ca2+ in NexCre 
cDKO+AAV-syn-Venus following gly+stry+CPA stimulation at t0, t10 and t40 in contrast to the other 
groups. Lastly, I illustrated the data obtained in NexCre cDKO mice following glycine and strychnine 
stimulation and of the APP/APLP2 deficient mice upon additional application of CPA (Figure 3.15C, C´). 
While cytosolic Ca2+ levels at baseline actvity were altered in NexCre cDKO mice transduced with AAV-
syn-Venus and rescued upon APPsα overexpression, only the glycine and strychnine stimulation resulted 
in impaired cLTP in the Venus treated cDKO cultures while co-administration of CPA elevated cLTP 
responses to an extent observed in APPsα overexpressing cultures upon glycine and strychnine 
treatment. 
Overall these data indicate that blocking the SERCA-ATPase resulted in highly significant elevated Ca2+ 
levels in NexCre cDKO cultures transduced with AAV-syn-Venus, while this effect was missing in cDKO 
cultures with APPsα overexpression. In conclusion, it could be assumed that in NexCre cDKO mice the 
activity of the SERCA-ATPase might be altered. Further, the read-outs on littermate cultures revealed 







Figure 3.15 (next page): Blocking of the ER-SERCA-ATPase elevates cLTP in NexCre cDKO cultures. Imaging time-points t-20 and 
t-10 mirror Ca
2+
 concentration at rest, while t0, t10 and t40 reflect quantified cytosolic Ca
2+
 amount upon glycine (gly), 
strychnine (str) and cyclopiazonic acid (CPA) application. (A) Blocking the SERCA-ATPase activity during cLTP induction resulted 
only in a significant increase in cytosolic Ca
2+
 levels in littermates with AAV-syn-Venus and AAV-syn-APPsα-Venus as well as in 
NexCre cDKOs overexpressing APPsα at t0, while no maintenance of Ca
2+
 level elevation was observable. In contrast, NexCre 
cDKO mice transduced with AAV-syn-Venus showed a highly significant increase in cytosolic Ca
2+
 levels at t0 and t10 and only a 
decrease at t40. (A´) NexCre cDKO cultures overexpressing Venus revealed significant lower cytosolic Ca2+ levels at rest, but 





 load at rest yielded only an initial increase (t0) in cytosolic Ca
2+
 upon gly+str stimulation when CPA was co-applied in 
both littermate cultures and NexCre cDKOs transduced with APPsα. In contrast, an intense increase was observable in NexCre 
cDKO cultures over-expressing Venus at t0 and t10, which was not maintained till t40. (B´) Comparing normalized Ca
2+
 levels 
between genotypes at single imaging time-points demonstrated the powerful Ca
2+
 increase in NexCre cDKO+AAV-syn-Venus 
following gly+stry+CPA stimulation at t0, t10 and t40. (C, C´) Ca
2+
 ratios obtained with gly+ str (red) and with gly+str+CPA (green) 
stimulation. While Ca
2+
 levels at rest were altered in NexCre cDKO mice transduced with AAV-syn-Venus and rescued upon 
APPsα overexpression, only the gly+stry stimulation resulted in impaired cLTP in the Venus treated cDKO cultures while CPA co- 
application elevated cLTP responses to an extent observed in APPsα overexpressing cultures. Significances were plotted as *p < 
0.05, **p < 0.01 and ***p < 0.001. Error bars indicate ± SEM, n= number of experiments, N= number of culture preparations.  
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3.7.2 Unaltered Ca2+ Signal Frequency in NexCre cDKO Mice 
Beside the investigation of quantitative changes of cytosolic Ca2+ levels, the frequencies of the Ca2+ 
signals occurring at the individual time-points were proven to be altered. Therefore, I plotted the 
frequency of spontaneous activity per minute again separately for each genotype over time or the Ca2+ 
signals of each genotypes per imaging time-point upon glycine (gly), strychnine (str) stimulation only or 
additional CPA administration (Figure 3.16).  
Upon gly+str stimulation all groups showed a significant reduction in Ca2+ frequency elevation when 
comparing the frequency of the spontaneous Ca2+ increase at rest (t-20, t-10) and following cLTP 
induction (t0, t10, t40, Figure 3.16A), indicating a synchronization of the network. Moreover, the Ca2+ 
signals quantified at the different imaging time-points were not different between analyzed groups 
(Figure 3.16A´), supporting that impaired Ca2+ homeostasis and cLTP in NexCre cDKO cultures transduced 
with AAV-syn-Venus were not caused by altered Ca2+ signal frequency. When I co-applied CPA with 
gly+str to induce cLTP while blocking the SERCA ATPase, I observed that the frequency of Ca2+ events was 
only initially (t0) reduced in both littermate cultures, while the frequency increased for t10 and t40, an 
effect which was also seen for NexCre cDKOs transduced with AAV-syn-APPsα-Venus (Figure 3.16B). In 
contrast, NexCre cDKO mice solely expressing Venus showed a significant reduction in Ca2+ signal 
frequency upon gly+str+CPA stimulation. When further comparing the Ca2+ signal frequency between 
genotypes at single imaging time-points no alterations between groups were detected (Figure 3.16B´). 
All in all, the results using gly+stry+CPA stimulation revealed that ER Ca2+ is necessary to maintain cLTP 
(Figure 3.15) and to synchronize the network (Figure 3.16), while blocking of the SERCA ATPase 
significantly enhanced Ca2+ responses upon stimulation (Figure 3.15) without affecting Ca2+ signal 
frequency (Figure 3.16).  




Figure 3.16: Unaltered Ca
2+
 signal frequency in NexCre cDKO mice upon cLTP induction with glycine and strychnine and when 
CPA is co-applied. Imaging time-points t-20 and t-10 reflect the frequency in number of spikes/min at basal Ca
2+
 concentration. 
t0, t10 and t40 depict the quantification of spikes/min upon glycine (gly), strychnine (str) stimulation only or additional CPA 
administration. (A) All groups showed a significant reduction in Ca
2+
 signal frequency upon gly+str stimulation. (A´)  Comparing 
the Ca
2+
 signal frequency between genotypes at single imaging time-points revealed no alterations. (B) Upon co-administration 
of CPA to gly+stry the frequency of Ca
2+
 events was only initially (t0) reduced in littermates, while the frequency increased for 
t10 and t40 also for NexCre cDKO transduced with AAV-syn-APPsα-Venus. NexCre cDKO mice solely expressing Venus showed a 
significant reduction in Ca
2+
 signal frequency upon gly+str+CPA stimulation. (B´) The comparison of Ca
2+
 signal frequency 
between genotypes at single time-points revealed no alterations between groups. Significances were plotted as *p < 0.05, **p < 
0.01 and ***p < 0.001. Error bars indicate ± SEM, n= number of experiments, N= number of culture preparations. 
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3.7.3 Spontaneous Ca2+ Dynamics in NexCre cDKO Cultures 
As mentioned in chapter 3.7.1. the influx of Ca2+ is mediated by Ca2+-permeable ion channels like voltage-
gated Ca2+ channels (VGCCs) or ionotropic glutamate receptors upon neuronal activation (LaFerla, 2002). 
Moreover, the cytosolic Ca2+ concentration is regulated by the SERCA ATPase, pumping Ca2+ into the ER 
and thereby maintaining cytosolic Ca2+ levels. However, the ER contains also Ca2+ leakage channels 
(Sec61) leading to a passive efflux of Ca2+ from the ER into the cytosol (Lang et al., 2011, Schäuble et al., 
2012). The depletion of ER Ca2+ stores initiates the influx of extracellular Ca2+ into the cytosol via SOCCs 
located in the plasma membrane. The study of Samtleben et al., (2015) showed that leaking Ca2+ from 
the ER is not taken up by the ER again but instead leaves the cell across the plasma membrane. The 
resulting loss of ER Ca2+ was shown to be compensated by a continuous Ca2+ influx at rest by activation of 
receptors with SOCC-like properties (Samtleben et al., 2015) like the ones activated upon ER store 
depletion. As the mechanism of capacitive Ca2+ entry is implicated in the pathogenesis of AD (Leissring et 
al., 2000, LaFerla, 2002) and has an important role at basal Ca2+ conditions I designed an experimental 
setup to investigate spontaneous Ca2+ activity without stimulation and to get insights into the function of 
SOCC channels (see Figure 3.17A). Therefore, I adapted the experimental time periods of my setup 
according to the publication of Samtleben et al., 2015.   
Following twenty minutes of adaptation of the cultures to the chamber conditions, I took one image of 
spontaneous Ca2+ activity of the cells, where NexCre cDKO cultures transduced with AAV-syn-Venus 
revealed lower basal Ca²+ levels in comparison to APP/APLP2 deficient ones overexpressing APPsα 
(Figure 3.17B´). Afterwards I reduced the external Ca2+ amount in the perfusion media from 3.8 to 1.3 
mM and acquired images after ten minutes (Figure 3.17A). While only a small decline in the alterations 
of cytoplasmic Ca²+ levels at spontaneous activity was observable in NexCre cDKOs treated with AAV-
Venus, a clearer effect was seen in cultures with AAV-syn-APPsα-Venus (Figure 3.17B). When moreover 
comparing both groups following reduction of external Ca2+, NexCre cDKO+AAV-syn-APPsα-Venus 
revealed by trend a higher change in cytosolic Ca2+ levels at spontaneous activity (Figure 3.17B´). Next, I 
switched the perfusion media back to 3.8 mM Ca2+ and observed the recovery of cytosolic Ca2+ five 
minutes later (Figure 3.17A). The re-addition of external Ca²+ led only to a small increase in the change of 
cytosolic Ca²+ levels at spontaneous activity in NexCre+AAV-syn-Venus cultures, but to a significant 
elevation in cDKOs transduced with AAV-syn-APPsα-Venus (Figure 3.17B, B´). Interestingly, the ratios 
obtained for NexCre cDKO+AAV-syn-Venus cultures were 0.17 before and 0.12 after the re-addition of 
Ca2+, while in NexCre cDKO+AAV-syn-APPsα-Venus the ratios were 0.20 before and 0.23 after Ca2+ re-
addition. These data indicate that under control conditions alterations in cytosolic Ca2+ levels at 
spontaneous activity were not completely restored in NexCre cDKOs, while upon APPsα overexpression 
cells got more sensitive to external Ca2+ and yielded higher changes in Ca2+ levels when cells were 
spontaneous active. To examine then the contribution of ER Ca2+ stores in the cultures, ER stores were 
depleted by co-administration of the SERCA-ATPase blocker CPA (10 µM) while cells were perfused with 
HBSS containing low Ca2+ (1.3 mM) (Figure 3.17A). Monitoring spontaneous Ca2+ signals at these 
conditions revealed reduced alterations in cytosolic Ca2+ levels in both groups at spontaneous cell activity 
with slightly higher ratios in NexCre cDKOs overexpressing APPsα (Figure 3.17B, B´). Afterwards, I 
monitored the SOCC dependent Ca²+ entry by looking at spontaneous Ca2+ signals evoked by restoration 
of external Ca2+ when the SERCA ATPase of the ER is moreover blocked (Figure 3.17A) (Parekh and 
Putney, 2005, Linde et al., 2011). The observation of the SOCC dependent Ca²+ entry revealed only an 
elevation of cytosolic Ca²+ levels in NexCre cDKOs transduced with AAV-syn-APPsα-Venus cultures at 
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times of spontaneous activity, while cDKOs treated with the control virus failed to show a change in Ca²+ 
levels when cells were spontaneous active (Figure 3.17B,B´). In contrast, NexCre+AAV-syn-Venus cultures 
exhibited even a small decline in Ca²+ levels detected at spontaneous activity indicating that the SOCC-
dependent Ca²+ entry might be impaired in NexCre cDKO cultures (Figure 3.17B).  
As under basal conditions, where no stimulation of cells occurred, also voltage-gated Ca2+ channels 
(VGCCs) contribute to the influx of external Ca2+ across the plasma membrane, I performed the same set 
of experiments while blocking these Ca2+ channels using 10 µM Nifedipine (Figure 3.17C). First of all, 
NexCre cDKOs transduced with the control or APPsα overexpressing virus revealed a decrease in the 
alterations of cytosolic Ca2+ levels at spontaneous activity after lowering the amount of external Ca2+ 
from 3.8 to 1.3 mM (Figure 3.17D, D´). In contrast to the series performed without the VGCCs blocker, 
now also NexCre cDKOs treated with AAV-syn-APPsα-Venus showed only a partial elevation in the 
change of cytosolic Ca2+ levels at spontaneous activity, when external Ca2+ was re-added, indicating that 
APPsα might rescue basal Ca2+ levels by enhancing VGCCs function. Next of all, I monitored the 
contribution of SOCCs to basal Ca2+ amounts after depleting ER Ca2+ stores with the SERCA ATPase 
blocker CPA (Figure 3.17C). I observed impaired uptake of external Ca2+ for both groups when cells were 
spontaneously active and when VGCCs and ER Ca2+ stores were blocked, but external Ca2+ in the 
perfusion media was re-stored.  
Overall these data indicate that NexCre cDKOs cultures might have impairments in SOCC-dependent Ca²+ 
entry and that APPsα seems to exert its trophic action at rest by enhancing the influx of external Ca²+ via 
VGCCs.  







Figure 3.17 (next page): Altered Ca
2+
 dynamic in NexCre cDKO cultures at basal conditions. (A) Experimental setup to quantify 
spontaneous Ca
2+
 activity (t1) and following reduction of the external Ca
2+
 amount to 1.3 mM (t2). Next Ca
2+
 was re-added and 
the recovery of Ca
2+
 signals observed (t3). Then, external Ca
2+
 was lowered to 1.3 mM and additionally ER Ca
2+
 depleted by CPA 
administration (t4). The subsequent restoration of external Ca
2+
 to 3.8 mM, while the SERCA-ATPase was blocked, monitored 
then the SOCC mediated Ca
2+
 influx into the cytosol (t5). (B) Small decline in the change of cytosolic Ca
2+
 levels at spontaneous 
activity in NexCre cDKOs+AAV-syn-Venus upon reduction of external Ca
2+
 that was only partial restored when external Ca
2+
 was 
increased to 3.8 mM. SOCC-dependent Ca
2+
 entry was not observable in NexCre cDKOs transduced with the control virus. APPsα 
treated cDKO cultures revealed a decrease in the alterations of cytosolic Ca
2+
 levels at spontaneous activity following reduction 
of external Ca
2+
 and full recovery of relative Ca
2+
 amounts when external Ca
2+
 was re-stored. Small, but detectable SOCC-
dependent Ca
2+
 entry in NexCre cDKOs+AAV-syn-APPsα-Venus cultures at spontaneous cell activity. (B´) Significantly lower basal 
Ca
2+
 levels in NexCre cDKOs transduced with AAV-Venus at spontaneous cell activity and by trend upon lowering of external Ca
2+
 
to 1.3 mM.  Significant smaller change in cytosolic Ca
2+
 levels in NexCre cDKOs+AAV-Venus cultures at spontaneous activity after 
external Ca
2+
 re-storation and when the SOCC-dependent Ca
2+
 entry was monitored. (C) Same experimental setup like shown in 
(A) beside that additional VGCCs were blocked for the whole imaging time by application of 10 µM Nifedipine. (D) Significant 
reduction in the alteration of cytosolic Ca
2+
 levels at spontaneous activity upon reduction of external Ca
2+
 to 1.3 mM and only 
partial recovery when the external Ca
2+
 amount was restored in both groups. No SOCC-dependent Ca
2+
 entry when VGCCs are 
blocked in both cultures. (D´) Unaltered Fura2-AM/Ca
2+
 ratios at spontaneous cell activity between groups when VGCCs were 
blocked additionally. Significances were plotted as *p < 0.05, **p < 0.01 and ***p < 0.001. Error bars indicate ± SEM, n= number 
of experiments, N= number of culture preparations. 
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3.7.4 External Ca2+ Modulates Spontaneous Ca2+ Frequency  
The experimental set-up used to investigate Ca2+ handling at basal activity, where no stimulation 
occurred, and to examine SOCC function in NexCre cDKOs provided me further the possibility to analyze 
the number of spontaneous Ca2+ spikes which occurred at the different experimental conditions as well 
as between groups at the different imaging time-points.  
The reduction of external Ca2+ from 3.8 mM to 1.3 mM significantly elevates the frequency of 
spontaneous Ca2+ spikes within the constant kept imaging duration per time-point (Figure 3.18A, B). This 
increase in spontaneous Ca2+ spikes per minute detected for both NexCre cDKOs cultures was 
independent of the transduced virus and decreased to the same spike number when external Ca2+ was 
re-stored (Figure 3.18B, B´). The same effect was observed when ER Ca2+ stores were emptied at low 
external Ca2+ conditions and after the re-addition of Ca2+ amounts from 1.3 to 3.8 mM (Figure 3.18A, B, 
B´).  
When I moreover applied during the imaging session the VGCC blocker Nifedipine (10 µM), I noticed the 
same behavior of NexCre cDKO cultures, that showed increased spontaneous Ca2+ frequencies at imaging 
time-points with low external Ca2+ (1.3 mM) in contrast to conditions with normal, 3.8 mM, Ca2+ (Figure 
3.18D, D´). There was only one time-point during the experimental setup where NexCre cDKOs 
transduced with AAV-syn-APPsα-Venus revealed a significantly higher spontaneous Ca2+ signal frequency 
when compared to cultures that received the control virus (p= 0.03), while at all other imaging time-
points no significant differences were found between both groups. Maybe the increased spontaneous 
Ca2+ signal frequency affected the SOCC dependent Ca2+ entry when VGCCS were blocked as no 
alterations in number of spontaneous spikes per minute were detected without Nifedipine application 
between groups (Figure 3.18B´, D´).  
Taken together, these results indicated that beside the one alteration found at the imaging time-point to 
monitor SOCC-dependent Ca2+ entry when VGCCS were blocked, the number of spontaneous Ca2+ spikes 
per minute was not altered between genotypes and did thus not influence the amplitude of spontaneous 






Figure 3.18 (next page): External Ca
2+
 modulates spontaneous Ca
2+
 frequency without stimulation in NexCre cDKOs. (A) 
Experimental setup to quantify spontaneous Ca
2+
 activity (t1) and following lowering the external Ca
2+
 amount to 1.3 mM (t2). 
Next, Ca
2+
 was re-added and the recovery of Ca
2+
 signals observed (t3). Afterwards, external Ca
2+
 was lowered to 1.3 mM and 
additional ER Ca
2+
 was depleted by CPA administration (t4). The subsequent restoration of external Ca
2+
 to 3.8 mM while the 
SERCA-ATPase was blocked monitored then the SOCC mediated Ca
2+
 influx into the cytosol (t5). (B) Reducing external Ca
2+
 from 
3.8 mM to 1.3 mM significantly elevates the frequency of spontaneous Ca
2+
 spikes within constant kept imaging duration per 
time-point independently of SERCA ATPase blocking. (B´) Unaltered spontaneous Ca
2+ 
signal frequency between groups at 
individual imaging time-points. (C) Same experimental setup like shown in (A) beside that additional VGCCs were blocked for the 
whole imaging time by application of 10 µM Nifedipine. (D) Significant elevation in spontaneous Ca
2+
 signal frequency upon 
reduction of external Ca
2+
 to 1.3 mM that is reduced to basal conditions when the Ca
2+
 amount was restored. (D´) Significant 
increased spontaneous Ca
2+
 signal frequency in NexCre cDKO+AAV-syn-APPsα-Venus when monitoring SOCC-dependent Ca
2+
 
entry while at all other imaging time-point the number of spikes per minute were not different between groups. Significances 
were plotted as *p < 0.05, **p < 0.01 and ***p < 0.001. Error bars indicate ± SEM, n= number of experiments, N= number of 
culture preparations. 
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3.7.5 APPsα Expression Rescues Spine Density in NexCre cDKO Cultures 
Spines build the active postsynaptic part of the synapse changing in number and shape during synaptic 
plasticity as they are single compartmentalized units (Engert and Bonhoeffer, 1999, Holtmaat and 
Svoboda, 2009, Ho et al., 2011). Thus fewer and less functional spines might cause reductions in synaptic 
activity as the neuronal network is kept in a more immature state which might further be visible in 
altered Ca2+ responses. Importantly Hick and colleagues (2015) described reduced spine numbers with a 
shift from mature mushroom spines towards immature stubby ones in NexCre cDKO hippocampal CA1 
neurons. Impaired spine density might therefore be linked to altered Ca2+ handling upon conditional APP 
and APLP2 deletion, while APPsα was shown to ameliorate spine numbers in APP/PS1ΔE9 tg mice 
(chapter 3.6). To this end I examined spine numbers in dissociated hippocampal cultures of littermate 
and NexCre cDKO mice transduced with the control AAV-syn-Venus or AAV-syn-APPsα-Venus virus after 
transfection of single cells with the fluorescent protein mApple.   
Consistently to the report of Hick and colleagues, hippocampal dendrites of NexCre cDKO cultures 
revealed significantly fewer spines per µm dendrite when compared to littermate controls 
overexpressing APPsα (p= 0.03, one-way ANOVA followed by Bonferroni´s post-hoc test) and by trend to 
littermate controls transduced with AAV-syn-Venus (p= 0.053, Figure 3.19B). Strikingly, viral transduction 
of APPsα rescued spine density in NexCre cDKO cultures (p= 0.024).  
Altogether the results indicate that beside a functional modulation of APPsα regarding Ca2+ channel 
function and ER Ca2+ stores, also a morphological rescue of spine density might contribute to restored 
Ca2+ handling and synaptic plasticity in NexCre cDKO mice and cultures. 
 





 order dendritic branches of hippocampal dendrites of CA1 and CA3 neurons transfected with mApple, scale bar 10 µm. 
(B) NexCre cDKO cultures transduced with AAV-syn-Venus had significantly less spines at dendrites in comparison to littermate 
controls overexpressing APPsα (p= 0.03) and by trend to littermate controls that received AAV-syn-Venus. APPsα overexpression 
rescued spine density in NexCre cDKO cultures (p= 0.024). N = number of embryonal cultures, n = number of neurons. Data 
represent mean ± SEM and were analyzed by one-way ANOVA followed by Bonferroni´s post-hoc test. 
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3.8  The 16 Amino Acid Difference Between APPsα and APPsβ and Its Effect on Synaptic 
Plasticity 
The previous results of this thesis showed that APPsα but not APPsβ was able to rescue severe LTP 
deficits and short-term plasticity in APP deficient mice (see 3.5) as well as in AD model mice (see 3.6). 
Moreover, APPsα restored the cLTP defect as well as altered Ca2+ homeostasis in NexCre cDKO cultures 
(see 3.7). This led me to further investigate if the 16 amino acids (Aβ1-16) building the difference 
between both extracellular released APP peptides, may represent the active neurotrophic domain of 
APPsα. To investigate the function of Aβ1-16 on activity-dependent synaptic plasticity, the murine 
peptide was synthesized and acutely applied on hippocampal slices of APP/APLP2 cDKO mice (NexCre 
cDKO) used already in the AAV overexpression (see 3.5) and Ca2+ imaging experiments (see 3.7). The 
experimental design for the ex vivo application of the recombinant peptide was similar to the one Hick 
and colleagues (2015) used in their study to examine the role of recAPPsα and recAPPsβ on synaptic 
plasticity. Therefore, I pre-incubated acute hippocampal slices of NexCre cDKO for one hour and applied 
the peptide or its scrambled control (Aβ1-16 scr) during the whole fEPSP recording. The peptide 
concentration of 10 nM was based on the effective dose of APPsα used in the experiments of Hick and 
co-workers (2015).    
The exogenous application of recAβ1-16 was sufficient to restore the pronounced deficit in induction 
and maintenance of LTP in NexCre cDKO mice (Figure 3.20A,B) as acute slices of cDKO mice treated with 
the scrambled inactive version of the peptide revealed a LTP curve progression that was significantly 
lower starting directly after TBS. The quantification of the initial potentiation levels during the phase of 
post-tetanic potentiation (PTP) yielded significantly higher potentiation levels for acute slices treated 
with the active Aβ1-16 peptide with 191.49 ± 8.82% when compared to the values reached with the 
inactive peptide (165.12 ± 8.82%, p= 0.041, Student´s t-test, Figure 3.20B). Furthermore, maintained 
potentiation levels following Aβ1-16 application were significant higher than that upon treatment with 
the scrambled peptide (148.08 ± 3.65% vs. 132.18 ± 4.26%, p= 0.0099, Student´s t-test). Moreover, I 
investigated basal synaptic transmission properties upon application of the respective peptide as NexCre 
cDKO mice itself revealed impaired presynaptic function (see 3.5 and (Hick et al., 2015)). The analysis of 
the input-output strength showed that recAβ1-16 nor its scrambled version had any significant effect on 
fEPSP slopes correlated to defined stimulus intensities (Figure 3.20C) or fiber volley amplitudes (Figure 
3.19D), observations that were in line with the results obtained before (see 3.5 and (Hick et al., 2015)). 
Strikingly and consistent with the results I gained with the viral driven overexpression of Venus or APPsα, 
the function of the presynapse was significantly rescued following Aβ1-16 treatment, as the curve of the 
PPF paradigm was at all inter-stimulus-intervals (ISI) applied higher than that of acute slices which 
received Aβ1-16 scr (Figure 3.20E). Significant alterations were observed at ISI of 160 (p= 0.003), 80 (p= 
0.02) and 40 ms (p= 0.002). Altogether, Aβ1-16 might be the neurotrophic domain of APPsα as it rescued 
the LTP deficit as well as short-term synaptic plasticity of NexCre cDKO mice without altering the 
function of the postsynapse.   
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Figure 3.20: Aβ1-16 enhances long and short-term synaptic plasticity in NexCre cDKO mice. Field excitatory postsynaptic 
potentials (fEPSPs) of acute hippocampal slices of NexCre cDKO animals were recorded in CA1 region by stimulating Schaffer 
collateral axons of area CA3 at a frequency of 0.1 Hz after 1 hour pre-incubation with 10 nM Aβ1-16 or Aβ1-16 scrambled. (A) 
LTP was induced by application of TBS after 20 min baseline stimulation (arrowhead). During sixty minutes of LTP recording 
acute slices of NexCre cDKO mice pre-incubated with scrambled Aβ1-16 peptide exhibited significant lower induction and 
maintenance of LTP. The LTP induction rate is shown as percentage % of mean baseline slope. Data points were averaged over 6 
time-points and error bars indicate SEM, n= number of recorded slices/N= number of animals. Data were analyzed by unpaired 
Students t-test. (B) Averaged potentiation levels at LTP induction (t20-25) revealed a significantly enhancement by Aβ1-16 
(191.49±8.82% vs. 165.12±8.82%, p=0.041) that was present over the whole recoding time. Maintained potentiation levels (t75-
80) were significantly increased in the presence of Aβ1-16 (148.08±3.65% vs. 132.18±4.26%, p= 0.0099). (C) No alterations were 
detected analyzing the Input-Output (IO) strength at any FV amplitude or stimulus intensity by Aβ-16 peptide application. (E) 
Aβ1-16 significantly enhanced short-term synaptic plasticity at inter-stimulus intervals of 160, 80 and 40 ms. 
3.8.1 Influence of the α7-nAChR in Aβ1-16 Mediated Signaling in Synaptic Plasticity 
As the results following APPsα and Aβ1-16 administration revealed that LTP as well as short-term 
plasticity and thereby presynaptic function were positively modulated, I proved which receptor might be 
involved in that mechanism. While for APPsα a putative receptor still remains elusive, two presynaptic 
receptors have been proved to be activated at pico- to nanomolar concentrations by the Aβ peptide, 
which contains like APPsα the 16 amino acids of Aβ1-16. Aβ was shown to directly activate the α7-
nicotinic acetylcholine receptor (α7-nAChR) and to thus regulate synaptic plasticity (Puzzo et al., 2008, 
Mehta et al., 2009, Khan et al., 2010) or to associate with metabotropic glutamate receptors (Chin et al., 
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2007). The study of Lawrence and colleagues (2014) further revealed that the N-terminal, hydrophilic 
part of Aβ (Aβ1-15), augments TBS-induced post-tetanic potentiation (PTP) and LTP in mouse 
hippocampal slice and that it moreover rescues the reduced LTP upon high levels of full-length Aβ. 
Within that study it was moreover shown that following bilateral injection of Aβ1-15 contextual fear 
conditioning was enhanced, but attenuated when the nicotinic antagonist methyllycaconitine (MLA) was 
co-applied. Besides MLA also α-Bungarotoxin (α-BTX) is a highly selective antagonist for the α7-nAChR 
and often administered during acute hippocampal slice recordings (Chen et al., 2006b, Puzzo et al., 2008, 
Criscuolo et al., 2015), so that I decided to use it to investigate if the action of Aβ1-16 at the presynapse 
might be mediated by the α7-nAChR. Hence, I pre-incubated acute hippocampal slices of NexCre cDKO 
for 1 h with recombinant Aβ1-16 (Aβ1-16) and provided the peptide further during the whole fEPSP 
recording, while inhibiting the α7-nAChR following administration of 10 nM α-BTX 10 minutes before the 
PPF paradigm was performed or before baseline recording of LTP started. To evaluate the effect of 10 
nM α-BTX itself, I further included a littermate (LM) control group that received no α-BTX or where 10 
nM α-BTX was administered in the same way like in NexCre cDKOs.   
First of all, the fEPSP recordings depicted in Figure 3.21A and B confirmed the potential of Aβ1-16 to 
rescue impaired LTP in induction and maintenance. The LTP curve of NexCre cDKO+Aβ1-16 was 
indistinguishable from that of LMs which is further represented by the quantified LTP values gained for 
the initial phase of LTP as well as during maintenance. To identify the effect of the α-BTX administration 
in LMs or NexCre cDKO mice, I plotted these two groups separately. Blocking of the α7-nAChR interfered 
only slightly with Aβ1-16 action as the initial curve and the quantified fEPSP slopes during PTP were only 
marginally reduced (180.39± 8.33% vs. 169.38± 7.01%, p= 0.34, Student´s t-test, Figure 3.21A´, B´). 
However, the maintenance of LTP was completely unaffected following α-BTX administration in NexCre 
cDKOs (145.88± 4.89% vs. 140.97± 4.43%, p=0.48, Student´s t-test). Contrary were the results I obtained 
upon α7-nAChR blocking in LMs (Figure 3.21A´´, B´´) with significantly reductions during the phase of PTP 
(184.01± 5.59% vs. 158.04± 8.35%, p= 0.026, Student´s t-test) and maintenance of LTP (147.25± 3.87% 
vs. 131.24± 4.99%, p=0.028, Student´s t-test), confirming that the α7-nAChR is involved in mechanisms of 
synaptic plasticity. Moreover, I assessed short-term synaptic plasticity using the PPF paradigm to 
investigate a potential presynaptic action of Aβ1-16 which might be blocked after α-BTX administration. 
Figure 3.21C illustrates that blocking of the α7-nAChR doesn´t alter presynaptic function, neither in the 
presence of Aβ1-16 nor in LMs. Based on this set of experiments I could not exclude that the α7-nAChR 
might be involved in Aβ1-16 mediated signaling as following α-BTX treatment the LTP curve of acute 
slices of NexCre cDKO mice with Aβ1-16 was slightly lower when compared to BTX untreated controls. 
This might be due to the fact that the α7-nAChR is also expressed at postsynapses which might have an 
additional influence besides the presynaptic action of Aβ1-16. Moreover, I found no hints of alterations 
in the functionality of the presynapse upon α-BTX administration in any group which might further 
underline a potential postsynaptic effect following α-BTX treatment.  
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Figure 3.21: α-Bungarotoxin significantly affects PTP and LTP in littermates and slightly interferes with Aβ1-16 at the phase of 
LTP induction in NexCre cDKO mice. After 1 hour pre-incubation with 10 nM Aβ1-16 acute slices were transferred to submerged 
recording chamber and fEPSP recorded at the CA3-CA1 pathway. 10 nM α-Bungarotoxin was washed-in 10 min before the PPF 
paradigm and was present throughout whole LTP recording. (A, B) 10 nM α-BTX significantly reduced LTP induction and 
maintenance in littermates (LM, open circles, B’’: t20-25: p= 0.026 and t75-80: p =0.028 with Students t-test, but not significant 
when plotting all groups and analyzing differences by 1-way ANOVA in (B). (A´, B’) NexCre cDKO treated slices with the α7-
nAChR blocker showed only mildly interference with Aβ1-16 at initial stages of LTP. Maintained potentiation levels were not 
significantly different following α-BTX administration in the presence of Aβ1-16 in NexCre cDKO mice. (C) PPF yielded no 
significant differences after α-Bungarotoxin treatment in littermates or NexCre cDKO mice. 
3.8.2 Co-application of Aβ1-16 and α-Bungarotoxin During Recordings of Synaptic Plasticity 
in NexCre cDKO Mice 
The acute inhibition of the α7-nAChR using 10 nM α-BTX did not confirm that the Aβ1-16 peptide might 
modulate synaptic plasticity by activating the receptor. As the enhancement of synaptic transmission by 
Aβ1-16 could not be reasoned without fail, I started another set of experiments. Thereby, I 
simultaneously pre-incubated the α7-nAChR blocker α-BTX with Aβ1-16 to prevent a possible interaction 
of Aβ1-16 with the nicotinic receptor already during the one hour of pre-incubation with the peptide 
alone.  
The administration of Aβ1-16 and α-BTX at the same time resulted in impaired induction and 
maintenance of LTP following TBS when compared to acute hippocampal slices of NexCre cDKO mice 
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that were treated with the Aβ1-16 peptide alone (Figure 3.22A). Quantification of the average 
potentiation levels during the initial phase of LTP, directly after stimulation revealed significantly lower 
levels for NexCre cDKO mice which received Aβ1-16 and BTX simultaneously (t20-25: 176.23 ± 4.69% vs. 
153.75 ± 5.05%, p= 0.01, Student´s t-test, Figure 3.22B). The same held true for the maintenance phase 
of LTP at the end of recordings where slices in which the α7-nAChR was blocked reached only 
potentiation levels of 129.24± 3.40% which were significantly reduced when compared to NexCre cDKOs 
treated with Aβ1-16 reaching 144.37± 2.34% (t75-80: p= 0.002, Student´s t-test, Figure 3.22B). I assessed 
moreover if following α-BTX administration basal synaptic transmission was altered. The comparison of 
fEPSP slopes at defined stimulus intensities revealed no differences in the input-output behavior 
between groups (Figure 3.22C). I further assessed short-term plasticity using the PPF paradigm and 
found no evidence for altered presynaptic function. Altogether these results indicated that the 
simultaneous application of Aβ1-16 and the α7-nAChR blocker α-BTX impaired activity dependent 
synaptic plasticity without affecting baseline synaptic transmission. 
 
 
Figure 3.22: Co-application of α-Bungarotoxin and Aβ1-16 alters synaptic plasticity in NexCre cDKO mice. After 1 hour pre-
incubation with 10 nM Aβ1-16 or 10 nM Aβ1-16 and 10 nM α-BTX acute slices of NexCre cDKO mice were transferred to a 
submerged recording chamber and fEPSPs were recorded at the CA3-CA1 pathway. Peptide and inhibitor used for pre-
incubation circulated throughout whole LTP recording. (A, B) Hippocampal acute slices treated with 10 nM α-BTX and Aβ1-16 
revealed significantly impaired induction and maintenance of LTP in comparison to slices of cDKO mice recorded in the presence 
of Aβ1-16 alone. (B) Averaged potentiation levels at the phase of post-tetanic potentiation (t20-25: 176.23±4.69% vs. 
153.75±5.05%, p= 0.01) and at the end of recording (t75-80: 144.37±2.34 vs. 129.24±3.40) were significantly reduced in the 
presence of 10 nM α-BTX. (C, D) Neither pre- nor postsynaptic basal transmission was affected by the applied compounds. 
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3.8.3 Efficacy of Aβ1-16 in Comparison to APPsα to Rescue Impaired LTP in NexCre cDKO 
Mice 
I showed already with several electrophysiological recordings that the acute application of Aβ1-16 was 
able to restore impaired synaptic plasticity in APP/APLP2 deficient (NexCre cDKO) mice in vitro (see 3.8 – 
3.8.2). Lastly, I wanted to see if the neurotrophic activity of Aβ1-16 and APPsα is similar in processes of 
activity-dependent synaptic plasticity. To this end, I applied both recombinant peptides in the same way, 
meaning one hour of pre-incubation and circulation during fEPSP recording, on acute hippocampal slices 
of NexCre cDKO mice.  
The fEPSP recordings depicted in Figure 3.23A and B show that the LTP curves following recombinant 
Aβ1-16 or recombinant APPsα administration were indistinguishable in induction and maintenance as 
seen comparing LTP values gained for the initial phase of LTP as well as during maintenance. During the 
phase of post-tetanic potentiation (PTP, t20-25) both groups revealed comparable potentiation levels 
with 198.53 ± 8.35% for NexCre cDKO+ APPsα and 191.49 ± 8.82% for NexCre cDKO+ Aβ1-16. The 
quantification of the last five minutes of LTP recording confirmed no differences in activity-dependent 
synaptic plasticity upon APPsα or Aβ1-16 application (146.15 ± 4.21% vs. 148.08 ± 3.65%). Analyzing the 
input-output strength at different stimulus intensities yielded that both peptides had no significant effect 
on the function of the postsynapse (Figure 3.23C). I further investigated the functionality of the 
presynapse and assessed if both peptides were able to enhance short-term plasticity to the same extent 
(Figure 3.23D). The curves generated applying the PPF paradigm revealed that APPsα and Aβ1-16 
modulate the function of the presynapse equally. Overall these data indicated that Aβ1-16 might be the 
functional domain of APPsα as I observed no differences in activity-dependent synaptic plasticity and 
basal synaptic transmission in NexCre cDKO mice upon treatment with any of the recombinant peptides.   
 




Figure 3.23: Acute application of recombinant Aβ1-16 and APPsα elevates LTP in NexCre cDKO slices to same extent. After 1 
hour pre-incubation with 10 nM Aβ1-16 or APPsα acute slices of NexCre cDKO mice were transferred to a submerged recording 
chamber and fEPSPs recorded at the CA3-CA1 pathway. (A, B) Induction of LTP by TBS resulted in unaltered strengthening of 
fEPSP signals initially and throughout 60 minutes of recording (t20-25: 198.53±8.35% vs. 191.49±8.82% and t75-80: 
146.15±4.21% vs. 148.08±3.65%). (C) The Input-Output curve revealed no alterations between applied peptides at different 
stimulus intensities tested. (D) Aβ1-16 and APPsα modulate presynaptic function of NexCre cDKO mice in the same manner. 
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4 Discussion 
Alzheimer´s disease (AD) is a neurodegenerative disorder with aging as the most significant risk factor. 
AD is the most common form of dementia, being responsible for 60 to 80% of the cases. The number of 
diagnosed patients per year is growing rapidly and intense research focuses on the development of 
effective therapeutics as well as on ways to prevent the disease. While it is well known that 
accumulation of the neurotoxic amyloid β (Aβ) peptide, a cleavage product of the amyloid precursor 
protein (APP), is the key event in the disease, the physiological role of the APP protein family is still not 
fully understood. To develop potential therapeutic approaches it is essential to understand first of all the 
physiological role of the APP protein family and their secreted peptides and as well how they modulate 
synaptic function. Another possibility for AD might be that decreased levels of APP proteolytic products 
generated in the healthy organism lead to synaptic dysfunction. Thus, I analyzed different gene-targeted 
mice in this thesis to elucidate the role of APP/APLPs and their functional domains in processes of 
activity-dependent synaptic plasticity in the hippocampus, a brain region severely affected by AD.   
First of all I could show that the so far less attended APP homolog APLP1 exerts an age-dependent role in 
supporting basal synaptic transmission at the hippocampal CA3-CA1 synapse (chapter 3.1). Moreover, 
the generation of a conditional APP triple KO mouse model allowed me to study synaptic plasticity in 
surviving adult mice and revealed an important role for all three family members during development 
(chapter 3.2). Besides investigating the APP proteins in full-length, I examined the role of their functional 
domains. Elucidating the role of the Fe65 protein family as downstream actors of APP confirmed an 
essential link between the adapter family and APP modulating synaptic function by intracellular signaling 
(chapter 3.3).   
In more detail I assessed the role of the α-secretase cleavage product APPsα and its claimed 
neurotrophic properties. While I found no impairments on hippocampal LTP following acute inhibition of 
the α-secretase ADAM-10 in wild-type mice (chapter 3.4), I show that stable, viral driven expression of 
APPsα in APP/APLP2 deficient mice as well as in a mouse model of AD (APP/PS1ΔE9 tg) restored LTP 
deficits presumably by acting at presynaptic terminals (chapter 3.5, 3.6). In contrast, the 16 amino acid 
shorter APP fragment APPsβ seems not to be involved in processes of synaptic plasticity. The analysis of 
dendritic spine density revealed a pivotal role for APPsα ameliorating spine density in AD mice and 
APP/APLP2 deficient cultures, while APPsβ was again ineffective (chapter 3.6.1, 3.6.2, 3.7.5).   
Moreover, I could show that chemically induced LTP is impaired in primary hippocampal cultures of 
APP/APLP2 deficient mice in Ca2+ imaging experiments. I observed a defect in Ca2+ homeostasis, which 
was rescued upon viral transduction of cultures with APPsα. Within these experiments a dysregulation of 
ER Ca2+ handling and SOCC channel activity was observed for APP/APLP2 deficient cultures consistent 
with results found in the literature for AD mice (chapter 3.7).   
Lastly, I studied the role of the 16 amino acids differentiating the two APP extracellular domains, APPsα 
and APPsβ. The administration of recAβ1-16 revealed that this domain mediates the functional 
neuroprotective properties of APPsα. Pharmacological experiments performed to provide a potential 
targeted receptor yielded that the α7-nAChR receptor might be involved in synaptic signaling during 
processes of synaptic plasticity (chapter 3.8).  
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4.1  APLP1 Deficiency Causes Age-Dependent Impairments in Basal Synaptic 
Transmission 
APLP1 exhibits like the other APP homolog APLP2 an overlapping sequence to APP and thereby also 
partial covering functions. In contrast to the two other family proteins, APLP1 shows restricted 
expression to the brain (Lorent et al., 1995) and is present only in one isoform (Wasco et al., 1992, Paliga 
et al., 1997). The highest presence at the plasma membrane has been observed for APLP1 suggesting 
that it might be the family member with the upmost potential to mediate cell contacts (Kaden et al., 
2009) being crucial to build and maintain synaptic contacts. Thereby enhanced trans or cis interaction of 
APLP1 proteins is accompanied by a reduction of ectodomain shedding (Stahl et al., 2014, Mayer et al., 
2016) and might therefore interfere with the ability to modulate synaptic function. While it was recently 
shown that APP and APLP2 exhibit basal adhesive properties, APLP1 mediated neuronal adhesion is 
dynamic and regulated by zinc (Mayer et al., 2016). Nevertheless, despite the generation and first 
characterization of the conventional APLP1-KO mouse in 2000 by Heber and colleagues, the in vivo 
function of this homolog has been less attended. Heber et al. (2000) described only minor (if any) distinct 
phenotypes of APLP1-KOs. The ablation of the APLP1 gene function caused a 10 % reduction in body 
weight, but did not result in impaired cognitive behavioral performance in the Morris-Water-Maze 
(MWM) task. The only read-out regarding synaptic plasticity was done in vivo at the perforant path-
granule cell synapse (PP-DG) in young adult mice (16–20 weeks old) and revealed unaltered short-term 
plasticity (STP) and LTP, but was associated with enhanced excitatory transmission (Vnencak et al., 
2015). Opposite to the APP/APLP2 DKO mice dying shortly after birth (Heber et al., 2000), the combined 
KO of APP and APLP1 caused no lethality. This underlines the redundant functions within the APP family 
but also unique properties of each member. Interestingly, aged APP-KO mice reveal age-dependent 
impairments in spatial learning (Ring et al., 2007), LTP (Seabrook et al., 1999, Ring et al., 2007) and 
neuronal morphology (Tyan et al., 2012, Weyer et al., 2014), while no age-dependent impairments were 
recognized for APLP2-KO mice (Weyer et al., 2011, Midthune et al., 2012, Weyer et al., 2014). In this 
thesis I addressed the age-dependent characteristics of APLP1-KO mice regarding activity-dependent 
synaptic plasticity. The analysis included young (4 – 6 months, chapter 3.1.1) and aged (11-13 months 
old, chapter 3.1.2) APLP1-KO mice versus their age-matched littermate controls. Following 20 minutes of 
stable baseline recording neither young nor aged APLP1-KO mice displayed alterations in LTP induction 
and maintenance (Figure 3.1A, B and 3.2A, B) in line with intact spatial memory performance in the 
MWM task reported by Heber and colleagues (2000). However, the analysis of basal synaptic 
transmission expressed as the strength of fEPSP responses to excitatory synaptic stimulation revealed 
impaired input-output behavior in aged, but not young APLP1-KO mice (Figure 3.1C, D and 3.2C, D). The 
amplitude of the fiber volley is representative for the number of axons firing an action potential and 
serves as an estimate of the strength of an afferent input. While the amplitude remained the same (like 
the stimulus intensity applied) in controls and APLP1-KOs, but evoked smaller fEPSP responses in aged 
APLP1-KO mice, the defect seems either to be related to postsynaptic alterations or could be due to a 
lower number of synapses at apical dendrites of CA1 neurons of the hippocampus. The latter can be 
proven by spine density analysis as the number of spines represents the amount of excitatory synapses 
and should be done in future experiments. Overall, the electrophysiological results indicate that APLP1 
might have an individual role at the synapse within the APP family, supporting postsynaptic transmission, 
as aged APP and APLP2-KO showed unaltered behavior within these paradigms (Ring et al., 2007, Weyer 
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et al., 2011, Midthune et al., 2012, Tyan et al., 2012). However, I additionally proofed for putative 
presynaptic changes using the paired-pulse-facilitation (PPF) paradigm that further provides information 
about STP in APLP1-KO mice. Analyzing the ratio of the second fEPSP slope versus the first revealed 
unchanged PPF characteristics in young (Figure 3.1E) as well as aged APLP1-KO mice (Figure 3.2E) and 
implied normal presynaptic function in APLP1 deficient mice when compared to littermate controls. 
These results are in line with the presynaptic characteristics described for young and aged APP-KO and 
APLP2-KO mice (Ring et al., 2007, Weyer et al., 2011, Midthune et al., 2012, Tyan et al., 2012) and the 
observations of Vnencak and colleagues (2015) reporting intact STP at PP-DG cell synapses in vivo for 
APLP1 deficient animals. Furthermore consistent with the results of Vnencak and coworkers (2015) I 
found no alterations in LTP in young APLP1-KO mice as observed for other single APP mutants. However, 
as for aged APLP2-KO mice displaying intact LTP (Seabrook et al., 1999, Ring et al., 2007) APLP1-KOs 
showed no age-dependent LTP deficit like the one observed for aged APP-KO (Ring et al., 2007). This in 
conclusion indicates that APP and APLP1 have distinct functions at the synapse. Age-related impairments 
in synaptic plasticity in APP-KO mice have been attributed to the loss of APPsα as the Knock-In of APPsα 
was sufficient to rescue LTP in aged APP-KO mice (Ring et al., 2007, Weyer et al., 2011). While all APP 
family members were shown to interact with NMDA-Rs, possibly by their extracellular domain (Cousins 
et al., 2015), the binding of APLP1sα might initiate different functions at the synapse when compared to 
APPsα.  
The strengthening of fEPSP response to excitatory stimulation (input–output curve) was significantly 
decreased in aged APLP1-KO mice, strongly suggesting that APLP1 is essential for normal postsynaptic 
signal transmission. To prove if aging itself might have an influence on the EPSP or FV read-outs 
performed, I plotted the input-output curves for littermate controls and APLP1-KO separately by age 
(Figure 3.3). While littermate controls showed unaltered neuronal excitability with age, older APLP1-KOs 
were impaired when compared to young mice. Here, altered basal synaptic transmission at the 
postsynapse suggests a loss of synapses, either anatomical or functional (Landfield et al., 1986, Barnes et 
al., 1992, Deupree et al., 1993). While I provide a functional read-out, anatomical alterations need to be 
examined e.g. by spine density and spine morphology analysis. However, while aged APLP1-KO mice 
have a postsynaptic signal transmission deficit, they didn´t show altered LTP meaning that they were 
able to compensate for their impairment upon high frequent stimulation. This might be due to the fact 
that APP is expressed in aged APLP1-KOs and APPsα release, known to facilitate NMDA-R function, is 
enhanced upon tetanic stimulation (Taylor et al., 2008, Moreno et al., 2015) and might thus compensate 
for the loss of APLP1 during LTP recordings.  
4.2  The APP Protein Family Is Essential During Brain Development and Adult Brain 
Function 
As mentioned in the previous chapter, the embryonic lethality caused by the co-deletion of APLP2 with 
one of the other family member indicates the essential role of the gene family in the mammalian 
organism. The only viable DKO is the APP/APLP1 mutant mouse displaying normal brain morphology, but 
reduced body weight (Heber et al., 2000). The differences in embryonic lethality upon APLP2 deletion 
with one of the other APP family member might arise from their overlapping expression patterns 
throughout the body. In contrast to APP and APLP2, APLP1 expression is restricted to the brain (Lorent et 
al., 1995) and thereby not able to overtake functions in the peripheral system, particularly at the 
neuromuscular junction (NMJ), where severe alterations in diaphragm morphology are seen when APP 
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and APLP2 are co-deleted resulting in breathing impairments directly after birth. Additionally the 
expression of APP and APLP2 in proliferative zones of the developing cortex and of APLP1 in the cortical 
plate are indicative for a role of the APP protein family during brain development (Lopez-Sanchez et al., 
2005). In conclusion, the triple KO (TKO) of APP, APLP1 and 2 results in a severe morphological brain 
phenotype which is associated with cranial abnormalities so that TKO mice die shortly after birth. 
Neuronal cells thereby migrate beyond their normal positions building ectopic clusters in dorsal regions 
of the frontoparietal cortex. This focal cortical dysplasia resembles type II lissencephaly of humans. 
Moreover, APP-TKO mice have a reduced number of Cajal Retzius cells which might induce less reelin 
secretion and thus result in neuronal over-migration (Herms et al., 2004). In order to investigate APP 
family protein functions in the adult brain, conditional DKO or TKO mice needed to be engendered. First 
of all, the generation of a conditional DKO for APP and APLP2 provided the possibility to study the 
function of these two proteins in the adult organism (Hick et al., 2015), especially their function in 
excitatory neurons of the forebrain as Cre-mediated deletion of APP was induced under control of the 
NEX promoter (Goebbels et al., 2006). Using a novel conditional approach developed by the laboratory 
of Ulrike Müller at the IPMB, Heidelberg, I was able to investigate adult APP cTKOs 
(NexCre+/TAPPflox/floxAPLP2flox/floxAPLP1–/–). In these mice, on an APLP1 deficient background the ablation 
of APP and APLP2 is initiated at embryonic day 11.5 (E11.5) under the control of the NEX promoter. 
While already the conditional double KO of APP and APLP2 resulted in defective hippocampus-
dependent memory and impaired activity dependent synaptic plasticity possibly caused by altered 
presynaptic function (Hick et al., 2015), APP cTKO mice revealed an even more severe synaptic 
phenotype. Beside a highly pronounced deficit in induction and maintenance of LTP, APP cTKO mice 
showed heavily impaired basal synaptic transmission at the postsynapse additional to already altered 
presynaptic function (Figure 3.4). These results support that APP, APLP1 and APLP2 have an essential 
synaptic role during early development and adult brain function and that the co-deletion of APLP1 
causes additional impairments in synaptic function. The additional postsynaptic transmission deficit is 
further in line with the observation gained for APLP1-KO mice (chapter 3.1, 4.1) revealing an essential 
role for APLP1 at this synaptic compartment. Moreover, during hippocampal slice preparation I 
recognized alterations in the shape of the hippocampus and a massively altered CA1-CA3 cell body layer 
suggesting atrophy that might contribute to the functional impairments in synaptic plasticity. Finally, 
both a morphological analysis by Nissl staining as well as a behavioral characterization and detailed 
analysis of dendritic and spine morphology needs to be done before further functional investigations can 
be performed and final conclusions can be made.  
4.3  The Fe65 Protein Family Interaction with APP/APLPs Is Essential for Synaptic 
Plasticity   
The Fe65 gene family is well-known to associate as adapter molecules by their phosphotyrosine binding 
domain with the intracellular domains of APP and APLPs (Borg et al., 1996, Bressler et al., 1996). The 
Fe65 proteins control the shuttling of a multimeric complex containing the APP intracellular domain 
(AICD), Fe65 and Tip60 into the nucleus where it was shown to regulate gene transcription (Cao and 
Sudhof, 2001), an essential feature regarding long-term modulation of synaptic transmission being 
dependent on new protein synthesis. In addition, Fe65 gene members co-localize with APP in the 
endoplasmatic reticulum (ER) and golgi apparatus and facilitate the translocation of the precursor 
proteins to the cell surface (Sabo et al., 1999). This process might be coupled to activity-dependent 
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synaptic plasticity as under resting conditions APP family members are enriched in intracellular 
compartments (Thinakaran and Koo, 2008) and thus be essential for synaptic function. Most intriguing is 
the fact that Fe65/Fe65L1 double deficient mice show a similar phenotype of cortical dysplasia as 
observed for the APP triple KO animals (Guenette et al., 2006) and have so far not been investigated 
regarding synaptic plasticity. By now only the isoform specific p97 Fe65-KO was shown to have deficits in 
non-spatial learning tasks like the temporal dissociative passive avoidance (Wang et al., 2004, Wang et 
al., 2009) and classical fear conditioning (Wang et al., 2009) independently of age. On the other hand, 
only aged (> than 14 months) p97 Fe65-KO mice revealed altered performance in the hippocampus-
dependent MWM task which is in line with the deficits seen in E-LTP at Schaffer collateral-CA1 synapses 
that was induced by a 100 Hz high-frequent stimulus in vivo (Wang et al., 2009). Hence the results of 
Wang and coworkers already indicated that Fe65 might also be involved in protein-synthesis 
independent forms of plasticity. The age-dependent impairments resemble those of APP-KO mice where 
the APP homologs compensate for the loss of APP at young ages, but fail to do so in older mice 
(Seabrook et al., 1999, Ring et al., 2007). In p97 Fe65-KO mice either a compensation of Fe65L1 or 
Fe65L2 might mask defects in young single KOs or the reported upregulation of the p60 Fe65 isoform 
upon p97 Fe65 deletion. The p60 Fe65 isoform lacks a binding domain being crucial to induce gene 
transcription, but should therefore not cause alterations in E-LTP recordings which is the form of 
plasticity being independent of new protein synthesis (Wang et al., 2009). To get a clearer picture of the 
role of the Fe65 protein family in activity-dependent synaptic plasticity I investigated a Fe65-KO mouse in 
which the p79 as well as p60 isoform were deleted as well as Fe65L1-KO and Fe65/Fe65L1 dKO animals. 
These mice were generated and partially characterized by Guenette and colleagues (2006). Fe65 KO mice 
reveal deficits in the hanging wire task while no overt abnormalities regarding brain morphology were 
noticed. The impairment was moreover seen in Fe65L1-KO mice while only Fe65/Fe65L1-dKOs exhibit 
deficits in neuronal positioning and axon outgrowth in the developing cortex (phenotype of cortical 
dysplasia mentioned above) (Guenette et al., 2006, Suh et al., 2015). The detailed investigation of Fe65-
KO, Fe65L1-KO and Fe65/Fe65L1-dKO mice regarding motor and cognitive function was performed in 
cooperation with P. Strecker and S. Kins from the University of Kaiserslautern and already published 
(Strecker et al., 2016). First of all we were able to show that Fe65-KO mice, also lacking the p60 isoform, 
yielded impaired spatial memory already at young ages. Moreover, impairments within the MWM task 
were noticed for the Fe65L1-KO, while Fe65/Fe65L1-dKO mice showed very strong deficits during the 
task due to altered anxiety, motor activity and impaired vision. Analysis of activity-dependent synaptic 
plasticity (Figure 3.5) revealed consistently pronounced deficits in induction and maintenance of LTP in 
dKO mice, while only the initial induction phase of LTP was affected in Fe65-KOs and no impairments 
were observed for Fe65-L1-KO mice. Interestingly, Fe65-L1-KOs were the only ones displaying 
impairments in presynaptic function (Figure 3.5E) while for Fe65/Fe65L1-dKO an indication towards 
altered postsynaptic function was gained by correlating fEPSP strength to defined stimulus intensities 
(Figure 3.5D). Overall these data led to the assumption that Fe65 proteins are crucial at synapses in 
order to trigger processes of synaptic plasticity, while comparably to the APP protein family, each 
member might have individual roles at synapses. However, the electrophysiological results did not fully 
represent the observations of the MWM task maybe due to slightly alterations in motor function upon 
Fe65 deletion which influenced the behavioral paradigm. Another important fact one needs to consider 
is the upregulation of another Fe65 isoform following the deletion of Fe65 alone or together with Fe65L1 
(Guenette et al., 2006). The p58 protein band found in western blot analysis has a so far unknown 
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identity and it´s increase of around 50 % upon deletion of Fe65 or Fe65L1 might mask deficits as for p90 
Fe65-KO mice. Nevertheless, the electrophysiological data revealed that Fe65 and Fe65L1 are important 
for presynaptic function. Support for the involvement of both Fe65 proteins at the presynapse originates 
from observations made in mature cortical neurons whereupon the lack of the three Mint/X11 proteins, 
which are critically involved in presynaptic vesicle release, increased amounts of Fe65 and Fe65L1 
proteins were noticed (Ho et al., 2006). Another possible important molecule mediating the interaction 
between Fe65 and APP and thereby presynaptic function is the small GTPase ARF6. ARF6 influences 
endocytic and membrane trafficking in neurons and may form a tripartite complex with APP and Fe65 
(Sannerud et al., 2011, Cheung et al., 2014, Tang et al., 2015). Fe65 was shown to stimulate the 
activation of ARF6. ARF6 in turn is involved in processes of activity-dependent synaptic plasticity via the 
regulation of AMPA-R trafficking (Oku and Huganir, 2013) and the cycling of readily releasable synaptic 
vesicles at presynapses (Tagliatti et al., 2016).   
Impaired locomotor activity, synaptic plasticity and deficits at the neuromuscular junction have been 
observed both for Fe65/Fe65L1-dKO and APP mice that lack the Fe65/Fe65L1 interacting site or carry a 
mutation within the binding motif on an APLP2 deficient background (Barbagallo et al., 2011, Weyer et 
al., 2011, Klevanski et al., 2015) confirming an interaction between the two protein families. In 
conclusion, Fe65 and Fe65L1 might mediate downstream signaling of APP/APLPs at the synapse, 
especially by nuclear signaling (Cao and Sudhof, 2001), via the regulation of the actin cytoskeleton 
(Lambrechts et al., 2000, Kimberly et al., 2001), the Ca2+ homeostasis (Nensa et al., 2014) and the 
proteosomal degradation of APP (Chow et al., 2015). Nevertheless, for a complete and clear picture it 
would be necessary to study additional combined DKOs of APP and Fe65 family members to underscore 
the role of both in the central nervous system.  
4.4  Acute Inhibition of α-Secretase Activity Does Not Influence Synaptic Plasticity 
Following α-secretase cleavage of APP family proteins mainly by ADAM-10, APPsα, APLP1sα or APLP2sα 
are released in the extracellular space (Lammich et al., 1999). Evidence from several studies in animals as 
well as in humans suggest that reduced APPsα levels aggravate AD symptoms. It was shown that a 
mutation within the α-secretase cleavage site of the human APP gene caused early onset of dementia 
(Kaden et al., 2012). Lowered production of APPsα lead at the same time to increased levels of toxic Aβ 
species. Moreover, supporting are observations that the complex of ADAM10/SAP97, which is 
mandatory for synaptic ADAM-10 localization, is reduced in AD patients (Epis et al., 2010). Additionally, 
forebrain-specific ADAM-10 conditional KO mice reveal increased Aβ levels and impaired short- as well 
as long-term synaptic plasticity (Prox et al., 2013). The α-secretase cleavage of APP family proteins was 
shown to be activity dependent so that neuronal depolarization, high frequency stimulation as well as 
the activity of metabotropic glutamate and acetylcholine receptors facilitates the production of 
extracellular peptides like APPsα (Nitsch et al., 1992, Nitsch et al., 1993, Fazeli et al., 1994, Gakhar-
Koppole et al., 2008). I addressed the question of whether the acute inhibition of the α-secretase ADAM-
10 in acute hippocampal slices of wildtype mice might interfere with the ability to show intact STP and 
LTP (chapter 3.4). Ten minute inhibition of ADAM-10 activity with the GI254023X compound (Weyer et 
al., 2011) resulted only in slightly lowered induction and maintenance of LTP (Figure 3.6A, B) which was 
not significantly different to vehicle treated controls. A possible explanation for this is that the inhibitor 
was not able to penetrate throughout the hippocampal slice during the application time, reaching the 
intact neuronal layers at around 150 µm depth where fEPSP recordings occurred. Another problem might 
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be that not only ADAM-10, but also ADAM9 and ADAM17 are located at the cell surface and are able to 
cleave APP at the α-secretase site (Lichtenthaler, 2012, Saftig and Lichtenthaler, 2015). While it has been 
reported that the acute application of recombinant APPsα rescues LTP, it needs to be considered that 
the application of the peptide was done for up to one hour before recordings (Hick et al., 2015) and thus 
represent a different “acute” timescale. Nevertheless, consistent to the acute application of recombinant 
APPsα, the acute inhibition of APPsα production does not alter basal synaptic transmission nor 
presynaptic function or STP. Using the GI254023X ADAM-10 inhibitor so far only one study reported 
significant changes in synaptic plasticity in vitro upon the treatment of APLP2 deficient OHCs for five 
consecutive days (Weyer et al., 2011). This further indicates that by the activity of other ADAM 
secretases enough APPsα, APLP1sα or APLP2sα might be produced to exhibit normal LTP when the 
GI254023X ADAM-10 inhibitor is applied acutely. Experiments performed with another ADAM-10 
inhibitor combined with in vivo recordings yielded reduced tetanically evoked NMDA-R currents (Taylor 
et al., 2008) assuming different target specificity and local diffusion problems on inhibitors that cause 
differences in the experimental read-outs. 
4.5  APPsα But Not APPsβ Is the Functional Domain Supporting Synaptic Plasticity 
The APPsα peptide liberated from α-secretase APP processing is a 612 amino acid long protein shown to 
promote the survival and growth of cultured neurons under physiological as well as non-physiological 
conditions including hypoglycemia and glutamate toxicity (Mattson et al., 1993, Furukawa et al., 1996) 
and quite interestingly, against Aβ toxicity (Barger and Mattson, 1996, Guo et al., 1998). Moreover, 
supportive for the neuroprotective function of APPsα are the observations where APPsα attenuates the 
effects of disease-associated insults like excessive NMDA-R activation (Ryan et al., 2013) or impaired 
proteosomal function (Copanaki et al., 2010, Kundu et al., 2016). Neuroprotective functions of APPsα are 
thereby regulated by the binding of APPsα to cell surface expressed APP which in turns initiates the Go 
protein triggered pro-survival Akt kinase pathway by its intracellular domain (Milosch et al., 2014). 
Another possibility might be that APPsα promotes its further production by blocking β-secretase activity 
in a positive feedback cycle (Peters-Libeu et al., 2015). A crucial role of APPsα in synaptogenesis and in 
modulation of spine density has been reported in several animal studies. The Knock-In of APPsα rescued 
the spine density deficit and spine type alterations described for APP-KO mice in vivo (Weyer et al., 2014) 
while only partial restoration was achieved by APPsα in cultured APP-KO neurons in vitro (Tyan et al., 
2012). These reports further depicted that APPsα mediates spine formation and maintenance by 
coupling to a so far unknown receptor distinct from APP as full-length APP is absent in the investigated 
mice and cultures. A recent study of Zou and colleagues revealed decreased cortical spine turnover rates 
in APP-KO mice in vivo, indicating that altered spine dynamics might contribute to impairments in 
synaptic plasticity and memory. Interestingly, APP-KO mice have decreased levels of D-Serine, a co-
agonist for NMDA-Rs (Zou et al., 2016), while recombinant APPsα infusion was shown to enhance 
NMDA-R function, but not recombinant APPsβ (Taylor et al., 2008). Especially the role of APPsα in 
processes of synaptic plasticity implies it to counteract the effects of Aβ. In the late 90´s Ishida and 
colleagues already showed the facilitation of LTP expression induced by 100 Hz stimulation by APPsα 
possibly mediated by a protein kinase G dependent mechanism (Ishida et al., 1997). Recently the acute 
synaptic function of APPsα was demonstrated by the incubation of hippocampal slices of APP/APLP2 
conditional KO mice using 10 nM of the recombinant peptide resulting in a rescue of the severe LTP 
deficit, while again in this context recAPPsβ was ineffective (Hick et al., 2015). Another recent study 
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reported that recAPPsα is able to rescue age-dependent LTP deficits in vitro (Moreno et al., 2015). These 
results were in line with previous findings of Taylor et al. (2008) reporting that intrahippocampal infusion 
of recAPPsα in the dentate gyrus (DG) of anesthetized rats enhances LTP recorded at the PP-DG pathway 
in vivo. Interestingly, that study showed that APPsα exerted an inverted U-shaped dose-dependent 
facilitation of LTP. High amounts of recAPPsα decreased fEPSP responses in the DG, consistent to what 
I´ve seen following the stable viral driven overexpression of APPsα in APP/APLP2 cDKO mice (Figure 3.7). 
Too high levels of APPsα caused toxicity, resulted in severe astrogliosis and increased the inflammatory 
factor Caspase 3 (Casp-3) (Figure 3.8C). Activated Casp-3 is considered as commitment to cell death 
(Elmore, 2007), while astroglios is indicative for cytotoxicity both resulting in a drastic loss of 
hippocampal neurons shown by Golgi-Cox staining of hippocampal sections of injected mice (Figure 
3.8B). Adenoviruses used to drive the transgene expression are immunogenic and used for vaccination of 
humans against infections (Puntel et al., 2010). Indeed, AAV vectors can also elicit dose-dependent 
inflammatory and cytotoxic effects (Thomas et al., 2001, Zirger et al., 2006). In this regard, Ciesielska et 
al. have shown that cell transduction in rodents by an AAV-based vector expressing the green fluorescent 
protein (GFP) increased immunological neurotoxicity when compared to similar vectors expressing 
endogenous proteins, observations that were supported by Samaranch et al. (Ciesielska et al., 2013, 
Samaranch et al., 2014) and consistent to what I have observed upon expression of the fluorescent 
protein Venus. Both studies used the same AAV serotype 9 that has been chosen as vector backbone for 
this thesis and induced immune responses when a foreign marker protein (GFP or in this thesis Venus) 
was expressed. It has in fact been shown that the expression of an endogenous protein in heterogeneous 
sites or at levels well beyond normal expression was sufficient to prime systemic immune responses 
(Chenuaud et al., 2004, Gao et al., 2004) and thus explains the unexpected results gained in the first 
series of recordings, where I was not able to reproduce the described LTP phenotype of NexCre cDKO 
mice. Following determination of a viral titer that was proven to be non-toxic with regard to neuronal 
cell death and did not prompt immunological responses in injected brain areas a next set of 
electrophysiological recordings was performed (chapter 3.5.2). The results indicate that with a well-
tolerated viral titer, APPsα is able to rescue the pronounced LTP deficit in induction and maintenance in 
NexCre cDKO (APP/APLP2 cDKO) mice paralleling enhanced LTP upon acute recAPPsα administration on 
hippocampal slices (Hick et al., 2015) or in the rat DG (Taylor et al., 2008). Furthermore, my results 
indicate that APPsα might exert its positive effects by improving the function of the presynapse 
something that has not been shown following recAPPsα application as PPF curves showed the same 
course for NexCre cDKO slices (Hick et al., 2015). On the contrary, the viral-driven overexpression of 
APPsβ yielded no potential to promote activity-dependent synaptic plasticity or to positively modulate 
the function of the presynapse when injected with the same titer in NexCre cDKO mice (Figure 3.10). 
These results were in line with the observations upon acute extracellular or in vivo application of APPsβ 
on rodent slices or in the rodent brain (Taylor et al., 2008, Hick et al., 2015). The results upon acute as 
well as viral-driven overexpression of endogenous APPsα highlight that the APP extracellular domain 
modulates synaptic function acutely as already established deficits could be rescued in APP deficient 
mice and age-dependent impairments in synaptic plasticity in wildtype rats were restored (Moreno et al., 
2015). The fact, that APPsβ was completely ineffective might be a consequence of the absent last 16 
amino acids compared to APPsα containing a neuroprotective domain (Furukawa et al., 1996). The 
shorter sequence might lead to different conformational structures of APPsβ that in turn might activate 
other types of receptors (Ludewig and Korte, 2017). Importantly, in contrast to APPsα the Knock-In of 
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APPsβ in mice was unable to rescue the perinatal lethality seen for APP and APLP2 DKO mice suggesting 
functional differences between these two large extracellular domains (Li et al., 2010, Weyer et al., 2011). 
Moreover, APPsβ was shown to be 50 to 100 times less protective against glucose deprivation and 
excitotoxicity (Furukawa et al., 1996, Barger and Harmon, 1997) and does not prevent against apoptosis 
mediated cell death (Copanaki et al., 2010). These reported APPsβ characteristics support the differences 
observed in the electrophysiological recordings, where only APPsα but not APPsβ was beneficial.  
4.5.1 APPsα, But Not APPsβ, Rescues the Synaptic Failure in an Alzheimer´s Disease Mouse 
Model  
Having confirmed the neurotrophic properties of APPsα also upon stable viral overexpression, I extended 
my research to the potential of APPsα as therapeutic agent. To this end I performed recordings on a 
APP/PS1ΔE9 tg mouse model of AD, upon the viral driven overexpression of APPsα in animals with 
already established plaque pathology and impairments in memory as well as synaptic plasticity. Thereby 
a single bilateral injection of AAV-APPsα particles was sufficient to mediate long-lasting expression of the 
APP extracellular domain over five months that was well tolerated without apparent adverse effects on 
brain morphology. These experiments were performed in cooperation with R. Fol, J. Bradeau and N. 
Cartier from the University Paris Sud and the INSERM U1169/MIRCen CEA in France and some results 
were already published (Fol et al., 2016) and shown in chapter 3.6. APP/PS1ΔE9 tg mice harbor a 
chimeric human/murine APP construct bearing the swedish double mutation as well as an exon-9-
deleted mutation in the presinilin-1 gene. These mutations lead to a shift in APP cleavage at the γ-
secretase site resulting in higher levels of the amyloidogenic Aβ42 peptide which is prone to aggregate 
(Jankowsky et al., 2004). Transgenic mice exhibit increased levels of Aβ at six months of age and develop 
an accelerated plaque pathology correlating with age. These pathological characteristics are 
accompanied by spatial memory impairments in the Barnes maze and MWM starting to appear at seven 
to eight months of age (Cao et al., 2007, Reiserer et al., 2007). The cognitive deficits become more 
pronounced with age and correlate with increased plaque deposition (Savonenko et al., 2005a, Zhang et 
al., 2011). In line with the literature we observed impaired spatial memory in the MWM task, increased 
Aβ42 levels and plaque load in aged APP/PS1ΔE9 tg mice that overexpressed the control virus AAV-Venus 
in comparison to littermate controls similarly expressing the fluorescent protein (Fol et al., 2016). The 
AAV-mediated APPsα expression was sufficient to rescue the impaired probe trial performance of mice 
in the spatial navigation task and reduced the levels of soluble Aβ species as well as the plaque load in 
the hippocampus and cortex. We moreover proved the modulatory potential of APPsβ in those readouts, 
but found beside a decrease in soluble Aβ levels no evidence for a modulatory role with respect to 
memory restoration or reduction in plaque load. The recognized reductions in Aβ levels by APPsα might 
thereby be mediated by the binding of the extracellular APP domain to the β-secretase BACE-1 leading to 
a reduction in Aβ production (Obregon et al., 2012). We further observed that following APPsα 
expression microglia were recruited and activated in the close vicinity to plaques, something that was 
absent upon APPsβ treatment. Moreover, the observation of an increased expression of TREM2, a 
receptor known to sustain the microglial response to Aβ and shown to function as a sensor for anionic 
lipids (Wang et al., 2015), suggested that microglia were active. The clearance of Aβ and plaques seems 
to be mediated by activated microglia as also the proteolytic enzyme IDE (insulin-degrading enzyme) 
which is produced by microglia (Leissring et al., 2003), was upregulated following APPsα overexpression. 
These results already indicate the pivotal neurotrophic role of APPsα so that I further tested whether the 
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improvements of spatial memory were also reflected on the functional network level. Therefore, I 
analyzed synaptic plasticity representing the cellular correlate of learning and memory as it reveals if 
synapses are able to increase their synaptic strength towards patterns of activity. Consistently to the 
results of non-injected APP/PS1ΔE9 animals (Spires-Jones and Knafo, 2012, Heneka et al., 2013), AAV-
Venus injected transgenic mice exhibited significantly lower induction and maintenance of LTP when 
compared to AAV-Venus injected littermate controls (Figure 3.11, 3.12). AAV-mediated expression of 
APPsα largely ameliorated LTP deficits of APP/PS1∆E9 tg mice as evidenced by a closely overlapping and 
statistically indistinguishable LTP curve to littermate controls. On the contrary, APPsβ overexpression 
failed to enhance LTP. The LTP deficit in APP/PS1∆E9 tg mice was thereby accompanied by impaired 
short-term plasticity evaluated by the PPF paradigm, while basal synaptic transmission was unaltered. 
Notably, AAV-APPsα treatment completely rescued presynaptic functionality while again APPsβ 
administration was proven to be ineffective with acute slices displaying a similar PPF curve which was 
seen for APP/PS1∆E9+AAV-Venus mice. This lead to the conclusion that APPsα positively modulates 
presynaptic function which might than in turn restore LTP. Evidence for that kind of APPsα action is 
based on studies showing that APP is localized at synaptic sites, especially the presynaptic active zone 
(Lassek et al., 2013, Wilhelm et al., 2014). Moreover, also in APP/APLP2 cDKOs APPsα positively 
modulated presynaptic function while viral overexpressed APPsβ showed no effect (Figure 3.9, 3.10). 
Further evidence for a presynaptic action of APP was described in the study of Weyer and colleagues 
(2011) where a reduction in the quantal content as well as in the ready releasable pool of synaptic 
vesicles has been observed at the NMJ for APP/APLP2 mutant mice. Moreover, it has been shown that 
the Knock-In of APPsα was sufficient to rescue impaired LTP in aged APP-KO mice (Ring et al., 2007) 
emphasizing the role of APPsα to positively modulate synaptic plasticity mechanisms.  
As spine density can be seen as a correlate for the number of excitatory synapses, I evaluated if spine 
numbers were changed in the same set of mice used for electrophysiology. Previous studies had 
indicated reduced spine density correlating with cognitive deficits in various AD mouse models as well is 
in AD patients, presumably due to Aβ-mediated toxic effects (Scheff et al., 1990, Scheff et al., 2006, 
Spires-Jones and Knafo, 2012). Consistent with the literature I observed an overall reduction in spine 
density in APP/PS1∆E9 tg mice at both dendritic compartments of CA1 and CA3 hippocampal neurons in 
comparison to littermate controls similarly injected with AAV-Venus (Figure 3.11, 3.12). Importantly, 
AAV-APPsα overexpression restored spine density in apical compartments of CA1 segments and CA3 
neurons, while APPsβ showed also regarding neuronal morphology no modulatory role. Several reports 
already indicated that APPsα might have synaptotrophic properties under pathological conditions, too. 
Mucke and co-workers (1996) reported that moderate overexpression of human APP (huAPP) in 
transgenic mice leads to increased spine density. On the contrary, the expression of mutant huAPP in 
Tg2576 mice decreased spine density in aged animals, whereas an increase in spine density was 
observed in young mice prior to plaque deposition pointing towards a possibly trophic effect of APPsα 
(Lee et al., 2010). Moreover, indirect upregulation of APPsα by transgenic expression of the α-secretase 
ADAM10 (Berger et al., 2015), that is enriched at synaptic contacts (Marcello et al., 2007), increased 
synaptic density supporting the observations I have gained following the analysis of spine numbers in the 
hippocampus of APP/PS1∆E9 tg mice.   
Overall, we could therefore show that increases in spine counts upon viral APPsα expression were 
reflected by a rescue of synaptic plasticity as well as improved spatial memory in AD model mice which 
might not only be important with regard to AD, but also emphasizes the ability of APPsα to enhance 
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memory in normal WT mice or to rescue age-dependent impairments in healthy rats (Moreno et al., 
2015, Xiong et al., 2017). While the receptor that might be activated by APPsα still remains elusive, 
APPsα was shown to facilitate tetanically evoked NMDA-R-mediated currents in vitro (Taylor et al., 2008) 
and might therefore compensate for the impaired expression of NMDA-Rs in AD model mice (Snyder et 
al., 2005). For transmembrane APP an interaction with GluN1/GluN2 NMDA-Rs has been shown in 
immunoprecipitation experiments leading to increased cell surface expression of receptors in vitro 
(Cousins et al., 2009, Cousins et al., 2013), while evidence for a role of APPsα within that mechanism is 
currently missing. Moreover supporting the role of APPsα in mechanisms of plasticity is the increase of 
synaptodendritic de novo protein synthesis upon recAPPsα administration (Claasen et al., 2009), which is 
inhibited in AD (Li et al., 2011). However, a recent study suggested that cell surface holo-APP is a 
receptor binding APPsα and conferring neuroprotection via a G protein-coupled activation of the Akt 
stress signaling pathway (Milosch et al., 2014). In the latter study holo-APP was assumed as a receptor 
mediating pro-survival and anti-apoptotic signaling, while the experiments of Hick and colleagues (2015) 
indicate that APPsα is able to mediate the rescue of LTP on an acute time-scale in the absence of APP 
and APLP2 using APP/APLP2 mutant mice. Despite the fact that the complete mechanism how APPsα 
might mediate its trophic properties is still not fully clarified, it provides evidence that synaptic repair 
might be an option to ameliorate pathophysiology and to improve the clinical outcome as an alternative 
to eliminate toxic factors as a recent concept (Lu et al., 2013). Synapses have a highly plastic nature so 
that synaptic dysfunction and loss of synapses are reversible processes and APPsα might be a potential 
therapeutic agent to rescue synaptic failures even in the presence of pathological symptoms. In this 
regard the review of Mockett et. al 2017 discusses the potential to either enhance α-secretase mediated 
APP processing or to upregulate APPsα expression by other means as an alternative to the promising 
results gained with anti-Aβ antibody treatments of AD patients (Sevigny et al., 2016). Besides in AD 
therapy, the administration of APPsα was also shown to protect against acute forms of brain injury in 
vivo like transient ischemia (Smith-Swintosky et al., 1994) or traumatic brain injury (Corrigan et al., 2012, 
Corrigan et al., 2014, Plummer et al., 2016) reinforcing the potency of APPsα as therapeutic tool.  
Despite the fact that APPsβ lacks only 16 amino acids compared to APPsα, the physiological function of 
this extracellular APP domain has been less attended so far. Only a few studies took APPsβ as control 
condition when investigating the biological functions of APPsα. Importantly, the neuroprotective 
properties of APPsα in comparison to APPsβ are best demonstrated by the study of Li and colleagues 
(2010). While the knock-in of APPsα rescued the lethality of APP/APLP2-DKO mice, APPsβ was ineffective 
(Li et al., 2010). With regard to synaptic plasticity, APPsβ cannot restore the LTP defect of APP/APLP2 
cDKO mice (Hick et al., 2015) and does not facilitate LTP recorded in vivo within the DG of rats (Taylor et 
al., 2008). APPsβ was further shown to have no influence on synaptic protein synthesis (Claasen et al., 
2009). Consistent with the functional readout on synapses, Tyan et al. (2012) showed that only APPsα 
but not APPsβ partially rescued defects in dendritic spine number and morphology of primary 
hippocampal neurons from APP-KO mice. In this thesis I consistently observed that APPsβ does not 
influence synaptic transmission neither in APP-deficient mice (chapter 3.5.3), in AD model mice (chapter 
3.6.2) nor in WTs (chapter 3.6.3). I further showed that APPsβ was ineffective to restore spine density in 
APP/PS1∆E9 tg mice and moreover slightly reduced spine numbers in WT animals. 
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4.6  The APP Family is Essential for Intact Ca2+ Homeostasis 
Neuronal calcium (Ca2+) signaling is an important prerequisite for normal cell function and impairments 
in Ca2+ handling have been implicated in a variety of neurodegenerative disorders including AD. 
Alterations in Ca2+ homeostasis have therefore been reported within several in vitro and in vivo studies 
of mice expressing the AD associated transgenes, presenilins (PS) and APP. It was shown that mutations 
within the genes causing familial AD affect endoplasmatic reticulum (ER) Ca2+ signaling by overloading ER 
stores resulting in exaggerated Ca2+ release (Etcheberrigaray et al., 1998). In 3x transgenic AD mice, the 
PSEN1-M146V mutation augmented Ca2+ release from IP3- and caffeine-gated stores in hippocampal and 
cortical neurons (Stutzmann et al., 2004, Stutzmann et al., 2006). Moreover, fibroblasts derived from AD 
patients carrying the Swedish APP-K670N/M671L double mutation, showed reduced bombesin-induced 
intracellular Ca2+ elevations compared to controls (Gibson et al., 1997) in vitro. In vivo Ca2+ imaging 
experiments performed on aged APP transgenics carrying the 2567 mutation and on APP/PS1ΔE9 mice 
revealed that neurons in close proximity to Aβ plaques were overloaded with Ca2+ when compared to 
controls (Kuchibhotla et al., 2008). The intracellular increase of Ca2+ results from pores in the cell 
membrane formed by Aβ and are further caused by an increase in the conductance of Ca2+ channels 
(Arispe et al., 1993, LaFerla, 2002). Under resting conditions, cytosolic Ca2+ is maintained at low 
nanomolar concentrations by a variety of pumps, buffers and transport mechanisms. Ca2+ entry into the 
cytosol is strictly regulated and originates from one of two major sources: the extracellular fluid by an 
entry across the plasma membrane through receptor-, voltage- and store-operated channels as well as 
Ca2+ exchangers and second from intracellular stores such as the ER and mitochondria (Berridge, 2010). 
Ca2+ signaling is essential to support synaptic function and transmission and as learning and memory are 
based on functional synapses and intact synaptic transmission which is impaired in AD and APP mutant 
mice, the APP gene family might indeed play an important role. The Ca2+-Imaging experiments I 
performed in this thesis emphasize a role for APP/APLPs to support Ca2+ homeostasis. Thereby I 
chemically induced LTP using glycine, a NMDA-R agonist, on a timescale that was comparable to my 
electrophysiological recordings. Glycine stimulation resulted in a strong and maintained increase of Ca2+ 
signals recorded at t0, t10 and t40 when compared to ratios obtained from spontaneous activity at 
baseline time-points in littermate control cultures (Figure 3.14). Evidence and support for a long-lasting 
increase in synaptic strength following a brief application of high concentrations of glycine comes from 
studies that applied the NMDA-R agonist in acute hippocampal slices and observed increased synaptic 
potentiation upon glycine treatment when compared to tetanus-induced LTP (Shahi and Baudry, 1993, 
Shahi et al., 1993). The same group showed that the glycine protocol represents tetanically induced LTP 
in OHCs (Musleh et al., 1997) which I could reproduce in our lab (Michaelsen-Preusse et al., 2016) and 
transferred it finally to primary dissociated hippocampal cultures.   
The analysis of NexCre cDKO primary hippocampal cultures revealed impairments in Ca2+ dynamics 
before and upon chemically induced LTP by glycine when they were transduced with the control AAV-
Venus virus, but restored upon APPsα overexpression (Figure 3.14). These results are consistent with the 
electrophysiological readouts of APP/APLP2 cDKOs upon viral-vector injection and suggest that altered 
Ca2+ signaling might indeed contribute to impaired synaptic plasticity (Figure 3.9), while the frequency of 
spontaneous Ca2+ signals itself was not altered between genotypes (Figure 3.16). Furthermore, it needs 
to be considered, that NexCre cDKO neurons show reduced spine numbers with a shift from mature 
mushroom spines towards immature stubby ones which is further attended by reduced PSD95 levels 
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(Hick et al., 2015). Consistently, impaired spine density was observed in NexCre cDKO cultures 
transduced with the control virus, while APPsα overexpression rescued spine numbers to the level 
quantified in littermate controls (Figure 3.19B). Thus fewer and less functional spines might cause 
reductions in synaptic activity as the neuronal network is kept in a more immature state and is not as 
connected as in littermate cultures being in the end visible by decreased Ca2+ responses. Consistently, 
Ca2+ signaling in APP deficient astrocytes (Hamid et al., 2007, Linde et al., 2011) and fibroblasts (Leissring 
et al., 2002) was shown to be dysregulated. Further evidence comes from a mouse model of murine 
Down syndrome (Cardenas et al., 2002). In these mice the APP gene located on chromosome 16 is 
present in triplicate. Thus, a gene dosage effect caused higher intracellular Ca2+ concentrations 
paralleling the effects observed in the AD mouse model (Kuchibhotla et al., 2008). When APP expression 
was reduced to only 40% in the mouse model of Down syndrome a significant reduction in Ca2+ 
responses was observed already before cLTP induction (Rojas et al., 2008). This confirms reduced basal 
Ca2+ levels of NexCre cDKO mice at time points of spontaneous activity without any stimulation (Figure 
3.14). In conclusion the results show that APP and APLP2 are essential to maintain intracellular Ca2+ 
concentrations at time-points of spontaneous activity. Interestingly, the cDKO cultures were able to 
respond to the same extent with an increase in Ca2+ responses as observed for littermate cultures when I 
normalized cLTP responses to resting Ca2+ amounts supporting that despite described morphological 
alterations, NexCre cDKO neurons were as functional as littermate cultures regarding the ability to be 
stimulated. Consistently to what I observed in the electrophysiological recordings, APPsα rescued the 
cLTP deficit and moreover the impaired Ca2+ homeostasis at time-points of spontaneous activity, possibly 
by stabilizing intracellular Ca2+ levels (Mattson et al., 1993, Ma et al., 2009). Recently, Hefter et al. (2016) 
reported altered Ca2+ homeostasis in APP deficient mice. A transient induction of hypoxia disrupted 
electrical activity at the cellular and network level. APP-KO slices exhibited an increased rise of 
intracellular Ca2+, a faster loss of function as well as a higher incidence of spreading behavior so that the 
functional recovery upon re-oxygenation was significantly impaired. However, the selective expression of 
APPsα was able to rescue most of the alterations as well as the pharmacological inhibition of L-type Ca2+ 
channels (Hefter et al., 2016). Based on these results and the ones gained in this thesis, APPsα can 
indeed be seen as the neurotrophic functional domain of APP. Moreover, both studies highlight that not 
only morphological differences might contribute to disturbed Ca2+ handling in APP deficient mice, but 
that alterations within receptors regulating the entrance and efflux of Ca2+ as well as the function of 
internal Ca2+ stores might be regulated by APP family proteins.   
4.6.1 Alterations in ER Ca2+ Stores Contribute to Impaired cLTP in NexCre cDKO Mice  
In order to mechanistically address the question which receptors or internal stores might by affected 
upon APP and APLP2 deletion, I performed Ca2+-Imaging experiments in the presence of the sarco-
/endoplasmatic reticulum calcium ATPase (SERCA) blocker cyclopiazonic acid (CPA). The main internal 
Ca2+ stores in neurons are located in the ER and mitochondria. ER stores are refilled with cytosolic Ca2+ by 
the SERCA-ATPase, while the depletion of Ca2+ from stores is mediated by three different ways (LaFerla, 
2002). Either active G-protein coupled receptors on the plasma membrane induce an inositol-1,4,5-
trisphosphate (IP3) dependent activation of IP3-receptors or the influx of extracellular Ca
2+ into the 
cytosol triggers ryanodine receptors that in turn induce a Ca2+ induced Ca2+ release (CiCR) from the ER. 
The third option is mediated by ER leak channels composed of Sec61 core complexes enabling Ca2+ the 
efflux from the ER into the cytosol (S. Samtleben et al., 2013). The depletion of ER Ca2+ stores initiates 
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the influx of extracellular Ca2+ into the cytosol via store-operated Ca2+ channels (SOCCs) located in the 
plasma membrane. Hence, accumulated cytosolic Ca2+ is replenished and taken up in the ER by the 
SERCA ATPase. This mechanism is called capacitive Ca2+ entry and known to be implicated in the 
pathogenesis of AD (LaFerla, 2002; Leissring et al., 2000). Blocking of SERCA-ATPase activity during cLTP 
induction significantly increased Ca2+ responses in NexCre cDKO cultures transduced with the control 
AAV-Venus virus (Figure 3.15), while it prevented a stable increase in Ca2+ responses in littermate or 
NexCre cDKOs that were treated with AAV-APPsα. Based on these observations, altered SERCA-ATPase 
activity in NexCre cDKO cultures can be assumed. A possible mechanism might be that the ATPase 
pumps quite efficiently cytosolic Ca2+ in the ER so that cytosolic Ca2+ amounts are significantly lower in 
NexCre cDKO cultures. What can be excluded are potential effects of altered Ca2+ buffer protein 
expression or function as these are mainly located in inhibitory neurons of the hippocampus that 
comprise only 5 to 10 % in the cultures and their expression would take too long upon cLTP induction to 
have any influence on the experimental readout. However, evidence for the need of internal stores to 
maintain enhanced Ca2+ responses and to synchronize the network are based on the observations gained 
for littermates upon cLTP induction in the presence of CPA. The maintenance of cLTP was abolished upon 
CPA co-administration as well as a stable reduction in spontaneous Ca2+ signal frequency indicating no 
synchronization of the neuronal network. The Ca2+ store depletion is a rapid process and free Ca2+ from 
the ER and cytosol was shown to be continuously lost across the plasma membrane (Samtleben et al., 
2015). Thus Samtleben and colleagues propose that a prominent Ca2+ influx mechanism must be present 
to maintain ER Ca2+ levels at rest. This might be mediated by the already mentioned store-operated Ca2+ 
entry that is mediated by SOCCs. Continuous SOCC mediated Ca2+ entry does not need a stimulus and 
was shown to be present in neurons enabling them to balance cytosolic and ER Ca2+ levels and to 
maintain a moderate Ca2+ concentration in the ER which is essential to sustain Ca2+ oscillations (Pizzo et 
al., 2001, Samtleben et al., 2013). Interestingly, it was shown that presenilins (PSs) cause an ER Ca2+ leak 
function which is abundant in hippocampal neurons (Tu et al., 2006, Shilling et al., 2012). Defects in ER 
Ca2+ leakage were partially rescued by genetic removal of PSs causing a cell-autonomous compensatory 
upregulation of ryanodine receptors (Zhang et al., 2010). Further the study of Linde and colleagues using 
APP-KO astrocytes showed that the leakage of ER Ca2+ was significantly smaller in freshly plated 
astrocytes of APP-KOs or in WT cultures following the siRNA mediated Knock-down of APP. Moreover, 
SOCC mediated Ca2+ entry was significantly impaired in APP-KO astrocytes and further reflected by 
downregulated expression of TRPC1 (C-type transient receptor potential) and Orai1 proteins, essential 
components of SOCCs (Liou et al., 2007, Luik et al., 2008, Malarkey et al., 2008, Linde et al., 2011). Zeiger 
et al. (2013) showed a dramatic reduction in Aβ secretion using a mutant of the luminal EF-hand domain 
of stromal interaction molecule 1 (STIM1), STIM1D76A, which leads to the constitutive activation of Ca2+ 
influx even when ER stores were depleted (Liou et al., 2005). In conclusion, Ca2+ influx pathways might 
have multiple effects on APP maturation and processing and are thus essential for Ca2+ homeostasis. 
With regard to AD, the familial linked PS1 mutation increases Aβ production and was found to decrease 
SOCC activity (Yoo et al., 2000). Further it was shown that STIM2 regulates neuronal SOCCs in 
postsynaptic spines which is essential for the stability of mushroom-type spines by maintaining the 
activity of synaptically expressed CamKII. In a mouse model of AD that carries a PS mutation 
downregulated STIM2-SOCC-CamKII activity has been observed and resulted in a drastic loss of 
hippocampal spines (Sun et al., 2014). Additionally also the Knock-In of APP caused the loss of mushroom 
spine on hippocampal neurons as a result of accumulated extracellular Aβ42 in the cell culture media 
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(Zhang et al., 2015b). Zhang and colleagues (2015) argue that Aβ over-activates mGluR5 receptors in 
APP-KI neurons that cause on the one hand an elevation of ER Ca2+ levels and on the other hand a 
compensatory downregulation of STIM2 that in turn impairs synaptic SOCC function and CamKII activity. 
Overall recent publications point toward an essential function of SOCC activity to support normal Ca2+ 
handling in neurons which might be regulated in different ways by APP family proteins and their 
proteolytic domains. 
4.6.2 Evidence for Altered SOCC-Activity in NexCre cDKO Cultures  
Several studies indicate that neuronal SOCC function is indispensable for Ca2+ homeostasis (Pizzo et al., 
2001, Samtleben et al., 2013) and that APP family members might influence SOCC activity (Linde et al., 
2011, Zhang et al., 2015b) as for a number of AD models impaired  Ca2+ handling has been reported (Yoo 
et al., 2000, Sun et al., 2014, Zhang et al., 2015a). In order to investigate if SOCC activity might be altered 
upon APP and APLP2 conditional deletion, I performed Ca2+-Imaging experiments in the presence of the 
sarco-/endoplasmic reticulum calcium ATPase (SERCA) blocker cyclopiazonic acid (CPA) and modified the 
extracellular Ca2+ concentration in the perfusion medium. The simple reduction of external Ca2+ from 
around 4 to 1 mM resulted in a decline of spontaneously occuring cytosolic Ca2+ elevations for NexCre 
cDKOs transduced with AAV-Venus and APPsα. Interestingly, while the re-addition of external Ca2+ 
revealed a full recovery of intracellular Ca2+ amounts in the presence of APPsα at time-points of 
spontaneous activity, only a partial recovery was observed in NexCre cDKOs treated with the control 
virus (Figure 3.17A-C). To examine then moreover the contribution of intracellular ER Ca2+ stores within 
that refilling process, ER stores were unloaded by co-administration of the SERCA-ATPase blocker CPA 
while cells were perfused with HBSS containing low Ca2+ (1.3 mM). The observation of spontaneous Ca2+ 
signals evoked by restoration of external Ca2+ when the SERCA ATPase of the ER was moreover blocked 
allowed the examination of the SOCC dependent Ca2+ entry (Parekh and Putney, 2005, Linde et al., 2011). 
Remarkably, I was only able to observe a SOCC dependent Ca2+ entry in NexCre cDKOs transduced with 
AAV-syn-APPsα-Venus, while cDKOs treated with the control virus failed to restore basal Ca2+ levels at 
time-points of spontaneous activity (Figure 3.17A-C). NexCre+AAV-syn-Venus cultures showed even a 
small decline in the change of intracellular Ca2+ levels during spontaneous activity indicating that the 
SOCC-dependent Ca²+ entry might be impaired upon APP and APLP2 deletion. However, it needs to be 
taken into account that changes in Ca²+ dynamics occur on a very rapid timescale in neurons and are 
regulated by a variety of channels so that important Ca²+ dynamic contributors might not be addressable 
with this method. 
In another experimental set I moreover excluded the impact of voltage-gated Ca2+ channels (VGCCs) 
which are expressed in the cell membrane and are almost exclusively conductive for Ca2+ (Zuccotti et al., 
2011). When VGCCs were blocked by co-application of Nifedipine no differences in the change of  Ca2+ 
levels between cultures treated with control and APPsα virus was detectable when simply reducing and 
restoring extracellular Ca2+ amounts in the perfusion medium (Figure 3.17D-F). Quantification of Ca2+ 
concentrations revealed for both cultures only a partial restoration in the change of intracellular Ca2+ 
amounts at spontaneous activity. These results indicate that the additional increase observed for APPsα 
transduced cultures upon external Ca2+ reconstitution without VGCC blocker might be mediated by 
enhanced VGCC function and are maybe driven by the non-amyloidogenic APP extracellular domain. 
From the literature it is known that the expression of Cav1.2 L-type VGCC channels is driven by Aβ 
(Webster et al., 2006) and its blockage has been identified as a potential pharmacotherapeutical target 
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for AD (Anekonda and Quinn, 2011, Lovell et al., 2015). APPsα contains the sequence of Aβ which might 
alter Cav1.2 function while APP deficiency prevented the production of Aβ in NexCre cultures. Moreover, 
it was shown that APP directly regulates Cav1.2 channels in cultured GABAergic neurons of the 
hippocampus and striatum with APP deletion leading to aberrant activity of Cav1.2 that resulted in 
altered short-term plasticity (Yang et al., 2009). Further evidence for APP to modulate VGCC function is 
based on impaired Ca2+ oscillations upon human APP expression in rat primary cortical neurons (Santos 
et al., 2009) and by the neuroprotective role of APP to regulate VGCC activity in response to hypoxia 
(Hefter et al., 2016). Nevertheless, a balanced activity of Ca2+ channels to maintain Ca2+ homeostasis is 
the key role that might be regulated by APP/APLP2 and their proteolytic peptides in different ways. 
APPsα is in this regard the extracellular domain mediating neuroprotective and neurotrophic effects, 
whereas amyloidogenic cleavage products cause harmful events. This in turn implicates that a shift in 
APP cleavage disturbs the balance and causes a loss of neuroprotective functions driving disease 
development.  
 
4.7  The 16 Amino Acid Difference between APPsα and APPsβ Mediates the 
Neurotrophic Peptide Functions     
Compared to APPsα, APPsβ lacks the 16 amino acids present at the N-Terminus of the Aβ peptide 
(Chasseigneaux et al., 2011). Only a few studies in the literature focused on the physiological role of 
APPsβ and most of them could not show any effect when compared to APPsα (Copanaki et al., 2010, Hick 
et al., 2015). Nevertheless, trophic effects for APPsβ have been reported albeit overall less efficient than 
those exerted by APPsα. APPsβ seems to be more potent than APPsα to induce neuronal differentiation 
of pluripotent stem cells (Freude et al., 2011) and was demonstrated to stimulate the activation of 
microglia (Barger and Harmon, 1997) as well to promote neurite outgrowth in vitro (Chasseigneaux et al., 
2011). Notably, APPsβ was shown to undergo further cleavage resulting in a 35 kDa APP peptide which 
binds to the death receptor 6 resulting in the activation of caspase-6 and thus mediating deleterious 
effects resulting in neurodegeneration (Nikolaev et al., 2009). Evidence pointing to a role of APP 
fragments in processes of synaptic plasticity arose from the observations that APP processing by α- and 
β-secretase is activity-dependent (Nitsch et al., 1993, Fazeli et al., 1994, Kamenetz et al., 2003, Gakhar-
Koppole et al., 2008) and can thus be potentiated by neuronal depolarization or high frequency 
stimulation (HFS). APPsα was shown to facilitate LTP within several studies, while APPsβ had no influence 
(Ishida et al., 1997, Taylor et al., 2008, Hick et al., 2015, Moreno et al., 2015). Together with the findings I 
gained within that thesis, that viral driven overexpression of APPsα rescued LTP in APP/APLP2 deficient 
and AD model mice and restored moreover impairments in Ca2+ homeostasis, several evidence exists 
that APPsα is crucial for normal synaptic function. The 16 C-terminal amino acids present in APPsα but 
not in APPsβ could cause a shift in functionality or alter the conformation of the peptide in a critical way 
and thereby modify its signaling (Ludewig and Korte, 2017). To elucidate if the functional differences 
arise from the additional amino acids, I investigated the role of the synthetized 16 amino acid murine 
peptide (recAβ1-16) in processes of activity-dependent synaptic plasticity (chapter 3.8). The exogenous 
application of recAβ1-16 was sufficient to restore the pronounced deficit in induction and maintenance 
of LTP in NexCre cDKO mice (Figure 3.20A, B) that was still present in acute slices treated with the 
scrambled and therefore inactive version of the peptide. Moreover, recAβ1-16 enhanced like APPsα 
short-term plasticity without altering the function of the postsynapse indicating that Aβ1-16 might be 
 94 | D i s c u s s i o n  
 
the neurotrophic domain of APPsα as also the direct functional comparison of APPsα and recAβ1-16 
revealed no modulatory differences in electrophysiological recordings (Figure 3.23). In line with these 
observations are the reports concerning the short functional domain Aβ1-15 (or Aβ1-16) which was 
shown to be generated by successive α- and β-secretase activity (Portelius et al., 2011). Aβ1–15 
significantly enhanced PTP and LTP without altering baseline synaptic transmission at femtomolar 
concentrations, while higher amounts had no effect on hippocampal LTP (Lawrence et al., 2014). A dose-
dependent activity was also shown for APPsα, with low picomolar and very high nanomolar 
concentrations having no effect on fEPSP strengthening that is dependent on NMDA-R activity (Taylor et 
al., 2008, Ryan et al., 2013). Besides the facilitation of LTP by Aβ1-15 in WT mice, Lawrence and 
colleagues (2014) further showed that the short APP fragment is able to rescue LTP deficits that are 
caused by synthetically applied Aβ42 or present in APP/PS1 tg AD model mice. The latter supports my 
results gained following the viral driven overexpression of APPsα in APP/PS1 tg mice which might be 
caused by the 16 amino acid sequence.   
Interestingly, Lawrence et al. (2014) documented that Aβ-15 injection in the dorsal hippocampus 
augmented contextual fear conditioning in wildtype mice which was attenuated by the co-administration 
of the nicotinic antagonist methylcaconitine (MLA). While for APPsα a putative receptor still remains 
elusive two possible targets at the synapse have been proposed for the amyloidogenic Aβ peptide itself. 
Aβ contains like APPsα the 16 amino acids that are absent in APPsβ. Potential targets are the nicotinic 
acetylcholine receptor (nAChR; (Wang et al., 2000a, Liu et al., 2001, Pettit et al., 2001) and certain 
metabotropic glutamate receptors (Chin et al., 2007). The agonist-like action of Aβ regulating synaptic 
plasticity was suggested to happen at presynaptically expressed nAChRs (Dougherty et al., 2003, Mehta 
et al., 2009) especially via the alpha-7 subtype (Tong et al., 2011). Consistently, the acute and chronic 
administration of nicotine enhanced memory (Levin and Simon, 1998) and increased LTP (Fujii et al., 
2000) not only in animal models of AD, but was moreover shown to improve cognition in AD patients 
(Newhouse et al., 1988). Interestingly, Aβ and the α7-nAChR are both present in neuritic plaques and 
were shown to co-localize in neurons of the cortex in pathological brain material of AD patients (Wang et 
al., 2000a, Wang et al., 2000b). The α7-nAChR is abundantly expressed in neurons of the basal forebrain 
which projects to the hippocampus and cortex, the brain areas exhibiting severe plaque pathology in AD 
(Wang et al., 2000b). Overall, there is strong evidence that α7-nAChR activity plays a critical role in the 
pathogenesis of AD: Aβ induced LTP deficits were shown to be caused by a deterioration of α7-nAChRs 
activity (Chen et al., 2006b), while functional α7-nAChRs augment memory formation in the 
hippocampus of AD mouse models through an acute influx of Ca2+ (Hunter et al., 1994, Wang et al., 
2000b). In this regard the α7-nAChR might be a possible target also for APPsα and Aβ1-16. Beside MLA 
also α-Bungarotoxin (α-BTX) is a highly selective antagonist for the α7-nAChR and often administered 
during acute hippocampal slice recordings (L. Chen, Yamada, Nabeshima, & Sokabe, 2006; Criscuolo, 
Accorroni, Domenici, & Origlia, 2015; Puzzo et al., 2008). The application of 10 nM α-BTX significantly 
reduced LTP initially as well as its maintenance confirming that the α7-nAChR is involved in mechanisms 
of synaptic plasticity under control conditions (Figure 3.21A’’, B’’) consistently to what is observed in the 
literature (Chen et al., 2006b, Criscuolo et al., 2015). In contrast, the inhibition of the α7-nAChR 
interfered only slightly with Aβ1-16 action in APP/APLP2 cDKO mice (Figure 3.21A’, B’). Further testing 
for a presynaptic action of Aβ1-16 by the PPF paradigm revealed that blocking of the α7-nAChR does not 
alter presynaptic function, neither in the presence of Aβ1-16 nor in LMs (Figure 3.21C’,C’’). This might be 
due to the fact that α-BTX treatment might have additional modulatory effects on postsynapses as α7-
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nAChRs are also expressed at these synaptic compartments (Orr-Urtreger et al., 1997). Furthermore, the 
acute inhibition by α-BTX might just have been to short or at the wrong time, so that during the one hour 
Aβ1-16 pre-incubation already modulatory effects in the hippocampal slices could have happen and thus 
mask potential effects during the acute inhibition of the α7-nAChR. Conceivable effects could here be 
the activation of kinases which modulate α7-nAChRs or other receptors. To circumvent this problem, I 
simultaneously pre-incubated the α7-nAChR blocker α-BTX with Aβ1-16 preventing a possible interaction 
of Aβ1-16 with the nicotinic receptor already during the one hour pre-incubation period with the peptide 
alone. This experimental setup showed that the α7-nAChR is a potential target for Aβ1-16 as activity-
dependent synaptic plasticity was impaired, while I could not observe any effects regarding baseline 
synaptic transmission or STP (Figure 3.21). Nevertheless, an important point that needs to be considered 
are dose-dependent effects that are not only mediated by the APP peptide (Wang et al., 2000a, Taylor et 
al., 2008, Lawrence et al., 2014), but also by the inhibitors applied (Chen et al., 2006b).  
Overall the results obtained by recAPPsα and recAβ1-16 application on acute hippocampal slices of 
APP/APLP2 deficient mice provide evidence for a neurotrophic role of both peptides, positively 
modulating synaptic plasticity. With regard to therapeutic treatment of AD, the smaller Aβ1-16 peptide 
has several advantages. It would be easier to apply than APPsα as direct stereotactical injections needed 
to deliver the longer peptide into the brain could be circumvented as Aβ1-16 might directly cross the 
blood-brain-barrier. Thereby a more efficient sequence of action can be achieved. Nevertheless the 
detailed mode of action of APPsα and Aβ1-16 would need to be first of all to be clarified in detail as the 
inhibition of α7-nAChR function did not reveal any changes in presynaptic transmission that was clearly 
modulated by both peptides and so far hypothesized to be the basis for the LTP rescue in APP/APLP2 
cDKO and AD mice.       
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4.8  Conclusion and Outlook 
In this thesis I could show an indispensable role of the APP protein family in the rodent CNS during 
development as well as in the mature and aging brain. The so far less attended, but exclusively neuronal 
expressed APP homolog APLP1 was shown to have an age-dependent role in maintaining basal synaptic 
transmission at postsynapses in aged animals. These results highlight that each APP family member has 
individual roles at synaptic compartments and that impairments at young ages might be compensated by 
the two other gene members. It would be essential to test whether synaptic alterations are caused by 
impaired structural or functional plasticity upon APLP1 deletion. Analysis of spine density representing 
the number of excitatory synapses would indicate if aging decreases the number of active synapses in 
APLP1-KO mice. Moreover, interaction studies regarding APLP1 and postsynaptic surface receptors like 
the NMDA-Rs would provide insights about signaling cascades triggered which might be different to the 
ones by APP and APLP2.  
I further successfully reproduced the previously described developmental role of APP and APLP2 in 
excitatory principle neurons regarding synaptic plasticity. I demonstrated that the additional conditional 
co-deletion of APLP1 caused an even more severe synaptic phenotype. Beside a highly pronounced 
deficit in induction and maintenance of LTP, APP cTKO mice yielded heavily impaired basal synaptic 
transmission at the postsynapse additionally to already altered presynaptic function observed in 
APP/APLP2 (NexCre) cDKO animals. As I noticed during hippocampal slice preparations alterations in the 
shape of the hippocampus and massive changes in the CA1-CA3 cell body layer suggesting atrophy, it is 
necessary to perform a detailed morphological characterization of APP cTKO brains. Impairments in 
neuronal architecture would influence functional synaptic plasticity and should thus be verified.   
One more important finding of this thesis is the interaction of Fe65 family proteins downstream to 
APP/APLPs. Not only that Fe65/Fe65L1 double deficient mice show a similar phenotype of cortical 
dysplasia as APP triple KO animals, they also reveal impaired activity-dependent synaptic plasticity when 
Fe65 and FE65L1 (like APP and APLP2) are co-deleted. It could therefore be assumed that Fe65/Fe65Ls 
mediate downstream signaling of APP/APLPs at the synapse. Nevertheless, for a complete and clear 
picture it would be necessary to study additional combined DKOs of APP and Fe65 family members to 
underscore the role of both and their interaction in the central nervous system.    
Another key finding gained within this thesis is the neurotrophic role of the APP extracellular domain 
APPsα. Exogenous application of recombinant APPsα consistently restored impaired LTP in NexCre cDKO 
acute hippocampal slices as already reported. Furthermore, the re-expression of APPsα by AAV viruses 
upon their stereotactic injection rescued activity-dependent synaptic plasticity and restored presynaptic 
function in the hippocampus of APP/APLP2 cDKO mice. These results indicate that APPsα might 
modulate the presynaptic transmitter release or increases the amount of vesicles in the ready releasable 
pool in the presynapse additional to the described facilitation of NMDA-R currents at postsynapses. 
Moreover, I demonstrated that viral driven expression of APPsα in aged AD model mice, with already 
established plaque pathology and cognitive impairments, rescued impaired LTP and restored the 
functionality of the presynapse. Additionally, I showed that APPsα ameliorated spine density in 
APP/PS1∆E9 tg mice and NexCre cDKO primary hippocampal cultures. Overall these results emphasize 
that APPsα is essential for proper neuronal function and that decreased levels of the proteolytic APP 
peptide might contribute to impairments in activity-dependent synaptic plasticity in rodents. As APPsα 
re-expression is able to functionally restore synaptic plasticity and rescue spine density, it might be a 
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potential therapeutic target for AD and other neurodegenerative diseases. The investigations of the 16 
amino-acid shorter APPsβ peptide which was comparably re-introduced in the hippocampus of NexCre 
cDKO mice and AD model mice revealed that it has no potential to rescue deficits in LTP or spine density, 
highlighting that the functional domain might be located within the short sequence difference of both 
extracellular APP domains.   
Interestingly, I could indeed show that the application of the synthesized amino acid sequence, building 
the difference between APPsα and APPsβ, enhanced LTP to the same extent like recAPPsα when applied 
on acute hippocampal slices of NexCre cDKO mice and thus rescued activity-dependent synaptic 
plasticity in this gene-targeted APP mouse model. As moreover presynaptic function was improved by 
recAβ1-16 several evidence exists to assume that this amino acid sequence harbors the neurotrophic 
properties of APPsα and builds the functional difference to APPsβ. Still further work is needed to 
examine how these 16 amino acids cause the shift in functionality. A thinkable phenomenon might be a 
conformational change resulting from the C-terminal sequence elongation in APPsα modifying its 
signaling. To elucidate potential interaction partners of APP proteolytic and functional domains, pull-
down assays could be performed with APPsα, APPsβ and Aβ1-16.   
The experiments regarding neuronal Ca2+ signaling suggest that impairments in Ca2+ handling might 
contribute to a variety of neurodegenerative disorders including AD. I could show that APP and APLP2 
deficiency causes severe alterations in Ca2+ homeostasis paralleling the impairments in activity-
dependent synaptic plasticity. In this regard I demonstrated once again the neuroprotective role of 
APPsα restoring normal Ca2+ levels during time-points of spontaneous activity in NexCre cDKO primary 
hippocampal cultures. Virally expressed APPsα moreover prevented the deficit in induction and 
maintenance of chemical LTP in cultured neurons. Besides morphological differences, that are well-
characterized for these APP/APLP2 cDKOs also receptors and internal stores balancing intracellular Ca2+ 
levels were shown to be regulated by APP family proteins. In detail, I could show that NexCre cDKO 
cultures reveal altered SERCA-ATPase activity of the endoplasmatic reticulm (ER). A thinkable mechanism 
might be that the ATPase pumps quite efficiently cytosolic Ca2+ in the ER, so that cytosolic Ca2+ amounts 
are significantly lower in NexCre cDKO cultures. While it seems unlikely that altered Ca2+ buffer protein 
expression contribute to reduced Ca2+ levels at rest, Western Blot analysis could reveal if protein 
expression of calbindin, calretinin, parvalbumin or calmodulin are different in NexCre cDKOs. However, 
the results gained for littermates upon cLTP induction in the presence of CPA evidence the need of 
internal stores to maintain enhanced Ca2+ responses and to synchronize neuronal networks. Moreover 
essential is the continuous SOCC mediated Ca2+ entry which doesn´t need a stimulus and was shown to 
be altered in APP/APLP2 deficient cultures. As the SOCC dependent Ca2+ influx was shown to be present 
in neurons enabling them to balance cytosolic and ER Ca2+ levels and to maintain a medium-high Ca2+ 
concentration in the ER, Ca2+ oscillations might be affected upon APP and APLP2 co-deletion by impaired 
SOCC function. I could further show that APPsα was able to partially restore SOCC-mediated Ca2+ entry 
and that it might modulate VGCC function in vitro. Overall my Ca2+ imaging results indicate that a 
balanced activity of Ca2+ channels to maintain Ca2+ homeostasis is the key role that might be regulated by 
APP and APLP2 and their proteolytic peptides in different ways. APPsα is in this regard the extracellular 
domain mediating neuroprotective and neurotrophic effects, whereas amyloidogenic cleavage products 
cause harmful events. This in turn implicates that a shift in APP cleavage disturbs the cellular 
homeostasis and causes a loss of neuroprotective functions driving disease development. 
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6 List of Abbreviations  
 
AAV    Adeno-associated virus 
AC    Adenylyl cyclase 
ACFS     Artificial cerebrospinal fluid 
AD     Alzheimer’s disease 
ADAM     A disintegrin and metalloproteinase 
AICD    APP intracellular domain  
AM    Acetoxymethyl 
AMPA-R    α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic receptor 
APLP    Amyloid precursor protein-like protein 
APP    Amyloid precursor protein 
APPsα or sAPPα  secreted Amyloid precursor protein ectodomain after α-secretase 
    cleavage 
APPsβ or sAPPβ  secreted Amyloid precursor protein ectodomain after β-secretase 
    cleavage 
APV    2-amino-5-phosphonopentanoic acid 
Aβ    amyloid ß 
Aβ1-16    C-terminal 16 amino acid sequence of APPsα 
BACE     β-site APP cleaving enzyme 
BDNF    Brain-derived nerve neurotrophic 
CA     cornu ammonis (hippocampal subfields) 
CaMKII    Calcium / calmodulin-dependent kinase II 
cDKO    Conditional double knock-out 
cKO    Conditional knock-out 
cLTP    chemically induced long-term potentiation 
cTKO    Conditional triple knock-out 
CNS    Central nervous system 
CPA    Cyclo piazoic acid 
DG     Dentate gyrus 
DIV    Days in vitro 
DKO    Double knock-out 
DM    Double mutant 
DMSO    Dimethyl sulfoxide 
EC    Entorhinal cortex 
(f)EPSP     (Field) excitatory postsynaptic potential 
ER    endoplasmatic reticulum 
FV    Fiber volley 
GABA     γ-aminobutyric acid 
IP3R    Inositol-1, 4, 5-tris-phosphate receptor 
ISI    Inter-stimulus interval 
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KI    Knock-in 
KO     Knock-out 
LFS    Low-frequency stimulation 
L-LTP    Late-long-term potentiation 
LM    littermate 
LTD     Long-term depression 
LTP     Long-term potentiation 
mEPSC    miniature excitatory postsynaptic potential 
Nex    neuronal helix-loop-helix protein 1 
NFT    Neurofibrillary tangles 
NGF    Nerve growth factor 
NMDA-R    N-methyl-D-aspartate receptor 
NO    Nitric oxide 
n.s.    Not significant 
OHC     Organotypic hippocampal culture 
p75NTR    Pan neurotrophin receptor 75 
P    postnatal day 
PPD    Paired pulse depression 
PPF    Paired pulse facilitation 
PSD    Postsynaptic density 
PSEN    Presenilin 
PTP    Post-tetanic potentiation 
PKA    Protein kinase A 
rec    recombinant 
ROI    Region of interest 
RRP    Readily releasable pool 
RT    Room temperature 
RyR    Ryanodine receptor 
SEM    Standard error of the mean 
SERCA    sarco / endoplasmic reticulum calcium-ATPase 
SOCC    store-operated Ca2+ channel 
TBS     Theta-burst stimulation 
TrkA    Tropomyosin receptor kinase A 
VGCC    Voltage gated calcium channel 
wt     Wildtype 
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